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SUMMARY
The definition of the anaesthetic state is discussed. 
We see the anaesthetic state as a central nervous system 
state, which results from the interaction between the 
effects of anaesthetic dose and the effects of surgical 
stimulation on that system. However, the effects of 
surgical stimulation, although they may be described as an 
ordered sequence of events, cannot be quantified. And the 
wide variation in anaesthetic requirement means that 
anaesthetic dose can, at best be, defined with respect to 
a single point (or points) on a qualitative scale. It is 
therefore difficult to assess the various techniques 
proposed as monitors of the anaesthetic state.
These techniques are reviewed and it is apparent, 
that without a clear definition of the anaesthetic state, 
these techniques cannot be fully assessed. There is 
therefore a need for an individually valid anaesthetic 
state ("gold standard") to which other methods can be 
compared.
Clinical signs form the basis for the administration 
of thousands of successful anaesthetics each day and, 
d esp i te  some inadequacies, are currently the only 
practical, universally accepted indicators of anaesthetic 
adequacy. However, their interpretation is both subjective 
and variable. A reproducible, individualised description 
of the anaesthetic state, based on clinical signs would 
allow this and other techniques to be more fully assessed.
The objective of the work presented in this thesis 
was to investigate whether a c linically acc ep ta bl e 
anaesthetic state could be produced by a control system
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designed to maintain the patients systolic arterial 
pressure (SAP) at a predetermined level by altering the 
inspired concentration of enflurane or isoflurane. Such a 
control system, though limited in that it uses only one 
clinical sign, should help to standardise the management 
of the anaesthetic state.
A proportional - integral control system was set up 
with an RML 380Z-D computer interfaced to a Critikon 
Dinamap 1846 and a vaporizer controller. A program, 
written in BASIC, was designed to maintain the patients 
SAP at 90% of that predicted from age and sex standardised 
tables. The controller took data from the Dinamap, which 
was set to cycle at one minute intervals, and changed the 
inspired v ol atile concentration via the vaporizer 
controller.
In a p r e l i m i n a r y  s t u d y  s o m e  p a t i e n t s  w e r e  
h ypoten si v e,  relative to the target SAP, following 
induction but prior to surgery. These patients therefore 
received minimal concentrations of volatile anaesthetic 
initially. Others received a r el ative overdose of 
anaesthetic during the procedure. Two additional rules 
were incorporated in the control algorithm to limit these 
effects. First, a minimum inspired concentration of 0.6% 
was delivered for the first 10 minutes and second, if the 
inspired dose of volatile anaesthetic exceeded a preset 
limit, the controller instructed the anaesthetist to give 
a bolus of morphine and reset the integral. This limit was 
defined as a total inspired concentration of more than 15% 
over 5 consecutive vaporizer settings with each individual 
setting exceeding 2.5%. This rule could only be activated
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once in 15 minutes.
The study was carried out on 57 ASA I and II female 
patients admitted for routine gynaecological surgery. All 
patients were artificially ventilated and received a 
standard, nitrous oxide based anaesthetic supplemented 
with morphine at induction, and enflurane (22 patients) or 
isoflurane (35 patients). The dosage of volatile 
anaesthetic and the requirement of additional morphine 
were determined by the controller.
During surgery cardiovascular data and the inspired 
volatile requirement were recorded every minute and 
clinical signs "scored". Recovery times were measured and 
all patients interviewed post-operatively to discover 
whether they had been aware during anaesthesia.
An adequate anaesthetic state was defined by strict 
criteria based on cardiovascular variables, the goodness 
of control, recovery time and absence of awareness post- 
operatively. No patient recalled any intraoperative event. 
Overall, 53.8% of cases satisfied all criteria. A failure 
to achieve two or more of these criteria occurred in 7.5% 
of patients in the groups not requiring additional 
morphine compared to 83.3% of the patients who did require 
additional morphine.
The use of SAP as the sole variable to control the 
delivery of anaesthetic agents, can be criticised on 
s e v e r a l  g r o u n d s .  H o w e v e r ,  it is one of the few 
quantifiable indices available and increases in SAP are 
commonly treated with anaesthetic agents. Further, we 
carefully excluded those cases in whom SAP is likely to 
unreliable e.g. hypertensive patients.
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Although our method of selecting the TSAP is crude, 
and those patients who required additional morphine may 
reflect those in whom the TSAP is low, the controller 
achieved the immediate aim of controlling SAP and also 
produced a pattern of clinical signs recognisable as 
general anaesthesia.
Pupil di am et er  was measured in 34 patients. A 
significant correlation was found between pupil diameter 
and SAP in 5 cases. There was no dif fe re n ce  in the 
clinical anaesthetic state in those patients in whom a 
significant correlation was found and those in whom there 
was no significant correlation.
Spectral edge frequency (SEF) was measured in eight 
of the patients who received isoflurane using a Neurotrac 
monitor. Due to limitations in data recording we were not 
able to correlate SEF with SAP. However, SEF was plotted 
against SAP for seven patients during relatively stable 
periods of SAP control. A visual relationship was apparent 
between SAP and SEF in 4 cases. The significance of this 
finding is unknown. In a further case the EEG became 
isoelectric at the time a morphine bolus was requested by 
the computer. The processed EEG may be a better method of 
assessing a relative anaesthetic overdose than SAP alone 
during nitrous oxide-morphine-isoflurane anaesthesia.
In summary, a computer control system has been 
d e v el op ed  and tested. The c on troller achieved the 
immediate aim of controlling SAP and also produced a 
p attern of clinical signs reco g ni sa bl e as general 
anaesthesia.
INTRODUCTION
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WHAT IS "GENERAL ANAESTHESIA" ?
The introduction of the word "anaesthesia" into the 
English language is generally attributed to Oliver Wendell 
Holmes. It is currently defined in the Oxford dictionary 
as "Absence of sensation, esp. artificially induced 
insensibility to pain". This definition of "Anaesthesia" 
refers only to sensory block, and as such does not clearly 
define the state induced by, or the objectives of, general 
anaesthesia. Although the introduction of new terminology 
has been suggested (1), the term is deeply entrenched and 
it is now more appropriate to redefine what the term 
"general anaesthesia" actually implies.
A HYPOTHETICAL DEFINITION OF THE STATE OF ANAESTHESIA.
The anaesthetic state is a functional state of the 
central nervous system which results from the interaction 
between anaesthetic drugs and surgical stimulation. 
As a d e q u a t e  g e n e r a l  a n a e s t h e s i a  e x i s t s  w h e n  the 
anaesthetic state is appropriate for surgery, the true 
definition of anaesthesia will be synonymous with the 
criteria which define this state. Therefore, anaesthesia 
should ideally be defined with reference to a specific 
level (or levels) of central nervous system activity.
However, although the intra-operative anaesthetic 
state, as we see it, results from the "balance" between 
the effects of surgical stimulation and the effects of 
anaesthetic dose on the central nervous system, it is not 
known if any of the methods proposed as as monitors of 
anaesthetic adequacy truly reflect this balance, if they 
monitor it completely or what level (or levels) of CNS
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activity are most appropriate during general anaesthesia 
and surgery. Therefore, anaesthesia cannot currently be 
defined in these terms.
It should be noted that this hypothesis assumes that 
an "ideal" anaesthetic state can be described which is 
appropriate to all patients and all types of surgery, and 
that the d eterminants of the anaesthetic state are 
anaesthetic dose and surgical stimulation.
ALTERNATIVE DEFINITIONS OF ANAESTHESIA.
White recently described general anaesthesia as "... 
a reversible state of depression of the central nervous 
system of such a degree that consciousness is lost and 
that on recovery nothing is recalled relating to the 
period of anaesthesia " (2). This approach is fraught with 
difficulty as it involves circular arguments. Not only 
must each individual aspect of the definition be defined 
before the description can have any real meaning, but also 
these criteria may be fulfilled during surgery when the 
patients degree of responsiveness suggests that the 
anaesthetic state is inadequate i.e. when the clinical 
signs are untruthful.
Prys-Roberts (3) has argued that the only common 
e f f e c t  of all g e n e r a l  a n a e s t h e t i c  a g e n t s  is "the 
suppression of perception" and, that anaesthesia should be 
considered as "that state which ensures the suppression of 
the somatic and visceral sensory components [to the 
noxious effects of surgical stimulation], and thus the 
perception of pain". And he suggests that analgesia, 
muscle relaxation and the suppression of a u t o no mi c 
activity should not be considered as compon e nt s of
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anaesthesia (4,5) but as desirable supplements to the 
anaesthetic state. As the perception of any sensation 
r e q u i r e s  an a w a r e n e s s  of t h a t  s e n s a t i o n  ( i.e.  
consciousness) this definition is, in essence, identical 
to that of White.
These definitions seem to imply that the only 
necessary "component" of anaesthesia is lack of awareness. 
It follows, that the anaesthetic state which achieves this 
objective, in conjunction with the suppression of 
peripheral responses to surgical stimulation by non­
anaesthetic drugs (e.g. vasodilators and adrenergic 
blocking drugs), would be considered adequate. While this 
may be true, the author believes that the "ideal" 
a n a e st h et i c  state is likely to require the central 
suppression of more than memory function.
THE OBJECTIVES OF GENERAL ANAESTHESIA
The objective of general anaesthesia is to safely 
provide the best possible conditions for surgery. The 
anaesthetist therefore aims to produce a reversible state 
which includes:
1 Hypnosis, that is the patient should have no recall 
of intra-operative events.
2 M a i n te n an c e  of physiological variables within 
boundaries, defined by himself for each case, and 
which depend on:
a) Patient factors ie disease status.
b) Surgical factors e.g. the provision of 
hypotension or muscle relaxation.
(continued)
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3 The degree of reflex s up pression to surgical 
stimulation necessary to attain the first and second 
goals.
4 A safe and comfortable post-operative recovery, which 
can be defined as the rapid recovery of protective 
reflexes, p hysiological stability and adequate 
analgesia.
DEFINING ADEQUATE GENERAL ANAESTHESIA.
A d e q u a t e ,  as o p p o s e d  to i n a d e q u a t e ,  g e n e r a l  
anaes t he si a may be defi n ed  as the i n tr a- operative  
a n a e s t h e t i c  state w h i c h  a l l o w s  t h e se  g o a l s  to be 
fulfilled. Modification of these goals is necessary when 
specific types of surgery, drugs or pathological condition 
are considered e.g. a rapid recovery may not be a 
desirable objective following maxillofacial surgery. In 
general failure to achieve these objectives implies that 
the anaesthetic state induced was inadequate. As 
achievement of these goals cannot be confirmed until the 
post-operative period "anaesthesia" is a retrospective 
diagnosis.
The quality of anaesthesia may be considered relative 
to these goals and considered adequate or inadequate. And, 
if inadequate, as insufficient or excessive i.e. the 
d i ff e re nc e between the a n ae st h e t ic  state and these 
anaes t he ti c goals is the basis, of the concept, of 
anaesthetic depth.
THE CONCEPT OF ANAESTHETIC DEPTH.
Depth of anaesthesia is a concept used to describe a 
patients anaesthetic state relative to an assumed scale
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which could range from full consciousness to death. 
Although this scale is related to anaesthetic dose, 
individual variations in drug response and the confounding 
effects of drug combinations and surgical stimulation mean 
that the relationship is not simple.
As the mechanism of action of anaesthetic drugs is 
unknown, no technique can be proven to assess anaesthetic 
depth. Further, if the depression of multiple nervous 
system sites is necessary or desirable for the achievement 
of adequate general anaesthesia then assessment of 
'anaesthetic depth' may involve more than one technique 
and more than one scale.
With this in mind it is reasonable to describe any 
t e c h n i q u e  w h i c h  i m p r o v e s  the d e s c r i p t i o n  of the 
anaesthetic state, and therefore allows the objectives of 
general anaesthesia to be more reliably attained, as a 
monitor of anaesthetic depth.
THE DEFINITION OF SOME POINTS ON THE ANAESTHETIC SCALE.
If a single scale can be used to describe the 
anaesthetic state then some points can be provisionally 
identified (Figure 1).
CONSCIOUSNESS.
At induction and during recovery a transition between 
the conscious and unconscious states occurs. Consciousness 
is however difficult to define. The definition most 
relevant to this aspect of anaesthesia depends on the 
ability of a patient to register, integrate and recall 
information from his memory. Aspects of consciousness 
assessed by other mental functions (e.g. arithmetic
increasing Dose
DAO
 ZSA----------
Figure 1.
Some points on the anaesthetic scale
C = Conscious 
DAO = Dangerous anaesthetic overdose 
ZSA = Zone of surgical anaesthesia 
(see text for details)
Death
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performance) or by psychomotor reaction times are 
irrelevant during anaesthesia while definitions relating 
to enviromental inter-action (e.g. responses to pain) are 
only important if patient should move (disrupting surgery) 
or recall the precipitating event (e.g. skin incision). 
U n c o n sc i o u s n e s s  will occur when one or more of the 
processes involved in memory function is disrupted to the 
necessary degree.
DANGEROUS ANAESTHETIC OVERDOSE.
Dangerous anaesthetic overdose is a more clinically 
relevant end-point than death and may be defined as the 
dose of anaesthetic at which physiological parameters 
(e.g. blood pressure) cannot be maintained within safe 
limits. These limits will depend on patient factors (e.g. 
hypertension or cerebro-vascular disease), drug factors 
(e.g. the concomitant use of vaso-di lators or beta- 
blockers) and anaesthetic technique (e.g. ventilated or 
non-ventilated patients).
A ZONE OF ANAESTHESIA.
Between these ill-defined extremes a zone of surgical 
anaesthesia (ZSA) can be described. This zone may be 
defined as the spread of drug dose over which all the 
anaesthetic goals defined above are achieved.
DEFINING THE OF THE ZONE OF ANAESTHESIA.
Individual anaesthetists achieve the goals of 
anaesthesia in most of their patients. Each anaesthetist 
does this by anaesthetising to his/her own personal 
"standard" and it follows that each anaesthetist can 
clinically identify a ZSA, for individual patients, with
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the techniques he uses. The exact location and best 
definitions for the boundaries of this zone are unknown 
but, in the establishment of their personal standard, 
general 'thresholds' of response (the limits within which 
an anaesthetist allows a variable or group of variables to 
change before taking action) must be made. Defining these 
thresholds should allow the clinical boundaries of this 
zone to be described.
For each patient the zone of surgical anaesthesia 
will lie between two physiological boundaries which are 
defined by the anaesthetist for that individual. If the 
patient's clinical state should reach a boundary the 
anaesthetist will always act by either increasing or 
decreasing the dose of anaesthetic. Interventions may be 
made prior to a boundary crossing, the action itself 
dependent on the degree, rate of change and "truth" of the 
variables monitored e.g. heart rate changes will have less 
significance after the administration of atropine.
THE BOUNDARIES OF THE ZONE OF SURGICAL ANAESTHESIA.
The lower boundary of this zone will lie within 
clinically accepted 'safety' limits and may be defined as 
the maximum dose of anaesthetic at which the criteria 
describing it can be maintained. The upper boundary 
describes the situation where the degree of physiological 
disruption is either deemed dangerous, or "cortical 
awareness" is felt to be likely.
The variables used to assess the anaesthetic state 
c l i n i c a l l y  are a f f e c t e d  by o t h e r  e v e n t s  and the 
anaesthetist takes these into consideration. In some
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extreme situations, for example cardio-pulmonary bypass 
surgery, clinical signs may give no or minimal information 
a b o u t  the p a t i e n t s  a n a e s t h e t i c  state; in o t h e r s  
complicating factors e.g. concomitant drug therapy may 
detract from the usefulness of clinical signs and increase 
the risk of a relative under- or over-dose of anaesthetic.
Figure 2 shows a possible relationship between the 
ZSA and the true anaesthetic state.
DIFFICULTIES IN MEASURING THE ANAESTHETIC STATE.
A l t h o u g h  it is r e a s o n a b l e  to a s s u m e  that the 
anaesthetic state results from the interaction between two 
CNS "inputs", assessment of the various methods proposed 
as monitors this state is difficult because:
1 Surgical stimulation, although it may be described as 
an ordered sequence of events (Figure 3), cannot be 
quantified.
2 The large inter-individual variation in anaesthetic 
requirement means that anaesthetic dose can at best 
be defined with respect to a single point (or points) 
on a q u a l i t a t i v e  s c a l e .  T hi s  i m p o s e s  s e v e r e  
l i m i t a t i o n s  on its use. The l i m i t a t i o n s  of 
anaesthetic dose as a measurement of anaesthetic 
adequacy are discussed further in the following 
section.
W h e n  t h e s e  p r o b l e m s  are c o n s i d e r e d ,  the m o s t  
appropriate method of assessment is to determine an 
individually valid functional anaesthetic state ("gold" 
standard), to which other m ethods can be compared. 
Although several workers have used, or suggested, that a
c ZSA DAO
True Anaesthetic State
Surgical Stimulation 
<3=
150 00
Hypertension
Dose
=>
Qinical Anaesthetic State
50
=o
Hypovolaemia
MAC
Figure 2.
A Possible Relationship between the ZSA and the True 
Anaesthetic State.
The upper line depicts the true anaesthetic state, 
ranging from consciousness (C) to dangerous anaesthetic 
overdose (DAD). The Zone of Surgical Anaesthesia 
(ZSA) lies between these points. The lower line 
depicts a representative clinical anaesthetic state 
defined, in this case, by Systolic Arterial Pressure 
(SAP). A relationship between these scales will 
exist, and may be measured at any fixed level of 
response (eg. MAC). However, the validity of the 
response is unknown and any change in the level of 
surgical stimulation or in drug dose may effect the 
true scale to a greater of lesser extent than the 
representative scale. Further, carplicating factors 
eg. hypovolaemia or hypertension in the case of SAP 
may shift the representative scale relative to the 
true scale.
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specific mental state or level of autonomic activity 
(6,7,8,9,10) is the most appropriate method of assessing 
the various techniques proposed as monitors of anaesthetic 
adequacy, the use of this method has not become wide­
spread. This may be because the definition and validation 
of such a state is difficult.
A CLINICAL STANDARD OT ANAESTHETIC ADEQUACY.
Clinical signs, despite some inadequacies (11,12), 
are currently the only practical, universally accepted, 
method of assessing the anaesthetic state. As such they 
are used successfully to guide the administration of 
thousands of anaesth e t i c s  each day. However, their 
i nterpre t a t i o n  is both subjective and variable. A 
r e p r o d u c i b l e ,  i n d i v i d u a l i s e d  d e s c r i p t i o n  of the 
anaesthetic state, based on clinical signs and validated 
against the "goals'1 of anaesthesia, may allow the use of 
this technique as a gold standard. If another method (or 
combination of methods) should prove superior it should 
then be accepted as the new standard and the zone of 
surgical anaesthesia redefined with respect to this 
method.
Anaesthetic dose and surgical stimulation, the 
determinants of the anaesthetic state, are discussed in 
the following chapters and the validity of this approach 
in the final chapter.
CHAPTER
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THE MINIMUM ALVEOLAR CONCENTRATION FOR ANAESTHESIA.
Many workers have concluded that the demonstration of 
a relationship between anaesthetic dose (usually expressed 
in terms of MAC) and a variable implies that a given 
technique measures anaesthetic depth; the effects of 
surgical stimulation being ignored. There are several 
limitations to the use of MAC in this context.
HISTORICAL ASPECTS AND THE DEFINITION OF THE MINIMUM 
ALVEOLAR CONCENTRATION FOR ANAESTHESIA.
Prior to 1946 agents were compared by the inspired 
concentration required in clinical practice. In 1946 
Robbins introduced the AD50 as the anaesthetic vapour 
co n ce ntration at which 50% of mice failed to remain 
upright for 15 seconds, after 1 0 minutes exposure, in a 
jar rotating at 14 revolutions per minute (13). Using this 
value, and the FD50 (defined as the concentration causing 
respiratory arrest in 50% of mice after 10 minutes 
exposure); induction times, recovery times, safety margins 
etc. for volatile anaesthetic agents can be compared.
The term MAC was introduced by Merkel and Eger (14) 
in 1963 as an index of comparison between halothane and 
halopropane, being defined as the "minimal anaesthetic 
concentration required to keep a dog from responding by 
gross movement to a painful stimulus". This concept has 
been expanded and is now used as a major indicator of 
anaesthetic potency.
MAC is defined in man as the alveolar concentration 
of anaesthetic vapour, expressed as a percentage of 
one atmosphere and held stable for 15 minutes, at 
which 50% of patients show no muscular response to an
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applied noxious stimulus (e.g. skin incision or 
electric shock) (15). A positive response is taken as 
"gross purposeful muscular movement" (16); facial 
grimacing, coughing, swallowing etc. are considered 
negative (16,17).
FACTORS AFFECTING MAC
MAC may be effected by a number of factors and these 
are listed in Table 1. Although the effect of some 
variables (e.g. age) have a predictable effect on MAC 
which appears to be agent independent and corrections can 
be made, the effect of other variables differs between 
agents. For example, it has been shown in dogs that a 
decrease in temperature from 38 to 28 °C results in a 50% 
decrease in the MAC value for halothane but of only 25% in 
the case of cyclopropane (18).
In some studies (14,25) agents known to increase MAC 
e.g. cocaine (19) or decrease it e.g. thiopentone (16) 
were used. This may have effected the calculated values.
DIFFICULTIES IN TERMINOLOGY.
The term "Minimal Alveolar Concentration" has been 
described as "poor" (26), and may be misleading. MAC, as 
defined, describes a median effective value for the 
population with respect to one aspect of the overall 
response to a defined stimulus. MAC does not define a 
minimum alveolar concentration for anaesthesia in the 
individual.
De Jong and his co-workers (27) extrapolated 'MAC ' 9 5  
values (the end-tidal concentration at which 95% of the 
population will shown no response to skin incision), for 9
Table 1. Some Factors That Affect MAC.
Mo or Minimal Effect Decrease MAC Increase MAC
Hypocarbia
Hypercarbia
Hypoxia
Metabolic Alkalosis 
Stimulus Intensity 
Induced Hypertension
Increased Age 
Hypothermia 
Narcotics 
Sedatives 
Muscle Relaxants 
Nitrous Oxide
Acute Haemorrhagic
Hypotension
Decreased Age 
Pyrexia
CNS Stimulants 
Alcohol Abuse
Metabolic Acidosis 
References: 14,15,16,17,18,19,20,21,22,23,24
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different volatile agents, using log dose-probit
response lines, calculated from pooled data. In absolute
$
terms these values are 5-40% greater than MAC . These 
workers felt that a minimum, rather than a median, value 
would be more clinically useful. Knowledge of these 
values, or values described for other end-points is 
unlikely to alter the administration of drugs in clinical 
practice.
THE COMPONENTS OF MAC.
The determination of MAC requires the measurement of 
end-tidal anaesthetic concentration, the application of a 
noxious stimulus, and assessment of the subjects reaction.
END-TIDAL CONCENTRATION.
Waud and Waud (28) have suggested that the major 
c o nt r ib u ti o n  of MAC was the emphasis on end-tidal 
( a l v e o l a r )  c o n c e n t r a t i o n  r a t h e r  than i n s p i r e d  
concentration, a view reiterated by Quasha, Tinker and 
Eger in a recent review article (17). The alveolar 
concentration, after an equilibrium period, is used as an 
index of cerebral concentration, a useful trade-off 
between ease of sampling and indirectness of measurement, 
a vast improvement to the earlier emphasis on inspired 
concentrations.
* For clarity, "MAC" is used as an abbreviation for the 
classical minimum alveolar concentration, introduced by 
Merkel and Eger and defined on pages 27-28; " 'MAC' " is
u s e d  as an a b b r e v i a t i o n  f o r  " m i n i m u m  a l v e o l a r  
concentrations" described by other workers for different 
end-points. These are differentiated in the text by the 
subscripts used by the authors who described them.
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STIMULI AND END-POINTS OF RESPONSE.
Although the end-point and stimulus used in the 
calculation of MAC are well described, some workers have 
not adhered strictly to the criteria. Nicodemus et al (29) 
used "limb movements or facial grimacing" to indicate 
"lack of effective anaesthesia" which may explain the 
discrepancies between their results and previous work 
(30).
Some early work (16) suggests that some stimuli e.g. 
the tail c l a m p  u se d  in a n i m a l  s t u d i e s  of M AC  are 
maximal. That is, the application of two such stimuli do 
not increase MAC in that subject. Skin incision is not 
such a stimulus and it is debatable as to whether a 5 inch 
incision on the trunk is as "stimulating" as a 5 inch 
incision on the face where the pain receptors are more 
prolific. Further, this work suggests that, in the 
presence of a stimulus of varying intensity (e.g. during 
surgery) the anaesthetic dose required to prevent a motor 
response will itself vary. Work by Ausems (31,32) seems to 
confirm this, although autonomic variables were included 
in his definition of responders and non-responders (figure 
4).
'MAC' AND OTHER END-POINTS.
’MAC* values have been described for a number of 
different stimuli and end-points.
1 ,mac'baR' a9 e~adjusted anaesthetic dose required
to block the adrenergic response to skin incision 
(defined as a 1 0 % or greater increase in heart rate, 
blood pressure, pupil diameter or noradrenaline 
leve ls ) in 50% of s u b j e c t s .  A v a l u e  has b e e n
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Figure 4 The dependency of dose-response curves on the 
type of stimulus.
Plasma alfentanil concentration-effect curves 
were determined for three stimuli (intubation, 
skin incision and skin closure) from the quantal 
date in the upper diagram by logistic regression, 
The bars indicate the standard error of the 
dose required to prevent a response in 50% 
of subjects (from ref. 32).
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determined for halothane, enflurane and morphine 
(25). In each instance 60% nitrous oxide was given, 
all patients had their t r a c h e a s ' sprayed with 
lignocaine (2 mg/kg) and some received thiopentone at 
induction. With enflurane, the car di ov a sc ul ar  
response to skin incision (as determined by changes 
in rate pressure product) was shown not to decrease 
with increasing doses of the drug, unlike those 
patients in the halothane and morphine groups. As 
pupillary changes were "estimated by approximation 
with a ruler", significant (1 0 %) changes may have 
been missed.
2 1 M A C ' 3 j , the alveolar concentration required to 
p r e v e n t  a h e a r t  r a t e  r e s p o n s e  to s u r g i c a l  
stimulation in 50% of subjects. The value derived in 
this study was probably affected by the use of 
atropine as a premedicant (33).
3 'MAC'Ej , the minimal alveolar concentration required 
to prevent a motor response to intubation in 50% of 
cases and MAC0^ , that required to prevent a motor 
response to laryngoscopy in 50% of patients (34,35).
4 'MAC* awake / the alveolar concentration at which 50% 
of people can be expected to respond to command (36). 
This study is complicated in that those patients 
a n a e s t h e t i s e d  w i t h  e t h e r  and f l u r o x e n e  w e r e  
volunteers and not exposed to surgery, while those 
anaesthetised with halothane and methoxyflurane were. 
The values determined in these studies are listed in 
table 2 .
Although the number of stimuli and end-points
Table 2. 'MAC' Values determined for different Stimuli and 
End-Points.
AGENT Mac
Awake
Mac Mac95 MacSI MacEI MacBAR*
Halothane 0.41
0.57
0.75 
1 . 00
0.90 
1 .20
1 .46 
1 .95
1 .52 
2.02
Enflurane 1 .68 
1 .00
1 .88 
1 .02
1 .97 
1.17
2.93 
1 .74
3.66
2.12
Isoflurane 1 .2 
1 .0
1 .63 
1 .36
Methoxy- 
flurane
0.08
0.48
0.17 
1 .00
0.22 
1 .29
Diethyl-
ether
1 .41 
0.74
1 .9 
1 .0
2.22
1.17
The upper figures are the end-tidal concentrations (ii
required to fulfil the criteria of any given response
the lower f igures represent the ratio of that dose to
The responses are defined in the text.
* these values were determined in the presence of
nitrous oxide, 0.57 MAC has been allowed for the nitrous 
oxide.
See Text for References
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available for study is almost inexhaustible, knowledge of 
the 'MAC' values which relate to them is unlikely to alter 
clinical practice (vide infra). The importance of using 
one group of subjects, to minimise experimental error, in 
the calculation of 'MAC' ratios has been stressed (28).
MAC AND COMBINATIONS OF ANAESTHETIC AGENTS
MAC values have also been calculated for combinations 
of anaesthetic agents (37,38,39,40,41,42). Although it is 
generally accepted (17) that combinations of anaesthetic 
agents are additive (figure 5), the number of combinations 
studied is small and both synergism and antagonism have 
both been demonstrated (43,44).
Little work has been done to d e termine whether 
anaesthetic agents are additive when different end-points 
of response are considered, however Stella and his co­
workers (33) found that the end-tidal concentration of 
enflurane required to ablate the heart rate response to 
skin incision in 50% of subjects was only decreased by 53% 
when 70% nitrous oxide was added, less than would be 
anticipated from the additive effect of the nitrous oxide 
previously described (15,37,38,39,45).
MAC AND DOSE-RESPONSE CURVES.
MAC values are frequently used to derive dose- 
response curves. Waud and Waud have classified these 
(dose-response curves) as graded, quantal or ordered (28). 
Graded responses are those which can be measured on a 
continuous scale (e.g. blood pressure); quantal responses 
represent all or none responses in which the number of 
subjects reaching a defined end-point are plotted against
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Figure 5. Combinations of nitrous oxide and volatile 
anaesthetic appear to be additive.
The vertical axis represents the fraction of MAC of 
four anaesthetic agents.. The value 1.0 represents 1 MAC 
of each agent. The horizontal axis represents the MAC 
fraction of nitrous oxide. The values obtained for the 
four anaesthetics fall near the line of simple addition, 
(from ref. 38).
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concentration (eg MAC); and graded responses, empirical 
scales in which a number of end-points can be placed in 
order but in which the "distance between end-points" can 
have no meaning (e.g. Guedel's (46) classification of 
ether anaesthesia or Prys-Roberts (3) ranked suppression 
of noxious stimuli).
MAC refers to one point on a dose response curve. 
Comparison of anaesthetic agents using MAC is only valid 
at that point. Comparison using multiples or fractions of 
MAC can only be valid if the dose-response curves of the 
two agents are parallel (figure 6 ).
Although the ratios of anaesthetic requirement to MAC 
for a number of different end-points have been shown to be 
relatively constant for some agents (33,34,35) this is 
not always true
K i s s i n  (47) d e r i v e d  'MAC* v a l u e s  for t hr ee  
anaesthetic end-points (righting reflex, abolition of 
purposeful movement and heart rate response) for a variety 
of agents and concluded that the heart rate response to 
noxious stimulation, in contrast to the loss of righting 
reflex, has a constant ratio to MAC. Shim and his co­
workers (48) found no common dose-ratio relationship for 4 
different end-points (righting reflex, abolition of 
purposeful movement, respiratory and cardiac arrest) with 
8 different agents.
Shim (48) has suggested that MAC results from the 
summation of different effects (eg. reflex suppression and 
analgesia) and therefore represents the sum of points on 
two or more dose response curves (figure 7). If this is 
true, MAC cannot be used to compare anaesthetic agents
CONCENTRATION OF ANESTHETIC
Figure 6. A limitation of MAC.
Anaesthetic depth is plotted against anaesthetic 
concentration and the dose response curves for three 
imaginary agents drawn. If the drugs are compared at 
one level of response (the window in the diagram), 
it is impossible to detemine if the dose response curves 
are parallel (from ref. 28).
I m o g i n o r y  o n e s f h e l i c  . 
d o s e - r e s p o n s e  c u r v e s  *
' — “  R e f l e x ,  d ep r e s s
——  A n o l g e s i o
_ _ _ _  R e s u l t o n !
o p p r o o c h  to M A C
0  L o s s  o f
r i g h t i n g  r e f l e x
M A C
Figure 7. MAC as a combination of effects.
Hypothetical curves for three agents showing that 
unresponsiveness to skin incision at MAC may result 
from a combination of analgesia and reflex depression. 
The effect at MAC of agent A consists of 25% analgesia 
and 75% reflex depression; with agent B, 50% of each 
component; with agent C 25% reflex depression and 75% 
analgesia. As the righting reflex disappears at a 
certain level of reflex depression it would disappear 
well below MAC with agent A but at MAC with agent C 
(from ref. 48).
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above or below the point of measurement i.e. the use of 
MAC multiples (or fractions) is meaningless.
Parallelism of dose-response curves, calculated for 
the volatile agents from pooled data, is the exception 
rather than the rule (27,49). This supports the view that 
the use of MAC multiples is scientifically not justifiable 
(28).
Further, the MAC value calculated for any given agent 
is very dependent on technique (50) and differences of 
over 1 0 % are present in some studies done by the same 
group (16,51). Any error in the calculation of MAC would 
increase with m ul t ip l i c at i on  and detract from any 
comparison made using MAC multiples.
USES AND ABUSES OF MAC.
MAC is a useful concept but the limitations inherent 
to its definition must be remembered. As the MAC value for 
an anaesthetic agent roughly corresponds with the 
concentrations which will be required in clinical practice 
it is a useful yardstick for the comparison of anaesthetic 
drugs with regard to physiological effects, side-effects 
etc.
However, MAC refers to the population and not the 
individual and although it (MAC) has been described as a 
point of "prime practical and theoretical significance" on 
the continuum from "analgesia to death" (52), MAC 
describes only one point on a specific dose-response 
curve, relates to only one aspect of the overall response 
to a set stimulus, is not directly applicable to the 
individual and cannot be applied to the multiple agent
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techniques used in routine anaesthetic practice. Further, 
the presence or absence of a specific response (e.g. 
movement) is dependent on the balance between drug dose, 
stimulus type and stimulus intensity and cannot be defined 
with respect to one dose related parameter.
The usefulness of MAC in the assessment of techniques 
proposed as monitors of anaesthetic adequacy is limited.
CHAPTER
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THE EFFECTS OF SURGICAL STIMULATION.
The anaesthetic state is clinically assessed by the 
patients residual responses to surgical stimulation. Some 
of the reflex responses evoked by surgical stimulation are 
discussed in this chapter.
REFLEX ACTIVITY AND SURGICAL STIMULATION.
A large number of somatic and autonomic reflexes can 
be initiated by surgical and other manipulations (eg 
laryngoscopy and intubation). Although these reflexes are 
suppressed in an ordered sequence by general anaesthetic 
agents (3) and a graded scale can be created (figure 1), 
it is not known if these reflexes are representative of 
the anaesthetic state.
AUTONOMIC NERVOUS SYSTEM.
The autonomic nervous system must be regarded as 
completely integrated, not as two mutually opposing 
parts:- the sympathetic and parasympathetic. The system 
consists of sensory organs, afferent and efferent pathways 
and numerous central connections. Although the limbic 
region may be regarded as the “visceral brain", both 
higher inputs and reflex activity (at various levels) 
determine the overall activity.
The most relevant reflexes are those in which the 
"end-organ" is the cardio-vascular system. Some of these 
reflexes will now be described in more detail:
1. Viscero-vascular reflexes.
2. Somatosympathetic reflexes.
3. Defence Reactions.
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VISCERO-VASCULAR REFLEXES.
Experimentally, stimulation of abdominal and pelvic 
organs is associated with a variety of effects. For 
example, gallbladder distension in anaesthetised or 
spinal cat preparations initiate a hypertensive reflex, 
secondary to reflex vasoconstriction of the splanchnic 
vascular bed reinforced by catecholamine release from the 
adrenals. In the pelvis, stimulation of the rectum 
initiates a fall in blood pressure; with stimulation of 
the bladder having the opposite effect (5 3 ).
In patients with low spinal injuries (L2), bladder 
distension leads to reflex vasoconstriction of the lower 
limbs and an associated hypertension. Those with T5 
lesions, suffer vasoconstriction of the upper limbs as 
well. In cats it has been demonstrated not only that both 
the renal and splanchnic vascular beds are involved but 
also that the rise in blood pressure is limited by the 
baroreceptors (53).
The haemodynamic responses of brain dead organ donor 
patients to surgical stimulation have been investigated 
(54). In the patient studied, and nine cases reviewed 
r e t r o s p e c t i v e l y ,  a p r e s s o r  r e s p o n s e  to s u r g i c a l  
stimulation occurred. The occurrence of a "mass reflex" 
was felt to be unlikely, and the authors concluded that 
residual lower medullary function (although compatible 
with the clinical diagnosis of brain death) may have been 
an aetiological factor.
Generally visceral reflex activity is increased in 
spinal preparations, whilst somatic reflexes are reduced. 
In decerebrate specimens the opposite tends to hold true:
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somatic reflexes are increased, visceral reflexes being 
reduced (53). Wang (55) has shown that removal of the 
entire brain stem is necessary to abolish stimulus induced 
responses, except in chronic spinal preparations.
VISCERO-VASCULAR REFLEXES INITIATED BY ABDOMINAL SURGERY.
Manipulation of the upper abdominal viscera may lead 
to profound hypotension, with minimal change in the heart 
rate. Burstein (56) called this the coeliac plexus reflex 
and believed it was due to a sympatheticotonic state 
produced by the combination of atropine (as a premedicant) 
and ether, often in association with "light" anaesthesia. 
Smith (57) reported on 10 cases in 1953 and concluded that 
the fall in blood pressure was secondary to vagal cardiac 
inhibition.
In 1 957 Roco and his co-workers (58) studied 6 8  
patients undergoing laparotomy in an attempt to clarify 
the effect of manipulation on abdominal viscera. A variety 
of anaesthetic techniques were used. They found some areas 
(the upper anterior parietal peritoneum and the region of 
the common bile duct) to be particularly sensitive to 
stimulation. Hypotension, which the authors felt vagal in 
origin, occurred in 55 patients.
Folkow (59) studied 14 patients in 1961 and found 
hypotension and bradycardia to occur on mesenteric 
traction and hollow organ distension, a response which 
could be elicited by direct stimulation of the nerve 
fibers running to these organs. Vagal stimulation did not 
elicit this response and atropine, although reversing the 
bradycardia did not fully restore the blood pressure. As 
limb plethysmography suggested relaxation of capacitance
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vessels as an aetiological factor the authors concluded 
that the reflex constituted a vagal bradycardia associated 
with a generalised decrease in sympathetic tone.
Seltzer (60) investigated this phenomenon in patients 
undergoing aortic aneurysm surgery. In these patients, 
suffering from a variety of pathological states, 
h y po te n si o n occurred in 19 out of 20 cases during 
controlled mesenteric traction. This was due to fall in 
systemic vascular resistance only partially compensated 
for by an increase in cardiac output. The maximal response 
occurred after 5-10 minutes, and was associated with 
flushing in some cases. These findings led the group to 
investigate a further 8 patients. They demonstrated that 
the fall in SVR was directly related to a rise in 
prostaglandin levels, confirming their suspicion that the 
primary effect was hormonal (61).
That Stoetling (62) was unable to show any effect 
after 30 seconds traction on the gallbladder was probably 
due to the short stimulation period and the short time for 
which the patients were monitored.
SOMATO-SYMPATHETIC REFLEXES.
S a t o  a n d  h i s  c o - w o r k e r s  (63) s t u d i e d  t h e  
cardiovascular effects of cutaneous and muscle nerve 
stimulation in cats anaesthetised with chloralose and 
urethane. Their results are summarised in table 3. In 
those animals demonstrating a tachycardia, continued 
stimulation led to a fall in heart rate, which reached a 
plateau at around 50% of the peak value. No direct 
correlation between heart rate and blood pressure occurred
Table 3. The Effects of Stimulating Cutaneous and Muscle 
Afferents (after Sato et al, ref. 63).
Stimulated Nerve 
Cut. Group II 
Cut. Group III
Cut. Group IV
Muscle Group I 
Muscle Group II 
Muscle Group III 
Muscle Group IV
(Cut = Cutaneous)
Effect 
No Effect
Bradycardia or tachycardia, direction 
of response unpredictable
Tachycardia
No Effect 
No Effect
Tachycardia or bradycardia(40%)
Tachycardia, increase proportional to 
stimulus strength.
Latency
Cutaneous 3secs(2.5-7.5secs), Peak change at 20-30secs 
Muscle 10secs( 8-16 secs), Peak change at 20-30secs
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in this study. In some cases heart rate changes occurred
in isolation and in others tachycardic responses occurred
in association with hypotensive or mixed blood pressure
changes. Sato concluded that the relationship between the 
somatic afferent system and the autonomic efferent system 
is much more complex than the concept of "pressor and 
depressor" afferents would suggest. And he proposed that 
the nature of the autonomic output would depend on the 
type, site and duration of stimulus as well as the general 
experimental conditions.
Kissin and his co-workers (64) demonstrated that the 
cardiac acceleratory response to stimulation of the 
superficial peroneal nerve in dogs is proportionally 
depressed by increasing end-tidal concentrations of 
halothane. They suggest that the autonomic response to 
stimulation, as measured by the cardiac acceleratory 
response to stimulation, might be used as a graded index 
of anaesthetic depth. These workers felt that their work 
confirmed the everyday practice of the anaesthetist who 
uses the cardiovascular response to surgical stimulation 
as a guide to anaesthetic adequacy. No information is 
given of blood pressure changes in this study.
Savege (65) investigated the cardiovascular response 
to tibial pressure in patients anaes t he ti se d with
althesin. Changes in cerebral activity, as measured by the
the
CFM, did not correlate with^cardiovascular response to 
stimulation. Fentanyl obtunded the autonomic response to 
the stimulus, and did so during increasing CFM activity. 
The authors suggested that Althesin and similar agents 
should only be given in doses large enough to suppress
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consciousness, as larger doses would not appear to effect 
the quality of anaesthesia.
DEFENCE REACTIONS.
Specific autonomic responses can be elicited by 
stimulating different hypothalamic regions. These 
reactions are complex and probably continually modulated 
by inputs from other centres. One of these reactions, the 
defence reaction, is a behavioural reaction which prepares 
the body for "fight or flight" (6 6 ). The response is 
present in all animals, and it would appear that although 
humans can override the initial emotional reaction, the 
individual organ responses persist. After decortication 
the response may be initiated by trifling stimuli, 
suggesting that cortical input is usually inhibitory. The 
cardiovascular response consists of: -
Sympathetic vasoconstriction in most vascular beds 
(including the renal and splanchnic circulations), an 
exception being skeletal muscle. The result is a 
tachycardia and increase in arterial pressure. This 
neurogenic response is reinforced by adrenal 
catecholamine release. The reflex is associated with 
strong inhibition of the baroreceptor reflex (66,67).
Although the full response is unlikely to occur in 
clinical practice, a modified response may be common 
intraoperativly. Workers in Sweden have investigated the 
comparative effects of a variety of anaesthetic techniques 
on the cardiovascular consequences of defence area 
stimulation in cats (68,69). Under both chloralose and 
fentany 1 -diazepam-nitrous oxide anaesthesia somatic
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afferent and defence area stimulation led to the sequence 
mentioned above, the degree of response being similar. 
Droperidol, despite minimal effects on resting arterial 
p r e s s u r e ,  w a s  f o u n d  to g r e a t l y  a t t e n u a t e  the  
vasoconstrictor response in both the renal and intestinal 
systems. The overall hypertensive response was also 
attenuated. Whether the effect was per ip he ra ll y or 
centrally mediated is unknown. Isoflurane has also been 
shown to attenuate the response to both stimuli, in a dose 
related manner, when compared to the basic anaesthetic 
mentioned above (69).
CONCLUSIONS.
Surgical stimulation initiates a large number of 
somatic and autonomic reflexes. In clinical practice it is 
these reflex responses which are used to determine a 
patients anaesthetic requirement. However, some of the 
reflex responses used by the anaesthetist to determine the 
patients anaesthetic state may be poor indicators of the 
true anaesthetic state. The major difficulty of this 
approach is therefore to determine which reflex responses 
(autonomic, somatic, EEG etc.) are representative of the 
true anaesthetic state. These problems will be discussed 
later.
CHAPTER
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METHODS OF ASSESSING THE ANAESTHETIC STATE 
I ) CLINICAL METHODS.
A. HISTORICAL ASPECTS.
From the time of Snow until the early part of this 
century anaesthesia was customarily divided into four 
stages (70):
Stage I (Stage of Induction): from the beginning of
administration to the loss of consciousness.
Stage II (Stage of Struggling, or Breatholding, or 
Delirium, or Dreams): from loss of consciousness 
to the onset of surgical anaesthesia.
Stage III (Surgical Stage): characterised by deep,
regular automatic breathing.
Stage IV (Overdose, or Stage of Bulbar Paralysis): 
not well described, but associated with shallow 
irregular respiration and fixed dilated pupils.
GUEDEL'S DESCRIPTION.
Guedel a cc u rately d escribed the clinical signs 
associated with di-ethyl ether (46). This allowed the 
clinical recognition of four stages and the subdivision of 
the third stage into four planes:
Stage I (Analgesia), from induction to loss of 
consciousness.
Stage II (Delirium), from loss of consciousness to 
the onset of automatic breathing.
Stage III (Surgical), from onset of autom at ic  
breathing to respiratory paralysis.
Plane (i) Indicated by regular respiration
Plane (ii) Indicated by cessation of eyeball
activity. No change in respiration. (continued)
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Plane (iii) Indicated by the start of intercostal 
paralysis
Plane (iv) Indicated by c o m plete intercostal 
paralysis
Stage IV (Respiratory Paralysis), from respiratory 
paralysis to death.
The clinical signs used to indicate these relate to 
respiration, eyeball movement, pupil size, and the eyelid, 
swallowing and vomiting reflexes (figure 8).
Guedel recognised that diff e r e n t  "levels" of 
anaesthesia are required to control the reflexes initiated 
by different types of surgery, and more specifically that 
operations not requiring muscle relaxation could be 
carried out in the lighter planes of Stage III. Use of his 
chart, in conjunction with the relevant section of his 
monograph, enabled the anaesthetist to attain the required 
"depth" for a wide variety of procedures (71). For example 
superficial operations might be carried out under Stage 
III(i) whilst the relaxation necessary for abdominal work 
would require Stage III (ii-iii).
SOME LIMITATIONS OF GUEDEL'S SIGNS.
Guedel recognised his chart to be accurate in only 
90% of cases, accepting that "No set of signs can be 
constant.". He also appreciated that other factors (eg. 
premedication) might effect these signs and made 
allowances for some of these (71). Figure 8 demonstrates 
the effects of premedication on the pupillary signs.
NO + 4- + +
Column 1. Respiration 
Column 2. Eyeball activity  
Columns 3, 4, 5. Pupils 
Column 6. Eyelid reflex 
Column 7. Area of swallowing 
Column 8. Area of vomiting
Figure 8. Guedel's signs and stages of anaesthesia.
The figure is explained in the text. Column 3 represents 
the eye signs in those patients not receiving premedication, 
Column 4 in those receiving atropine and Column 5 in 
those receiving morphine as premedication (from ref. 71).
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FURTHER LIMITATIONS.
Clinical signs are dependent on a number of factors 
w h i c h  r e l a t e  to the p a t i e n t ,  p r e m e d i c a t i o n ,  the 
anaesthetic agents used and the technique by which it is 
administered (46). Gillespie (70), citing cyclopropane as 
an example, emphasised that reliance on G u e d e l 1s 
respiratory signs, can be misleading:- especially if the 
airway is compromised. Having noted these inadequacies, 
and explained that the majority of difficulties which 
beset both the anaesthetist and the surgeon are caused by 
unv/anted reflex activity, stressed the importance of 
reflex signs as guides to anaesthetic adequacy. Gillespie 
concluded that Guedel*s classification of the stages and 
planes of anaesthesia should be retained, but equal 
importance given to signs of reflex activity (70). To this 
end he modified Guedel*s chart, a version of which is 
still taught today (figure 9) (72).
CAN GUEDEL'S WORK BE MADE MORE RELEVANT ?
Mushin (73) stressed that the "signs" of anaesthesia 
are motor responses, elicited by an applied stimulus and, 
that in the absence of such a stimulus, it cannot be that 
implied a specific reflex is obtunded. This is especially 
relevant to ether, whose vapour represents such a 
stimulus. A patient breathing quietly on 10-15% ether will 
not react to skin incision, the same cannot be said for a 
patient breathing a less irritant vapour (eg. halothane or 
cyclopropane). Mushin felt that a better understanding of 
these signs, and the reasons for their demonstration with 
one agent (ether) would allow appli c a t i o n  of this 
knowledge to other agents.
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Figure 9. Guedelfs chart "today".
A modification of Guedelfs chart, based on work by 
Gillespie (70) and published in "A synopsis of anaesthesia" 
(from ref. 72).
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Ellington has supported this view stating: "...the
classification still gives considerable information that 
can, with exceptions, be used as a guide to "depth of 
anaesthesia" for various drugs " (74).
Although this approach is still taught today
(75) its application would require learning complete sets 
of signs for each agent and combination of agents as well 
making allowances for the technique of administration and 
the quantity and timing of doses. A number of patient 
factors eg. concomitant drug therapy, the patient's 
disease status and the effects of surgical stimulation 
would also have to be allowed for.
OTHER APPROACHES.
Others have suggested that with redefinition and 
adaption, Guedel's observations may be applied to modern 
anaesthetic practice (76,77,78). Guedel's system is only 
applicable to ether. Stages and planes may be described 
for other agents but, for the reasons mentioned above, it 
is not practical. The limitations of Guedel's approach are 
not descriptive. They stem from its relevance to a single 
anaesthetic agent.
COMPONENTS OF ANAESTHESIA.
The introduction of specific pharmacological agents 
(and in particular muscle relaxants) highlighted the 
limitations of Guedel's approach. Patients apparently 
deeply anaesthetised with some agents (eg. thiopentone), 
as defined by Guedel, were found to respond to surgical 
stimulation. Gray suggested that a new approach to 
anaesthesia was necessary and introduced the "triad of
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anaesthesia" (79) - narcosis, analgesia and relaxation.
Later renamed narcosis, relaxation and reflex depression 
(which is more descriptively accurate) (4).
The reflexes he refers to are motor, visceral and 
endocrine. He summarises: "... these reflexes are open to 
modification by the anaesthetist and awareness of their 
presence and of the extent to which they can and should be 
depressed is of far more importance than any consideration 
of the "signs" of anaesthesia."
Woodbridge suggested a similar approach, although he 
described four components (1):
1. Sensory (afferent)
2. Motor(efferent)
3. Reflexes
4. iMental (sleep)
Woodbridge also suggested a scoring system for each 
of these components but the system is complex and not 
clinically applicable.
Although the approach these workers have taken is 
more relevant to today's practice they do not tell us how 
to measure anaesthetic depth but rather what is required 
from an anaesthetic.
More recently Pinsker (5) has suggested "..the 
concept that paralysis, unconsciousness, and attenuation 
of the stress response are the necessary and sufficient 
components of the anesthetized state." Defining paralysis 
as the absence of movement in the surgical field and 
emphasising that attenuation of the stress response only 
refers to those aspects of the whole which we can readily 
measure, and therefore control. The analgesic component
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is not included as pain requires a conscious brain to 
"interpret the impulses from the periphery", a situation 
which does not occur if unconsciousness is achieved. This 
approach emphasises the importance of the patients 
response to surgery. It is this response by which a 
patients anaesthetic state is determined, not the patients 
response to anaesthetic agents.
DIFFICULTIES WITH TERMINOLOGY.
Prys-Roberts (3) in a recent editorial, suggested 
that difficulties in defining anaesthesia may be that 
"...successive generations of practitioners of the art 
have centred their concepts around the effects of the 
drugs available to them, rather than the responses of the 
patient to the trauma of surgery, and the suppression of 
those responses". A similar problem has arisen in the 
interpretation of clinical signs.
"Clinical signs" may reflect one of two effects (or a 
combination of the two):
1 Drug related effects.
2 The residual autonomic and somatic responses to 
surgical stimulation during anaesthesia.
In the fist case the signs are agent dependent e.g. 
the dose related fall in blood pressure associated with 
isoflurane or the tachypnoea associated with increasing 
halothane concentrations, are described as signs of 
"anaesthetic depth" in that they are dose related. These 
signs are agent dependent i.e. not all anaesthetic agents 
have these effects. Drug dependent effects are rarely used 
in the assessment of the anaesthetic state during surgery,
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although they may complicate the interpretation of 
clinical signs (vide infra).
During surgery the anaesthetist assesses the clinical 
anaesthetic state from the residual autonomic and somatic 
responses to surgery. These responses reflect the balance 
between surgical stimulation and anaesthetic dose and are 
u s e d  by the a n a e s t h e t i s t  to a s s e s s  the p a t i e n t s  
drug requirement. Drug related effects (e.g. the 
c a r d i o v a s c u l a r  stimulating effects associated with 
ketamine) complicate the interpretation of these reflex 
s i g n s .  A k n o w l e d g e  of the b a s i c  p h a r m a c o l o g y  of 
anaesthetic (and non-anaesthetic) agents is required to 
allow the anaesthetists to determine which signs reflect a 
patient's response to surgery; which signs reflect a 
patient's response to the drug; and which signs are 
invalidated (or have less meaning) due to concomitant drug 
therapy (e.g. heart rate changes in a patient being 
treated with B-blocking drugs).
That the anaesthetists is successful in achieving the 
ZSA in the vast majority of patients suggests that the 
autonomic and somatic responses are adequate predictors of 
the anaesthetic state in most patients.
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METHODS OF ASSESSING THE ANAESTHETIC STATE
I) CLINICAL METHODS (continued).
B. THE CLINICAL ASSESSMENT OF THE ANAESTHETIC STATE.
After surgery has commenced the anaesthetist is 
guided by the patients residual autonomic and somatic 
responses to surgical stimulation. The range of autonomic 
response which can be measured is vast, however the 
constraints of surgery, ethics and the theatre environment 
limit the number which can be objectively monitored. The 
information presented to the anaesthetist may be 
qualitative or q u antitative and results from the 
interaction between a large number of variables (figure
10). Each clinical index of anaesthetic adequacy will be 
considered separately.
INDICES USED IN THE ASSESSMENT OF ANAESTHETIC ADEQUACY 
DURING SURGERY.
A. CARDIOVASCULAR INDICES OF AUTONOMIC RESPONSE
1. Peripheral Circulation.
Digital plethysmography is now widely available and 
has been suggested as a monitor of anaesthetic adequacy 
(30). Johnstone suggests that the dose of halothane 
necessary for surgery in a paralysed patient may be 
defined as the minimal dose required to block the 
v a s oconstrictor response to surgical stimulation. 
Difficulty in interpreting the trace might arise during 
hypocapnia, hypovolaemia or hypothermia and its use may 
not be applicable to other anaesthetic techniques.
Surgical
Stimulation
Central Nervous System
Anaesthetic
Dose
=> Autonomic Nervous SystemReflexes
Organ Responses
Clinical Signs
Interpretation of
Clinical Stgne
Figure 10. The determinants of the clinical anaesthetic 
state.
Although clinical signs, based on the patients' residual 
responses to surgical stimulation are used to assess a 
patients anaesthetic requirement, these clinical signs 
do not directly reflect the central nervous system 
balance which results from the interaction between the 
effects of anaesthetic dose and surgical stimulation.
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2. Heart Rate & Blood Pressure,
Although heart rate and blood pressure are often used 
as part of the assessment of anaesthetic adequacy a number 
of complicating factors must be considered. Reflex changes 
during surgery may not always reflect changes in the 
a n a e s t h e t i c  s t a t e  and use of t h e s e  v a r i a b l e s  is 
complicated by changes in blood volume, carbon dioxide 
status, the anaesthetic technique used, a variety of 
disease states and the medications they entail.
3. Beat to beat heart rate variability (HRV)
Heart rate variability is a complex phenomenon which 
is incompletely understood. It is principally attributed 
to arterial pressure fluctuations, sinus arrythmia and 
variations in response to thermal regulation. Although HRV 
is associated with anxiety and pain (81) Carter and 
Asbury (82) found little correlation between periods of 
light anaesthesia and increased periods of variability.
B. EYE SIGNS.
1. Pupillary Diameter
The balance between sympathetic and parasympathetic 
tone is often said to determine pupil diameter, the 
situation is however extremely complex and involves both 
ascending and descending inputs (83). Although there is a 
close relationship between the spinal afferents associated 
with pupillary dilatation and the fibers carrying pain 
nerve impulses (53), the interpretation of pupillary signs 
during anaesthesia is difficult as a number of other 
variables are involved.
The volatile agents, intravenous induction agents,
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opiates, and other drugs (eg atropine) all have different, 
and sometimes conflicting effects on the pupil. Mushin
(76) has said that:
"....importance should be attached to the size of the 
pupil only if it is other than the expected effect of 
the principle pre-anaesthetic drug which has been 
administered."
In anaesthetic practice today it may be difficult to 
determine which agent has the predominant effect and even 
when using "pure" volatile techniques determination of 
anaesthetic depth, on the basis of pupillary diameter, may 
be misleading. It is well known that large pupils may 
indicate both light and very deep levels of anaesthesia.
To measure pupillary diameter accurately requires 
specialised equipment, and although this has been 
developed (84) and used in clinical practice (85) the 
relevance of changes during anaesthesia are unknown. Evans 
felt that the variation in response to different agents 
was too great to warrant the inclusion of pupillary signs 
in a scoring system developed for assessing anaesthetic 
adequacy (86).
2. Pupillary Reflexes
The presence of the pupillary light reflex is 
generally taken as an indication of light anaesthesia, in 
the presence of miosis (eg. due to opiates) or mydriasis 
(eg. due to atropine) it may however be difficult to 
detect (86).
3. Oculo-micro tremor
Oculo-micro tremor is the smallest movement made by
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the human eye. In 1 976 Coakley demonstrated that the 
resting frequency decreased following induction with 
thiopentone (87). In one patient intra-operative recording 
was associated with a mean frequency some 40% below the 
control value. The sensitivity of the response to muscle 
relaxants would limit the use of oculo-microtremor as a 
monitor of anaesthetic adequacy should further evaluation 
demonstrate it to be of value.
C. LACRIMATION.
Increased lacrimation is often taken as a sign of 
inadequate anaesthesia. Although lacrimation can be 
assessed objectively, any interference with the eye (eg. 
wiping of tears) may be associated with increased 
lacrimation introducing artefacts. A further problem is 
establishing the relevance of tears in an eye in the 
horizontal position, and one that is not engaged in its 
normal function which directs tears into the nasolacrimal 
duct. Lacrimation may also be effected by anticholinergic 
agents.
D. SWEATING.
Sweating is another sign often taken to indicate 
light anaesthesia. Maryniak evaluated the production of 
palmar sweat and its correlation with heart rate in a 
group of patients undergoing cystoscopy (88). He 
demonstrated a close correlation between the two and 
concluded that palmar sweat production might be a useful 
indicator of the degree of sympathetic activity during 
anaesthesia and surgery. A previous study showed an 
increase in palmar sweat production following laryngoscopy
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and intubation, despite abolition of the heart rate 
response, with a bolus of alfentanil (30ug/kg) (89).
Sweating is however dependent on a number of factors: 
humidity, body position (which effects collection), 
metabolic rate, inter-individual differences in rate, age 
(due to an intrinsic deterioration in function and an 
altered extrinsic factor which effects sensitivity to 
stimulation) as well as being site dependent (90). The use 
of anticholinergic agents detract from the usefulness of 
this sign.
C l i n i c a l l y  t h r e e  l e v e l s  of s w e a t i n g  can be 
recognised; dry skin; feels moist; obvious beads of sweat 
(91). The complicating factors mentioned above, especially 
in relation to drugs and site of measurement, make 
assessment of this sign difficult.
E. RESPIRATORY SIGNS AND SKELETAL MUSCLE ACTIVITY.
Respiratory variables (tidal volume, respiratory rate 
etc.) are useful indicators of anaesthetic adequacy in the 
non-paralysed patient. While a skeletal muscle response to 
surgical stimulation, in the absence of neuromuscular 
blockade indicates (by definition) that anaesthesia is 
inadequate, both these signs are, at best, unreliable in 
the paralysed patient and will not be considered further.
The relationship between movement and consciousness 
in discussed later.
COMBINATIONS OF CLINICAL SIGNS.
From the above discussion it becomes apparent that no 
single clinical sign can be used as an indicator of 
anaesthetic depth in all cases. It also apparent that the
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relevance of a particular sign may be decreased in 
specific instances. The most obvious example being somatic 
responses following the use of muscle relaxants.
In routine clinical practice anaesthetists use 
combinations of clinical signs to determine a patient's 
anaesthetic state. As discussed, the interpretation of 
clinical signs is not uniform. Evans and Davis have 
introduced a scoring system to "..collate these clinical 
signs and measurements into a single entity" (86). This 
system is based on four variables; blood pressure, heart 
rate, sweating and tear formation and is called the PRST 
system. A score value of 0 - 2 is assigned to each 
variable (table 4), and a global impression of the 
clinical anaesthetic state determined by summing the 
individual PRST variables (table 5). Drug effects may be 
allowed for (table 6). The PRST score has been used 
successfully to determine the anaesthetic requirement 
during surgery (91).
Other workers (9,10,31,32) have used combinations of 
anaesthetic signs to define the adequacy of anaesthesia. 
For example, Ausems and his co-workers (31,32) defined 
anaesthesia as inadequate if:
1. Systolic arterial pressure rose by more than 15mmHg 
above the patients normal (which was determined from 
preoperative and preinduction measurements).
2. The heart rate exceeded 90 beats per minute in the 
absence of hypovolaemia.
3. If any somatic response occurred.
4. Any o t h e r  a u t o n o m i c  i n d i c a t o r  of i n a d e q u a t e  
anaesthesia e.g. lacrimation or sweating occurred.
Table 4. The PRST scoring system.
Index Conditions Score
SAP (mmHg) Less than Control + 1 5  0
Less than Control + 30 1
More than Control + 3 0  2
Heart Rate Less than Control + 1 5  0
(bpm)
Less than Control + 30 1
More then Control + 3 0  2
Sweat None 0
Skin moist 1
Visible beads of sweat 2
Tears No excess with eyes open 0
Excess visible with eyes open 1
Overflow with eyes closed 2
SAP = Systolic Arterial Pressure. Control values are taken 
prior to induction unless the patient is anxious when 
preoperative values are used.
(adapted from ref. 91).
Table 5. Assessing the adequacy of anaesthesia with the 
PRST score.
Total Score Clinical Impression
5 - 3  Marked autonomic response -
inadequate anaesthesia.
2 - 4  Acceptable level of response
0 - 2 Minimal response - evidence of
adequate or excessive anaesthesia 
(adapted from ref. 91)
Table 6. The effect of some variables on the PRST score.
Variable P R S T
Atropine + +
Pancuronium + + ns ns
Curare - ns ns ns
Gallamine + + ns ns
Digoxin ns - ns ns
alpha-blocker - ns ns ns
beta-blocker - - ns ns
Hypovolaemia + ns ns
Hypothermia ns ns
Several "non-anaesthetic" variables may effect the PRST 
score. They may either increase score ("+"), decrease 
score ("-") or have no effect ("ns"). These effects must 
be considered when the PRST score is used to evaluate the 
clinical anaesthetic state.
(adapted from ref. 91)
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These criteria were used successfully to determine 
the alfentanil requirement in patients undergoing a 
variety of surgical procedures. The use of clinical signs 
as a "gold" standard is discussed later.
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METHODS OF ASSESSING THE ANAESTHETIC STATE:
II) OESOPHAGEAL CONTRACTILITY.
ANATOMY AND PHYSIOLOGY.
The upper half of the human oesophagus is composed of 
striated muscle and the lower lower half of smooth muscle. 
Between these lies a transitional zone. The structure is 
innervated through the intra-mural and para-oesophageal 
plexuses which are supplied by the sympathetic and 
parasympathetic systems. The latter (via the vagus) is 
most important. Central neurological control of the 
oesophagus lies in the vagal motor nuclei and the adjacent 
reticular activating systems of the brain stem.
TYPES OF ACTIVITY.
Three types of activity may be recorded from the 
oesophagus:
1. Primary Peristalsis, activity initiated by swallowing 
and which conveys food down the oesophagus.
2. Secondary Peristalsis, activity arising in the main 
body of the oesophagus in response to a foreign body 
(e.g. food). This activity need not be preceded by 
swallowing and may be initiated by distending a 
balloon in the oesophagus (provoked lower oesophageal 
contraction - PLOC)
3. Tertiary Activity, non-propulsive activity which 
occurs spontaneously (spontaneous lower oesophageal 
contraction - SLOC). This activity appears to arise 
in the oesophageal motility centres of the brain 
stem.
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MEASUREMENT OF OESOPHAGEAL ACTIVITY.
During anaesthesia and surgery oesophageal activity 
can be measured using a special probe e.g. Antec Lectron 
301 (Antec Systems Ltd., Oxford). This system comprises a 
35cm long oesophageal probe with a distal, liquid filled 
balloon connected to a pressure transducer; and a 
proximal, air filled balloon designed to provoke secondary 
activity. The technique can only be used in artificially 
ventilated patients, or variations due to oesophageal 
pressure change cannot be differentiated from changes due 
to ventilation.
THE RELEVANCE OF OESOPHAGEAL ACTIVITY.
Although oesophageal activity may occur as a local 
reflex there is evidence that secondary oesophageal 
activity is a reflex mediated at the brainstem. Changes in 
PLOC during anaesthesia may therefore reflect changes in 
brain-stern activity (92). As physiological stress and 
acoustic stimulation are associated with an increase in 
tertiary activity (93), increased SLOC activity might 
indicate inadequate ("stressful") anaesthesia.
THE EFFECT OF NON-ANAESTHETIC AGENTS ON OESOPHAGEAL 
ACTIVITY.
Smooth muscle relaxants such as glyceryl trinitrate 
and sodium nitroprusside decrease (and may ablate) lower 
oesophageal contractility (86). Skeletal muscle relaxants 
have no effect on LOC (94) but intravenous atropine and 
ganglion blocking agents produce substantial changes (86). 
Oesophageal disease can also be expected to affect 
activity.
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CLINICAL EXPERIENCE.
An initial report (94) described an increase in the 
rate of SLOC, and increased amplitude of PLOC, when the 
dose of halo t h a n e  and other anaesthetic agents was 
reduced. In a later study (95) the PRST score (vide supra) 
was used to determine the need for althesin increments, 
and LOC measured before and after each bolus. SLOC rate 
was shown to increase prior to each increment and decrease 
following it. No change in SLOC amplitude occurred.
However, SLOC amplitude has been used successfully to 
determine the requirement of fentanyl supplements in a 
small number (10) of patients (86).
A later study (92) investigated the relationships 
between LOC, MAC and clinical signs (assessed by the PRST 
s c o r e ) .  T h i s  s t u d y  c o n f i r m e d  t h a t  d e c r e a s i n g  
c o n c e n t r a t i o n s  of halothane are associated with an 
increase in the rate of SLOC, an increased amplitude of
PLOC and a rise in the PRST score. Further, increases in
the PRST score, when the end-tidal halothane concentration 
remained stable, were paralleled by changes in LOC. This
suggests that LOC is sensitive to surgical stimulation
(assuming that the PRST score does reflect changes in the 
anaesthetic state).
Thomas and Aitkenhead (96) compared LOC activity in 
two groups of patients anaesthetised with 66% nitrous 
oxide in oxygen supplemented with 0.5% isoflurane. 
Paralysis was achieved with vecuronium. SLOC frequency and 
PLOC amplitude were significantly greater in the second 
group, who underwent abdominal hysterectomy, when compared 
to the first group, who underwent varicose vein surgery.
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The groups were otherwise comparable. This suggests that 
LOC activity reflects the degree of surgical stimulation, 
which is presumed to be greater in the second group.
However, Cox and White (97) found LOC to be absent in 
9 (out of 30) patients, despite clinical evidence of 
inadequate anaesthesia. And, in a study carried out pre- 
operatively (98), neither the rate and amplitude of SLOC; 
the amplitude of PLOC; or the oesophageal contractility 
index (which is derived from SLOC frequency and PLOC 
amplitude) could differentiate the conscious from the 
u nconscious state in the individual. In this study 
d i p rivan was used as the sole anaesthetic agent and 
consciousness was defined as the ability to squeeze the 
investigators hand on command. Overall, statistically 
significant increases did occur during awakening and 
statistically significant decreases during induction in 
all the variables studied.
CONCLUSIONS.
Dose-dependent changes in LOC have been observed and 
these changes can be related to the clinical assessment of 
anaesthetic adequacy. Surgical stimulation appears to be 
associated with increased LOC activity. However, in 
individuals, lower oesophageal activity may be absent 
despite clinically inadequate anaesthesia. Further the 
susceptibility of this response to atropine and the large 
intra-individual variation which occurs on recovery from 
anaesthesia would appear to limit the usefulness of this 
technique. The possible relationship between "stress" and 
LOC deserves further investigation.
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METHODS OF ASSESSING THE ANAESTHETIC STATE 
III) ELECTROENCEPHALOGRAPHY AND RELATED METHODS.
INTRODUCTION.
The electro-encephalogram (EEG) monitors neuronal 
electrical activity. It has been suggested that this 
activity reflects the anaesthetic state. The purpose of 
this section is to clarify the use of the EEG and its 
derivatives in the study of anaesthetic depth.
A CLASSIFICATION OF THE EEG.
Monitors of cerebral electrical activity may be 
classified:
1 Raw EEG
2 Processed (non-evoked) EEG
a) Time Domain Analysers e.g. the Cerebral Function 
Monitor (CFM) and the Anaesthetic Brain Monitor 
(ABM).
b) Frequency Domain Analysers e.g. Compressed 
Spectral Array (CSA).
c) Derived Univariant descriptors of EEG Activity 
e.g. Median Frequency (M F ) and Spectral Edge 
Frequency (SEF).
3 Evoked EEG (potentials)
a) Auditory Evoked Potentials (AEP)
b) Visually Evoked Potentials (VEP)
c) Somatosensory Evoked Potentials (SSEP)
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METHODS OF ASSESSING THE ANAESTHETIC STATE
III) ELECTROENCEPHALOGRAPHY AND RELATED METHODS.
1. THE RAW EEG.
The EEG is c o n v entionally recorded from paired 
electrodes placed symmetrically, in standard positions on 
the scalp (99). Each record consists of signals containing 
different frequencies (0-50 Hz) and amplitudes (10-100 
microvolts). These are nominally divided into five bands 
(1 0 0):
1 D e l t a  w a v e s  ( 0 .5 - 3 H z ,  1 OOuv ) : A s y n c h r o n o u s ,
symmetrical waves occurring in infants and sleeping 
adults, maximal in the frontal lobes.
2 Theta waves (4-7Hz, 1Ouv): Occur in the temporo­
parietal region.
3 Alpha waves (8-13Hz, 50uV): Synchronous, symmetrical 
waves occurring in the parietal and occipital regions 
and a u g m e n t e d  by c l o s i n g  the eyes and m e n t a l  
relaxation.
4 Beta waves (14-15Hz, 20uV): Asynchronous, symmetrical 
waves occurring in the fronto-central areas.
5 Gamma waves (26+ Hz, approx. 10uV): Rare in normal 
subj ects.
The p a t t e r n s ,  s i t e s  of m a x i m a l  a c t i v i t y  and 
amplitudes are different in children and infants. There is 
a large inter-individual variation. For example, in two 
thirds of the population the alpha rhythm disappears on 
eye opening, in one sixth it is present all the time and 
in the remainder tends to be absent when the eyes are 
closed (101 ) .
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USE OF THE RAW EEG IN THE ASSESSMENT OF ANAESTHETIC DEPTH.
Gibbs and his co-workers observed graded EEG changes 
in 3 volunteers under ether anaesthesia and suggested that 
the EEG might be used to assess anaesthetic depth (102). 
In 1950 Courtin and his associates further investigated 
the effects of ether on the EEG (103). They found 
consistent patterns and introduced a classification of 
anaesthetic depth based on these patterns (figure 11).
By the late 1950's the effects of several anaesthetic 
agents on the EEG had been documented. Martin (104) 
reviewed this work and concluded that anaesthesia tended 
to limit individual EEG variation, and constructed a 
general EEG classification associated with increasing 
anaesthetic dose. The 6 levels described were (figure 12):
1 At induction; an increase in frequency to 20 - 30Hz.
2 Associated with loss of Consciousness; large slow 
waves (1-5Hz, 50-300uV), that increase in amplitude 
as they slow.
3 Increasing Depth; waves of irregular form and 
repetition time, which may have faster components 
superimposed as anaesthesia deepens.
4 & 5 Increasing Depth; falling amplitude with periods
of inactivity (burst suppression). This period is 
divided into an early and a late phase.
6 Deep anaesthesia; isoelectric trace.
Faulconer and Bickford (105) cautioned that all 6 EEG 
levels did not occur with some agents and that a similar 
EEG level of anaesthesia does not necessarily indicate the 
same clinical state for different drugs. For example 7 EEG 
levels are described for ether anaesthesia (103); but only
Figure 11.
Level - I
VTT — --------- -------- ------------
O seconds 10
The seven electoencephalographic levels of ether 
anaesthesia described by Courtin and his associates 
(from ref. 103).
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A general classification of the EEG changes which occur 
during anaesthesia.
See text for details (from ref. 104).
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6 for halothane (106,107) and cyclopropane (108); and 5 
for thiopentone (109).
THE EXCITATORY AND DEPRESSANT NATURE OF EEG CHANGES DURING 
ANAESTHESIA.
Anaesthetic agents do not have a uniform effect on 
the EEG. For example, enflurane induces high voltage spike 
wave activity and burst suppression at high concentrations 
(110), not isoelectricity (as Martin's classification 
would require). Each agent, to a greater or lesser extent, 
does not fit Martin's general classification.
Clark and Rosner (111) suggest that drug structure 
systematically influences an anaesthetic agent's effect on 
neuroelectrical activity, with some agents causing central 
nervous system (CNS) excitation (figure 13). Winters (112) 
has proposed a m ul ti di re ct io na l schema to link the 
clinical progression of the anaesthetic state to the 
excitatory and depressive effects different anaesthetic 
agents have on the EEG. This schema proposes that, after 
an initial excitatory phase, anaesthetic agents produce 
their clinical effect by drug induced CNS excitation or 
depression (figure 14). Both these classifications suggest 
that the EEG cannot be used as a simple, uniform measure 
of the anaesthetic state.
Further, the EEG trace from an anaesthetised patient 
may be indistinguishable from that recorded during normal 
wakefulness (113). And a normal alpha rhythm, in the 
immediate post-operative period, may be associated with a 
n o n- re sp o ns i v e  patient (103). The EEG alone cannot 
differentiate the awake and anaesthetised states.
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Figure 13 Inhalational agents, arranged by structure and their 
neuro-electrical effects in man (from ref. 111).
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Figure 14 A multi-directional schema to relate EEG patterns to 
their clinical effects. •
Anaesthetic agents may produce their effects by CNS depression or 
CNS activation. Winters constructed a multi-directional schema to 
relate EEG patterns to their clinical effects (frcm ref. 112).-
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THE RELATIONSHIP BETWEEN DRUG CONCENTRATION AND THE EEG.
S e v e r a l  s t u d i e s  have s h o w n  t h e r e  is a good 
correlation between the EEG level of anaesthesia and drug 
concentration (10 8,114,115,116). The inter-individual 
variability between any single concentration measurement 
and EEG level was large. Both Faul c o n e r  and Possati 
(108,114) describe an "almost linear" relationship between 
drug concentration (of ether and cyclopropane) and EEG 
level. This relationship can only be fortuitous, as the 
units on the ordinate are empirical i.e. the EEG levels 
c a n n o t  be q u a n t i f i e d  but only p l a c e d  in ord e r  of 
occurrence. Brand was unable to correlate EEG changes with 
plasma thiopentone concentration (117).
THE RELATIONSHIP OF CLINICAL SIGNS TO EEG.
Faulconer commented that correlation between EEG 
changes under ether anaesthesia and Guedel's signs was 
inconcl u s i v e  (114). Galla (118), commenting that 
"..clinical signs and the e l e c t r o e n c e p h a l o g r a m  are 
variables related to the brain content of anesthetic" 
compared the traditional clinical signs of anaesthesia to 
visually recognised patterns of EEG activity; in an 
attempt to define the "clinical signs of anaesthesia most 
indicative of the anaesthetic state". He concluded that 
anaesthetic signs should be considered in terms of minimal 
necessary reflex depression and that a combination of 
these signs was a far more practical and sensitive 
indicator of anaesthetic adequacy than the EEG alone. Gain 
(106) failed to find any relationship between the EEG and 
clinical signs using halothane because "no reliable 
clinical signs" were present.
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D u r i n g  t h e i r  a s s e s s m e n t  of h a l o t h a n e  as an 
anaesthetic agent, Robson and Sheridan (107) investigated 
the relationship between EEG changes and the clinical 
signs of anaesthesia described by Guedel. They found these 
signs of anaesthesia to be indistinct. The information 
given suggests that the same clinical level of anaesthesia 
may be associated with different EEG levels. Galla and his 
co-workers were only able to identify two EEG levels of 
anaesthesia with halothane and found clinical signs to be 
more reliable (115).
THE RELEVANCE OF RAW EEG CHANGES TO CLINICAL PRACTICE.
The dose of a drug required to produce all the EEG 
changes described for it are often far in excess of that 
required in clinical practice. Robson and Sheridan (107) 
noted "inadequate respiration" in one patient at EEG Level 
3 under halothane anaesthesia and recorded systolic blood 
pressures of 60 mmHg or less at levels 4 to 6. Gain 
described profound hypotension at these levels (106). 
Galla (115) describes only two EEG levels under halothane 
anaesthesia and his conclusion, that clinical signs were 
more useful than the EEG in assessing anaesthetic 
adequacy, may be that the doses they used were in keeping 
with those required in clinical practice.
Similarly, it is unlikely (with the concomitant use 
of muscle relaxants) that an EEG level greater than 3 is 
necessary under di-ethyl ether anaesthesia or 2 of the 5 
described (110) when enflurane is used. Similar comments 
may be made about most agents.
The corollary of this is, that a pattern of burst
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suppression, which is generally assumed to indicate 
profound cerebral depression, may be associated with 
responsiveness to painful stimulation under hydroxydione 
anaesthesia (119), and retention of the eyelid reflex and 
"small jerky limb movements" following a bolus of althesin 
(120). In neither case can the patient be described as 
clinically anaesthetised. Brand (117) found that burst 
suppression during thiopentone anaesthesia, level 3 as 
described by Kiersey (109), can be associated with a 
response to minimal stimulation (venepuncture) in some 
cases, but be adequate for surgery in others.
PROBLEMS ASSOCIATED WITH THE USE OF THE RAW EEG.
Interpretation of the raw EEG requires specific 
training and is subject several problems (10):
1 Level definition: without a precise definition of 
anaesthesia the validity of the EEG as an indicator 
of anaesthetic adequacy is questionable.
2 Pattern definition: the subjective definition of what 
constitutes a pattern wave form is dependent on the 
observer.
3 Pattern variability: as different agents have 
differing effects on the EEG, pattern recognition is 
complex.
4 Inter-observer variability: experienced observers 
show a poor correlation with each other in the 
interpretation of individual EEGs (121).
Excluding these difficulties (vide supra), there are 
p r o b l e m s  w i t h  i n t e r f e r e n c e  (e.g. d i a t h e r m y )  and 
interpretation in the presence of changes in blood
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pressure, Pa02, PaC02, surgical stimulation etc. The 
standard recording rate of over 10,000 cm/hour makes the 
following of trends impossible.
C o m b i n a t i o n s  of a n a e s t h e t i c  a g e n t s  m a k e s  
interpretation of the EEG more difficult. Clark (111) has 
pointed out that the chaotic nature of the literature 
concerning the EEG effects of some drugs (halothane, ether 
and fluroxene) was due to the use of nitrous oxide by some 
workers. This "chaos" is likely to be greater in clinical 
practice where combinations of drugs are often used and 
other variables not controlled eg. blood pressure. Marshal 
(113) suggests that the effects of some factors may be 
additive e.g. moderate hyperventilation or a slight 
increase in inspired anaesthetic concentration may have 
minimal effects on the EEG alone but in combination 
produce marked changes.
SUMMARY.
The raw EEG will never be a practical tool in routine 
anaesthetic practice. Visual interpretation of the raw 
data requires expertise and is open to observer error. The 
EEG in isolation cannot differentiate the awake from the 
sleeping state and, although dose related changes do 
occur, the changes apparent within the clinical range are 
small and agent specific. The use of anaesthetic drugs in 
combination makes interpretation of these changes more 
difficult.
The literature on computer processed EEG techniques 
suggests that the EEG does contain sufficient information, 
inferring that automated analysis is required for its 
extraction. These techniques will be considered next.
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METHODS OF ASSESSING THE ANAESTHETIC STATE
III) ELECTROENCEPHALOGRAPHY AND RELATED METHODS.
2. THE PROCESSED EEG.
INTRODUCTION.
Micro-processor based, on-line data acquisition 
techniques make it possible to transform, compress and 
display the raw EEG signal into more easily understood 
forms. These techniques derive frequency and amplitude 
data from the raw EEG signal but generally ignore aspects 
such as wave-form.
During signal quantification some of the information 
contained in the original EEG signal is lost while other 
aspects may be enhanced. As this is dependent on the 
processor used, it is important to appreciate how the 
ch a ra cteristics of a given machine may effect the 
interpretation of a standard input signal.
THE FUNDAMENTALS AND LIMITATIONS OF SIGNAL PROCESSING.
Processing an EEG signal consists of 4 basic steps:- 
d a t a  a c q u i s i t i o n ,  s ig na l  a m p l i f i c a t i o n ,  s i g n a l  
quantification and display of the processed signal. Each 
of these effects the way the information contained in the 
original signal is presented to the user.
1. Data Acquisition.
The electrodes are potentially the weakest link in 
any EEG system. The electrodes must be properly applied 
and impedance monitored to warn the operator of output 
changes due to electrode drift. As the optimal recording 
site for the various clinical applications of these
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machines has not been determined some inconsistencies may 
be due to the use of different electrode positions.
Prior and Maynard (122) suggest the use of parietal 
electrodes as cerebral activity is maximal in this region 
during anaesthesia, it overlies the boundary zone between 
the three main cerebral arteries and minimises muscle 
artefact. The ABM (vide infra) uses a fronto-mastoid 
position to pick-up this "muscle artefact" which is then 
processed and displayed on a separate channel. Simple 
"stick-on" ECG electrodes can be used in the latter 
situation, which has an obvious practical advantage.
2. Amplification.
The ability of an EEG processor to accurately amplify 
the EEG signal depends on its sensitivity, linearity, 
frequency response, band-width, phase-shift distortion and 
noise rejection characteristics. As the amplifier 
characteristics of the various machines differ the output 
signal obtained from any given input signal varies between 
machines (figures 15 and 16).
3. Signal Quantification.
Although several automated analytical techniques have 
been used to quantify the EEG signal, few are available 
c om mercially (125). They may be divided into those 
analysing a period of time (time domain analysers) and 
those analysing a certain frequency range (frequency 
domain analyser). This distinction is historical and, to 
an extent, arbitrary but useful descriptively.
Time domain analysers determine the mean integrated 
voltage of successive EEG epochs to provide an overall
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Figure 15. Processed EEG amplitude from the ABM and ABM2 
Although the frequency response of the ABM and ABM2 are 
similiar; the output of the ABM2 is designed to be 
proportional to the input from 3-100 uv while the output 
of the ABM is proportional to the logarithm of the input 
from 3-60 uv (from ref. 123).
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Figure lb. The effect of different low cut off filters.
The time course of mean amplitude during carotid end- 
arterectomy. Tne four curves refer to four different 
low cut off frequencies. If a high cut off is selected 
a reverse in trend can be observed (from ref. 124).
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indication of amplitude. Most processors of this type 
derive frequency information from the analysed epoch. The 
ABM and CFM are examples of this type of machine and are 
discussed in more detail below.
F r e q u e n c y  d o m a i n  a n a l y s e r s ,  for e x a m p l e  the 
Compressed Spectral Array (CSA), generate successive power 
spectra from short (2-30 second) epochs using fast fourier 
transformation. Each spectrum is represented as a smoothed 
histogram (figure 17).
4. Display.
The alternatives for d is play of processed EEG 
information determined in the time domain are, to an 
e x t e n t ,  l i m i t e d .  T h e  f r e q u e n c y  a n d  a m p l i t u d e  
characteristics being displayed separately against time. 
The type of display and scale used differ greatly from 
machine to machine.
F r e q u e n c y  d o m a i n  a n a l y s e r s  use p s e u d o - t h r e e  
d imensional plots of s uccessive power spectra as a 
function of time. The method of display, duration and 
frequency of epoch analysis and amplitude scaling may 
effect the interpretation of data, obtained from the same 
amplifier.
ARTEFACT AND OTHER SOURCES OF ERROR.
Artefact may be intrinsic (ie. from unwanted 
biological sources eg. the heart, muscle and eye) or 
extrinsic (ie. from the environment eg. diathermy, faulty 
electrode contacts and the mains electricity supply). 
Artefact is detected in the raw EEG by visual examination, 
following processing this may be impossible. Automatic
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Figure 17. A schematic representation of the process of power 
spectrum analysis.
The original waveform (A) is digitised by repeated sampling at 
short intervals. Fourier analysis is carried out on each epoch 
of data (8). The results (C) give the amplitude of activity in 
each frequency band. These amplitudes are squared to produce 
power histograms (D) which are smoothed and plotted sequentially 
('£). Compressing (F) and suppressing lines that would lie 
behind a hill produces the final compressed spectral array (G) 
(from ref. 125).
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artefact detection systems remain to be perfected, and 
this alone must limit the clinical usefulness of these 
systems (126).
NUMERIC EEG INTERPRETATION.
Further simplification is possible, with the original 
signal being represented by a single number (eg. spectral 
edge frequency, median frequency, median power frequency 
etc.). This type of approach may be used to generate 
enormous amounts of data. For example, a system has been 
reported which separates the EEG into 30 1-Hz bins (0.5 - 
1.5, 1.5 - 2.5 Hz etc.) (126), and describes each bin 
numerically with regard to the number of waves and power 
present for any given epoch. This generates 153 numbers 
for each analysed epoch, which may itself be as short as 2 
seconds. The validity of these numbers as a measure of the 
anaesthetic state is unknown.
OVERVIEW.
The presentation and content of the information 
derived from any given EEG signal is highly dependent on 
the EEG processor used, as diffe r en t frequency and 
amplitude components contained in the original signal may 
be e n h a n c e d  or s u p p r e s s e d  d u r i n g  a m p l i f i c a t i o n ,  
quantification or display. Some systems, such as the 
compressed spectral array, contain a lot of information 
but present it in a form which may itself require skilled 
interpretation. Others such, as the univariate descriptors 
of E EG a c t i v i t y  m ay not a d e q u a t e l y  r e p r e s e n t  the 
multimodal power spectra often present during anaesthesia 
or fail to reveal some EEG patterns eg burst suppression
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(127). Figure 18 shows how the spectral edge frequency may 
misrepresent overall EEG activity.
THE CFM, CFAM AND ABiM.
The cerebral function monitor (CFM), cerebral 
function analysing monitor (CFAM) and the anaesthesia and 
brain monitor (ABM) have been most extensively studied in 
this field.
THE CEREBRAL FUNCTION MONITOR.
The CFM amplifies, filters, compresses and rectifies 
the original EEG signal to produce a trace on a slow speed 
semi-logarithmic chart (122). The trace is dependent on 
the frequency and amplitude characteristics of the 
original EEG signal and has two main characteristics; a 
lower border which gives an indication of overall cerebral 
activity and a width which reflects the variability of 
cerebral activity (figure 19).
The filter reduces the emphasises of the lower 
frequencies (diagram 20). This is necessary, as the 
electrical energy in the EEG tends to d ec rease with 
increasing frequency and weighting is required if the high 
frequency components are to be adequately represented on 
the display used.
Impedance is monitored on a separate channel and an 
overload network monitors the peak voltage, cutting out 
both channels if the system becomes overloaded. These 
aspects are useful for artefact detection.
THE CEREBRAL FUNCTION ANALYSING MONITOR.
The CFAM is a development from the original CFM
(128). Two input channels allow the operator to alternate
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Figure j.8. SEF and overall EEC activity.
A comparison of the SEF and the density modulated spectral array 
In this sequence a low frequency band slowly decreases in 
amplitude (density in the diagram) to (B) where it stops 
abruptly. A high frequency band gradually decreases in frequency 
and increases in amplitude. At (A) the SEF represents low 
frequency activity while after (B) the same numeric value 
represents high frequency activity (from ref. 127).
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Figure 19. Diagrammatic representation of the general types 
of CFM activity.
These traces may be described according to the level of 
activity, band width and degree of fluctuation. The lower 
border of the trace indicates the lowest peak to peak voltage 
against time, the upper border the highest peak to peak voltage 
against time and the width the variability in signal amplitude. 
Note the burst suppression in the low level trace (from ref. 122)
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Figure 20. The frequency response of the CFM.
The filter is designed to sharply reject frequencies below 2Hz 
and above 20Hz. Amplification increases with frequency from 
2Hz (from ref. 122).
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between recording sites. The amplitude distribution is 
smoothed over 20 seconds and plotted on a logarithmic 
scale as the mean, 10th. and 90th. centiles of the derived 
value. Absolute maximum and minimum amplitude values are 
superimposed. Frequency information is displayed as the 
percentage of activity in each of the classic frequency 
bands; very low frequency waves (less than 1 Hz) being 
plotted separately. The percentage of time that the EEG 
amplitude is below a pre-set level (1 - 5 Hz), and muscle 
activity (in the 200 - 1000Hz band) are both indicated on 
separate channels (figure 21). This machine may be used to 
measure evoked potentials.
THE ANAESTHESIA AND BRAIN MONITOR.
The ABM selectively filters the input signal through 
low and high pass filters to monitor both the EEG (1.5 - 
25Hz) and the EivIG (65 - 300Hz). Notch filters eliminate 
interference from the mains source and its harmonics and 
an additional filter removes the DC component to prevent 
errors in the calculation of the zero crossing frequency 
(ZXF). This technique is used to calculate the frequency 
content of the original signal (figure 22).
The filtered potentials are full wave rectified, 
integrated and passed through log amplifiers i.e. 
amplifiers whose output is proportional to the log of the 
input. Both the EEG and EMG amplitude data are presented 
on relative linear scales of 0 - 100 EEG (or EMG) units. 
One hundred EEG units represent 60uV and 100 EMG units 
15uV. The display is updated every 10 seconds (figure 23).
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Figure 21. A simulated CFAM trace.
From top to bottom. Time marker at one minute intervals; 
the 90th, mean and 10th centile of the weighted amplitude; 
muscle activity; the percentage activity in the beta, alpha, 
theta and delta bands; the percentage of very low frequency 
activity; the suppression band; and electrode impedance 
(from ref. 128).
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Figure 22. Calculation of the ZXF and integrated amplitude.
Each time the EEG crosses the isoelectric line an impulse 
is sent to the computer. The total number of pulses divided by 
the time epoch, expressed in seconds, is the ZXF. From the 
same epoch the voltage is integrated and the mean calculated, 
to give a value of amplitude (from ref. 129).
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Figure 23. The ABM display.
The display shows EMG (0-100 arbitrary units) and the EEG as 
the ZXF (0-20Hz) and integrated amplitude (0-100 arbritary 
units). An elevation of the base-line dot of the EMG and dotted 
EEG bars indicate artefacts (from ref. 123).
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THE RELATIONSHIP BETWEEN ANAESTHETIC DOSE AND THE
PROCESSED EEG.
Prior (130) and her co-workers compared visually 
rated EEG strips with CFM and CFAM traces obtained from 
unstressed primates anaesthetised with althesin infusions. 
The six recognised EEG "depths" of anaesthesia could be 
distinguished by the automated methods. The combination of 
absolute voltage, voltage variability and frequency 
content gave optimal recognition of the EEG "depth".
Frank (131,132) and others (133,134,135) have shown 
that single amplitude, frequency and other univariate 
descriptors of the EEG can be correlated with the plasma 
levels of induction agents (thiopentone, althesin and 
etomidate). These simple relationships may not hold 
following induction, during deep anaesthesia (125) or when 
combinations of drugs are used (136). The effects of 
surgical stimulation have not been evaluated (vide infra).
USE OF THE CFM IN CLINICAL PRACTICE.
Dubois and his co-workers (137) used the CFM to 
monitor 121 patients undergoing a variety of surgical 
procedures, lasting from 5 minutes to 6 hours. Induction 
and maintenance of anaesthesia was achieved with one of 
six intravenous agents, supplemented with fentanyl (1- 
5ug/kg). Several effects are described:
1. Changes at Induction.
2. Changes during maintenance.
3. The effect of surgical stimulation.
4. The effect of volatile agents.
It is difficult to draw conclusions from this work.
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Although a great deal of information is presented and a 
large number of patients were studied, the number who did 
(and did not) demonstrate the effects describe are not 
mentioned and the information given is qualitative rather 
than quantitative. However this work does form a base 
from which the processed EEG can be discussed. To prevent 
unnecessary repetition, information from other studies 
will be included in the relevant sections.
1. CHANGES AT INDUCTION.
At induction CFM activity increased to a peak, and 
the patients lost consciousness at this point (figure 
24). This effect was independent of the induction agent 
used. A similar effect, which might be anticipated from 
the work done on the raw EEG, has been demonstrated with 
the CFAM (128) and the ABM (138).
2. CHANGES DURING MAINTENANCE.
Changing the infusion rate during maintenance was 
followed by changes in CFM activity (figure 25). A group 
of ("mainly") gynaecological patients under CFM control 
was compared to a retrospective control group and a 30% 
reduction in althesin requirement described. Although the 
authors claim that the CFM allowed better regulation of 
a n a e s t h e t i c  dose, no m e n t i o n  is m a d e  a b o u t  the 
comparability of the groups with regard to age, type and 
duration of procedure, fentanyl dose-age, clinical state 
during the operation etc.
When the trace falls from above the base-line 
interpretation may be difficult, as this may represent 
lightening or deepening anaesthesia. The authors suggest
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Figure 24. Induction peaks on the CFM.
Following a bolus of anaesthetic an induction peak is seen on 
the CFM trace (from ref. 137).
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Figure 25. The effect of varying althesin infusion rates on 
the CFM trace.
Changes in the rate of althesin administration are associated 
with changes in the CFM trace (from ref. 137).
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that a bolus of anaesthetic will differentiate these 
states, a second peak indicating re-induction (and that 
the patient was light) and a fall in the trace deepening 
anaesthesia. Although Maynard and Jenkinson describe an 
increase of beta activity during lightening anaesthesia
(128), a high level of beta activity can occur during 
clinically adequate anaesthesia (139).
Sechzer and Ospina (140) assessed the CFM in 100 
p a t i e n t s  d u r i n g  s u r g e r y  u s i n g  a w i d e  v a r i e t y  of 
anaesthetic techniques. No change in CFM voltage occurred 
in 80 to 100% of the trials, depending on the agent used. 
With some agents activity increased in some cases, but 
decreased or did not change in others.
Major found the CFM to give no additional information 
and dispensed with it the latter part of his investigation 
of ai-isopropylphenol, relying on traditional clinical 
signs (141 ).
Edmonds (138) found that, neither alone or in 
combination did the frequency and amplitude parameters 
derived by the ABM consistently accompany clinical changes 
in anaesthetic depth. During recovery, the inter-patient 
variability was so large that emergence could not be 
distinguished from maintenance.
3. THE AROUSAL RESPONSE AND SURGICAL STIMULATION.
Surgical stimulation was associated with narrowing 
and/or upward movement of the trace, which the authors 
describe as "arousal" and suggest is due to inadequate 
analgesia. "Arousal" is not synonymous with "awareness", 
and describes changes in EEG activity which may be related
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to an external stimulus.
The "K complex" is a diffuse wave with at least two 
components which spreads over the cortex following sensory 
stimulation in the sleeping subject (142). The response 
only occurs if the subject fails to awaken (101), is 
exaggerated in patients with abnormally functioning brains 
and may occur spontaneously (i.e. no with no assignable 
cause) (142). It is maximal following auditory stimulation 
and the fast component may herald a partial arousal from 
sleep.
Suxamethonium induces low voltage, fast wave activity 
in adults and high voltage, slow wave activity in children 
anaesthetised with halothane (143). These responses are 
blocked by pre-treatment with gallamine and alcuronium; 
are associated with an increase in heart rate; and, in 6 
out of the 8 patients studied, with an increase in blood 
pressure. Oshima (144) studied 62 patients anaesthetised 
with halothane and observed these changes in 77% of cases 
following suxamethonium and in 88% of cases following skin 
incision. Increases in heart rate, blood pressure and 
pupillary diameter occurred in all cases. These workers 
concluded that the response was secondary to central 
nervous system activation. Infants (less than 2 months 
old) did not demonstrate eeg changes to either stimulus. 
No mention of possible artefact contamination, due to 
suxamethonium induced fasiculation, is made in these 
studies
Bimar (145) used a CSA to assess these responses in 
36 patients during surgery. Characteristic (vide supra) 
changes occurred in 24 patients. Irregular respiration
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occurred in 9 patients and cardiac arrythmias in 5. No 
mention is made of heart rate or blood pressure changes. 
These changes were usually associated with a surgical 
manoeuvre but this could not be quantified.
Savege and his co-workers assessed the autonomic and 
cerebral responses to pre-tibial pressure using the CFM 
(65). Light althesin and pancuronium anaesthesia was 
associated with continuous variability in blood pressure 
and heart rate. These became less variable as the dose of 
a l t h e s i n  i n c r e a s e d .  A s l i g h t  r e d u c t i o n  in t h e  
card io va sc ul a r response to stimulation followed an 
increase in anaesthetic depth, as judged by the CFM. 
Fentanyl in small doses obtunaed this response and, in 
larger doses (9ug/kg), had this effect despite increasing 
CFM activity. The authors concluded that althesin was a 
potent cerebral depressant which had minimal effects on 
the cardiovascular response to stimulation and that the 
dose of althesin should be limited to that required to 
"depress consciousness"; as larger doses delay recovery 
without improving the "quality" of anaesthesia.
4. VOLATILE AGENTS.
In the initial study of the CFM a small, unspecified 
number of patients were anaesthetised with halothane or 
enflurane in nitrous oxide. These agents caused a gradual 
increase in cerebral activity and attempts to "deepen 
anaesthesia and depress the trace" required concentrations 
of 3-5% which resulted in hypotension. The addition of 
halothane to a previously established intravenous 
anaesthetic was associated with depression of the trace.
The relationship between CFAM activity and volatile
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anaesthetic agents has been assessed by several workers: 
Sebel (139) describes increased delta and theta activity 
and a fall in amplitude during deepening halothane - 
nitrous oxide - oxygen anaesthesia. Increased alpha and 
beta a c t i v i t y  and a ri s e in a m p l i t u d e  f o l l o w e d  
discontinuation of the nitrous oxide. Discontinuing the 
halothane had minimal effects. In this study, minimal 
amplitude changes and significant beta activity were 
recorded from one of the five patients studied, despite 
clinically adequate anaesthesia.
Wark (146), used halothane as a sole agent in 8 
patients. The CFAM amplitude increased at 1 MAC and 
decreased at 2 MAC. A progressive decreases in beta 
activity and increases in delta activity occurred.
Williams (147) studied the effects of 10, 30 and 50% 
nitrous oxide in 15 volunteers. Only 9 completed the 
study. Significant reductions in amplitude occurred in the 
30 and 50% trials and significant increases in amplitude 
occurred on termination of the gas (with respect to the 
control values). However, the frequency changes were 
variable and the subjective effects of the nitrous oxide 
remained after the trace had returned to normal.
UNIVARIATE DESCRIPTORS OF ANAESTHETIC DEPTH.
EEG processing converts an analogue signal to a 
digital signal. The digitised signal may be described by a 
single number or a group of numbers. Some of these numbers 
have been used in the assessment of anaesthetic depth. On 
only three of these, Spectral Edge Frequency, Median 
Frequency and Zero Crossing Frequency, is there sufficient
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data available to allow evaluation.
1. SPECTRAL EDGE FREQUENCY (SEF).
R a m p i l  (148) d e f i n e d  the SEF as the " h i g h e s t  
frequency at which a significant amount of energy is 
present". Hudson (133) quantified this as the frequency 
below which 95% of the energy in the EEG is contained. 
This definition is not universal. The "Neurotrac" 
(Interspec Ltd.), for example, uses a 97.5% energy cut-off 
to define the SEF.
In the original animal study (148), the SEF responded 
r a p i d l y  to c h a n g e s  in h a l o t h a n e  a n d  e n f l u r a n e  
concentration and was not effected by nitrous oxide or 
phenylephrine induced hypertension. A large inter-animal 
variation in response was present although the effect was 
reproducible in each animal.
Hudson (133) has shown that the SEF reflects changes 
in thiopentone concentration at induction. Arden (134) 
demonstrated similar changes with etomidate but found 
discrepancies between drug concentration and the SEF 
during the the recovery (figure 26). In this study the 
median frequency was shown to change during both phases.
Patients with a SEF of less than 1 4Hz following 
induction with thiopentone, fentanyl and droperidol have a 
significantly smaller pressor response to laryngoscopy and 
intubation than those with a SEF greater than this value 
(149). No correlation was found between pre-induction 
blood blood pressure and the magnitude of the response. 
The SEF criteria described may be agent dependent and 
require determination for each drug and combination of 
drugs used.
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Figure 26. The effect of a bolus of etomidate on the SEF and MF,
Although the SEF reflects changes following induction with an 
infusion of etomidate, it does not reflect the recovery period. 
The median frequency reflects both phases (from ref. 134).
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The SEF is insensitive to low frequency changes or 
when the p o w e r  d i s t r i b u t i o n  is b r o a d  or b i - m o d a l  
(127,150). Further, up to 60% of the total EEG energy may 
occur in the 0.5 - 2Hz band during during surgery (150). 
The SEF may not adequately reflect overall EEG activity in 
this situation while other monitors e.g. the CFM filter 
out these components.
2. ZERO CROSSING FREQUENCY (ZXF).
The frequency information obtained from the ABM 
(which uses the ZXF) is of limited use (vide supra) in 
this field. Klein and Davis (151) used discriminant 
analysis, based on derived EEG and cardiovascular 
parameters, to differentiate between "light", "medium" and 
"deeply" anaesthetised subjects, in two patient group 
sets. The "lightly" anaesthetised group was given 70% 
nitrous oxide in oxygen (and used in both patient sets); 
the " m e d i u m "  g r o u p s  r e c e i v e d  60% n i t r o u s  o x i d e  
supplemented with 1% halothane or 1% enflurane; and the 
"deeply" anaesthetised received groups 60% nitrous oxide 
and 2% halothane or 2% enflurane. This study was carried 
out pre-operatively.
The best p r e d i c a t i v e  accuracy for the "light", 
"medium" and "deep" halothane groups were 90.0, 83.3 and 
86.7 percent; and for the enflurane groups 96.7, 83.3 and 
90 percent. Although these results may be described as 
"encouraging", the patients were not operated on and the 
discriminator appears agent dependent.
Use of the ZXF has been criticised by Levy (125). It 
is sensitive to small changes in amplitude and the same
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ZXF may be derived from very different EEG wave-forms 
(figure 27) .
3. THE MEDIAN FREQUENCY (MF).
The MF is defined as "the median (50% quantile) of 
the power spectrum regarded as a distribution" (150). 
Schwilden and Stoekel compared several univariate EEG 
descriptors, in 14 patients during surgery (150). The 
patients were paralysed and received either 1.3 MAC or 1.5 
MAC isoflurane in nitrous oxide and oxygen. Zero point six 
MAC was allowed for the nitrous oxide. The percentage of 
activity in 5 frequency bands, M F , SEF and overall 
amplitude were examined. None of the criteria could 
differentiate between the groups for any given epoch. MF 
was the best discriminator between the recordings during 
anaesthesia/ surgery and control/ recovery (figure 28). 
The authors concluded that MF, at a level of 5Hz signifies 
adequate anaesthesia as emergence occurred at frequencies 
greater than 5hz.
In this study periods of burst suppression (which 
violates the assumptions of spectral analysis) and 
a r t e f a c t  w e r e  r e j e c t e d  m a n u a l l y .  If any of these 
techniques are to be widely applied these functions must 
be automated.
A s t u d y  (152), in w h i c h  13 v o l u n t e e r s  were 
anaesthetised with methohexitone using a feed-back control 
system designed to maintain the MF at 2 - 3 Hz, confirmed 
that the most prominent frequency shift occurred in the
0.5 - 2 Hz frequency band. However, during the recovery 
phase, 3 of the 13 cases opened their eyes to command when 
the MF was at or below 5Hz.
Figure 27.
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Figure 23. The distribution of EEG activity: baseline, during 
surgery and following recovery.
The left hand side figures depict the preoperative distribution 
of percentage activity in 5 frequency bands, the median 
frequency, the SEF (95% quantile) and overall amplitude. The 
right hand side figures depict these variables during surgery 
(shaded) and following response to command (from ref. 150).
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e e g  r e c o g n i t i o n  o f  c l i n i c a l l y  d e f i n e d  a n a e s t h e t i c  s t a t e s .
Some of the techniques described have attempted to 
differentiate between two or more dose defined anaesthetic 
states. Others have attempted to use the processed EEG to 
differentiate between clinically identified anaesthetic 
states.
McEwen and his co-workers (10) defined 5 clinically 
significant levels of anaesthesia, based on non-EEG 
criteria, for patients anaesthetised with halothane and 
nitrous oxide:
1 . Conscious
2. Light Anaesthesia; tachycardia and hypertension to 
surgical preparation and stimulation.
3. L i g h t  S u r g i c a l  A n a e s t h e s i a ;  no r e s p o n s e  to 
preparation. Tachycardia and hypertension to surgical 
stimulation.
4. Surgical Anaesthesia; no response to surgery. Mild 
hypotension (blood pressure within 20% of normal).
5. Deep s u r g i c a l  A n a e s t h e s i a ;  b r a d y c a r d i a  and 
hypotension, blood pressure less than 20% of normal.
A computer based EEG pattern recognition system was 
devised using values extracted from sets of time and 
frequency domain features. Statistical analysis shov/ed the 
EEG criteria to correctly estimate the clinically defined 
anaesthetic state in 50 - 94% trials, depending on the 
type of analysis used.
A similar study (9) extracted features from power 
spectral analysis of the EEG. The performance of this 
system was estimated at 55 - 80%.
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W h e n  t h e  i n t e r - r a t e r  v a r i a b i l i t y  in E E G  
interpretation is considered (121), these systems are 
surprisingly good. Further work is required both in the 
anaesthetic definition and the feature extraction systems 
before the usefulness of this approach can be ascertained.
CONCLUSION
If t h e  r a w  E E G  s i g n a l  c o n t a i n s  s u f f i c i e n t  
information, and the relevant features can be identified 
and extracted by EEG processors then these techniques 
would be useful. Although some techniques have been shown 
to reflect changes in both determinants of the anaesthetic 
state (surgical stimulation and anaesthetic dose) it is 
not known if these are a valid reflection of the true 
anaesthetic state. Further, all automated techniques 
depend on the data following trend rules e.g. that is is 
analysable as a certain number of sine waves. These rules 
may be violated by some waveforms e.g. burst suppression. 
This limitation and, the limitations of automated artefact 
detection techniques must be overcome.
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METHODS OF ASSESSING THE ANAESTHETIC STATE
III) ELECTROENCEPHALOGRAPHY AND RELATED METHODS.
_3 THE EVOKED EEG.
INTRODUCTION.
S e n s o r y  e v o k e d  p o t e n t i a l s  ( S E P )  a r e  t h e  
electrophysiological response to the stimulation of 
peripheral or cranial nerves. They are believed to arise 
during the p r o p a g a t i o n  of impulses centrally and 
demonstrate the functional integrity of the speci fic 
sensory pathway under investigation and, to an extent, the 
function in adjacent structures (153). These stimulus 
specific, event-related potentials represent only 1% of 
the amplitude of ongoing EEG activity (154) and can be 
extracted from this background "noise", which is random in 
nature, by averaging or summing multiple EEG segments 
time-locked to a repetitive sensory stimulus. This may 
require over 2000 separate stimuli and take over 5 
minutes.
A lt h o u g h  SEP monitoring generates numerically 
quantifiable data with regard to the latency and amplitude 
components of the evoked wave-forms, recognition of the 
individual waveforms may involve a degree of subjectivity 
(155) and care must be taken to ensure the correct 
identification of the specific waves (156).
Auditory, visual and somatosensory stimuli may be 
used. Auditory evoked potentials are the easiest to record 
in theatre (157). Current nomenclature defines these 
potentials with reference to the point of measurement 
(i.e. electrode position) and by description of the 
extracted waveform; in terms of latency (in milliseconds),
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amplitude (in millivolts) and polarity. Potentials 
measured close to their source of generation are referred 
to as "near field" and those distally as "far field" 
(158). The latency and amplitude values are dependent on 
the technique used and normal values have to be defined by 
each laboratory (153).
With respect to anaesthetic depth, auditory evoked 
potential (AEP) have been have been most examined and will 
be described further.
The Auditory evoked responses consist of (figure 29):
1. A first section consisting of six peaks (I-VI) which 
can be recorded in the first 9 m s e c ”  ^ and are 
believed to arise from specific anatomical sites from 
the acoustic nerve to the medial geniculate body 
(brainstem component).
2. A s e c o n d  s e c t i o n  c o n s i s t i n g  of f i v e  w a v e s  
(No,Po,Na,Pa & Pb) recorded at 8-50msec”  ^ and are the 
result of neural activity between the thalamus and 
the cortex (early cortical or middle latency 
component).
3. A third section recorded at 50-500msec_i , represents 
wide-spread activation of the frontal cortex (late 
cortical component).
The e f f e c t s  of a n a e s t h e t i c  a g e n t s ,  or o t h e r  
variables, is described with reference to the latency and 
amplitude of the individual components. Latencies between 
individual peaks (IPL) allows assessment of the conduction 
times between the periphery and the brainstem (IPL I - 
III) and through the brainstem itself (IPL III - V) (154).
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Figure 29. The auditory evoked potential.
The upper diagram illustrates the AEP waveform and the lower 
diagram the different auditory pathways involved (from ref. 156).
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the e f f e c t s o f a n a e s t h e t i c  a g e n t s o n t h e a e p .
In a series of small studies (15 6,159,160,161, 
162,163) workers at Northwick Park found the volatile 
agents (isoflurane, enflurane and halothane) and the 
intravenous agents (althesin, etomidate and diprivan) 
cause d o s e  r e l a t e d  c h a n g e s  on the e a r l y  c o r t i c a l  
components of the AEP. These studies were were carried out 
pre-operatively. In general, the patients were induced 
with thiopentone, paralysed with pancuronium and 
ventilated to normocarbia with a mixture of nitrous oxide 
and oxygen.
The effects of the volatile and intravenous agents on 
the brain-stern components of the AEP are different.
VOLATILE AGENTS.
Although Duncan (164) and Rosenblum (165) found 
halothane and enflurane to have no effect on the brainstem 
components, other workers have described dose related 
changes with these (15 6,159,166) and other agents 
(163,167). The changes described by different groups are 
at variance. For example, Heneghan (163) found the 
latencies of waves III and V to increase with increasing 
isoflurane concentrations up to 2.85%, while Manninen 
(167) has desc r i b e d  a plateau effect at isoflurane 
concentrations greater than 1.0%.
Comparing the effects of halothane, enflurane and 
isoflurane on the AEP, with respect to MAC, Heneghan (163) 
found quantitatively similar changes in the latencies of 
waves III and V and the amplitudes of the middle latency 
waves Pa and Nb. The latencies of waves Pa and Nb were 
found to differ.
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In the studies done by the Northwick Park group (see 
above) a small number of patients (6 in total) were 
studied during the reversal of anaesthesia. With all 
agents recovery of waves Pa and Nb occured, although this 
was not always be associated with recovery of the 
brainstem components (156).
A recent cross-over comparison of nitrous oxide (60%) 
and isoflurane (0.6%) demonstrated a significantly lower 
amplitude in waves Pa and Nb in the isoflurane trials, 
despite similar MAC levels (168). Sebel investigated the 
effects of nitrous oxide on evoked potentials in 7 
volunteers (169). The latencies of brainstem audio-evoked 
potentials were not effected, however the amplitudes of 
both the v i s u a l  e v o k e d  p o t e n t i a l s  (VEP) and the 
somatosensory evoked potentials (SSEP) were significantly 
reduced.
The volatile agents all increase the latency and 
decrease the amplitude of the cortical components of the 
somato-sensory evoked potential (170,171). Peterson (171) 
found the changes to be most pronounced with enflurane and 
least with halothane. The effect of isoflurane was 
intermediate. In this study, discontinuation of nitrous 
oxide resulted in substantial recovery of latency and 
amplitude. Pathak (170) found isoflurane and enflurane to 
have a lesser effect on the cortical components of the 
SSEP than halothane. Both these studies suggest that, with 
respect to MAC, the three agents have different potency.
Dose related changes have been demonstrated on the 
cortical component of the VEP under halothane anaesthesia 
(172). A large inter-individual variation was present, the
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latency at the highest halothane concentration (1.13%), in 
some subjects, was less than the awake control value of 
others.
INTRAVENOUS AGENTS.
Etomidate and Althesin (160,162) have no effect on 
the brain-stern components of the AEP, but significant, 
dose related effects on the middle latency components Pa 
and Nb. Diprivan (161) increases the latency and decreases 
the amplitude of the middle latency components of the AEP 
and increases the latency of waves III and V of the 
brainstem component. No increase in brainstem conduction 
time (IPL III-V) was apparent.
It has been suggested (162) that the lack of effect 
of etomidate and althesin on the brainstem components of 
the AEP, in conjunction with studies of regional glucose 
metabolism in the rat under althesin anaesthesia (173), 
indicate that important site of anaesthetic action is in 
the forebrain.
OTHER FACTORS.
Stockara has emphasised a standard protocol and 
demonstration of reproducibility are crucial prior to 
interpretation (154).
C a r b o n  d i o x i d e  s t a t u s  is a v a r i a b l e  o f t e n  
uncontrolled during anaesthesia. Thornton (156) found an 
increased end-tidal carbon dioxide tension to have no 
effect on the latency of wave III and only a small, but 
statistically significant effect, on wave V at a constant 
end-tidal concentrations of enflurane. Hypocapnia has been 
shown to significantly increase the latencies of the
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brainstem components of the AEP (166). Other factors such 
as hypothermia may significantly increase latency (153).
THE EFFECTS OF SURGICAL STIMULATION.
In a small study of 11 patients, surgical stimulation 
increased the amplitudes of waves Nb and Pb/Pc in 8 and 9 
cases r e s p e c t f u l l y  (174). On l y  3 of the p a t i e n t s  
demonstrated an increase in autonomic activity and there 
was no relationship between the increased activity and 
changes in the auditory evoked response.
SUMMARY.
Both the evoked and non-evokea, processed EEG respond 
to changes in anaesthetic dose and surgical stimulation. 
It is therefore likely that some measure of EEG activity 
does reflect the true anaesthetic state. However, several
problems remain to be solved:
1 Artefact rejection systems must be perfected.
2 Although "arousal" responses have been demonstrated 
in response to surgical and other stimuli (vide 
supra), their relevance is unknown. Specifically, 
these responses have not been related to awareness 
(see chapter 4 ).
3 Many of the techniques described appear to be agent
dependent or are affected by "non-anaesthetic" 
variables e.g. carbon dioxide status.
4 The usefulness of the various techniques proposed 
have not been fully assessed.
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METHODS OF ASSESSING THE ANAESTHETIC STATE 
IV. ELECTROMYOGRAPHY.
In 1961 Fink (175) described electromyography (EMG) 
as an "interesting adjunct to the close observation of 
surgical patients." The introduction of the ABM (vide 
supra), which has the facility to monitor spontaneous 
frontalis muscle activity (SEMG), and the suggestion that 
increasing SEMG activity is an early sign "of arousal and 
potential awareness" (176), has revived interest in this 
technique. This suggestion followed the observation of 
increasing SEMG activity during the recovery period. Since 
that time several observations and claims have been made 
about the usefulness of SEMG (177):
1 Induction of anaesthesia is associated with a fall in 
EMG activity.
2 EMG a c t i v i t y  reflects the state of abdominal 
relaxation.
3 The frontalis muscle is resistant to neuro-muscular 
blocking agents.
4 Increased EMG activity indicates impending awareness.
Although EMG activity falls after induction the 
change cannot be quantified as the spontaneous activity in 
the awake subject often saturates the pre-amplifier (138). 
Although "adequate" anaesthesia was associated with 
decreased EMG activity in this study, no change in 
activity was found in 50 (of 58 cases studied) when 
"anaesthetic depth" was decreased. An abrupt increase in 
activity did occur during emergence but this was usually 
coincidental with movement.
Edmonds and his co-workers (178) found skin incision
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to have no effect on SEMG activity, mean arterial 
pressure, heart rate or zero crossing frequency. However, 
auditory stimulation caused significant increases in SEMG 
activity although the cardiovascular parameters remained 
unchanged. However the mean change was only 1.9uV and 
changes of this magnitude are not obvious on the ABM 
display.
A significant correlation between log EMG activity 
and log pain scores was found in the post-operative period 
and opiates (butorphanol and morphine) were associated 
with significant reductions in activity. However the fall 
in activity was not always associated with adequate 
analgesia•
SUMMARY.
Although selected individual case reports suggest 
that the SEMG may be useful in the assessment of the 
anaesthetic state (133,177) and some stimuli (e.g. sound) 
are associated with an increase in activity, the large 
inter-individual variability in the mean level of activity 
during surgery means that the absolute value of activity 
cannot differentiate between the awake and anaesthetised 
states. Further, the SEMG may be of limited value if 
opiates are used as part of the anaesthetic technique and 
it appears insensitive when compared to standard clinical 
methods (138,178). And, although the frontalis muscle is 
resistant to neuro-muscular blocking agents, their use 
makes interpretation of the SEMG difficult (138).
CHAPTER
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STATES OF AWARENESS.
Awareness is "The ability of a patient to recall, 
with or without prompting, any event occurring during 
anaesthesia" (179). This topic is well reviewed and the 
reader is referred to these articles (180,181). However, 
it is apparent that different "states" of awareness may 
occur.
UNCONSCIOUS PERCEPTION.
Several workers have demonstrated that "unconscious" 
perception of auditory material may occur during 
anaesthesia e.g. by post-operative hypnosis (182); by 
demonstrating an improved post-operative course after 
positive i n t r a - o p e r a t i v e  suggestion (133); or by 
demonstrating a motor response postoperativly following an 
intra-operative suggestion (i.e. "When I come to talk with 
you, you will pull on your ear." 184). This work has been 
criticised (185,186) and some studies have failed to 
demonstrate unconscious perception (187).
AMNESIC WAKEFULNESS.
If a tourniquet is applied to an upper limb, prior to 
the administration of muscle relaxants, the anaesthetist 
can assess motor activity in the isolated arm, despite 
intense neuro-muscular blockade elsewhere. Motor function 
is not impaired for some twenty minutes (183). Tunstall 
(188) introduced this isolated fore-arm technique (IFT) 
and described those patients who moved their hands in 
response to command as wakeful. Twelve patients undergoing 
Caesarean section were studied. Of these 9 showed 
considerable movement and 4 moved their hands in direct
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response to instruction. No patient recalled any intra­
operative event. In a second study (189) of 32 patients 
undergoing Caesarean section; 23 were wakeful in the first 
3 minutes following induction but prior to surgery, 31 
moved their arms spontaneously in response to skin 
incision and 2 responded to command at this time.
Russell (190) randomly assigned 55 patients, 
scheduled for major gynaecological surgery, to receive 
either a nitrous oxide anaesthetic supplemented with 
fentanyl and increments of thiopentone or an etomidate 
based a n a esthetic supplemented with fentanyl. The 
incidence of wakefulness was higher in the nitrous oxide 
group (6.7% vs. 44%). One patient in this group was aware. 
The incidence of wakefulness and "other signs of light 
anaesthesia" (e.g. sweating) was so high in the nitrous 
oxide group that this study was abandoned at the half-way 
stage. The results of the nitrous oxide group were 
reported in a letter (191) and "..all patients who had 
previous experience of general anaesthesia felt that in 
terms of post-op e r a t i v e  well being this was their 
anaesthetic of choice."
Beckendridge and Aitkenhead (192) used the IFT in 24 
patients undergoing elective intra-abdominal surgery. 
Surgery proved impossible while the tourniquet was 
inflated because of "purposeful movement of the arm". 
However, no patient responded to verbal instruction, 
recalled intra-operative events or remembered dreaming. 
The authors concluded that clinical signs are a more 
sensitive method of assessing anaesthetic adequacy.
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CONCLUSIONS.
Absence of a motor response to surgical stimulation, 
in the absence of neuromuscular blocking drugs, does not 
preclude unconscious perception (132) or factual recall of 
intra-operative events (193); although the latter is rare. 
On the other hand movement (even if purposeful or in 
response to command) during surgery is rarely associated 
with awareness. Although the IFT might be used to confirm 
the wakeful state during anaesthesia and surgery; and 
therefore to determine if other techniques (e.g. the EEG) 
can differentiate this state from the non-wakeful state, 
the relationship between this state and the "aware" state 
is unknown. Further, clinical signs may be a better method 
of assessing the adequacy of anaesthesia in lightly 
anaesthetised patients (vide supra).
The relationships between the arousal responses 
described during EEG and EMG monitoring; the wakeful 
state; unconscious perception; and awareness are unknown. 
The only proven method of assessing awareness is by post­
operative interview, and anaesthesia is therefore a 
retrospective diagnosis.
CHAPTER
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OBJECTIVES OF THE STUDY.
The t e c h n i q u e s  p r o p o s e d  as m o n i t o r s  of the 
anaesthetic state have been reviewed. It is apparent, that 
without the d e s c ription of an individually valid 
anaesthetic state, these techniques cannot be fully 
assessed. C l i n i c a l  signs, d e s p i t e  some o b v i o u s  
i n a d e q u a c i e s ,  are c u r r e n t l y  the only p r a c t i c a l ,  
universally accepted method of assessing anaesthetic 
a d e q u a c y .  As s u c h  t h e y  f o r m  t h e  b a s i s  for the 
administration of thousands of anaesthetics each day and 
there is therefore a large weight of evidence which 
suggests these signs are a valid measure of the true 
anaesthetic state in the vast majority of patients.
However, their interpretation is both subjective and 
variable. Until a reproducible, individualised description 
of the anaesthetic state is available the usefulness of 
clinical signs cannot be fully assessed nor can they be 
used as a standard with which other techniques may be 
compared.
Our overall objective was to develop a computer 
control system, operating from rules based on clinical 
signs, to produce an individually tailored anaesthetic 
state. In the future, this could then lead to the 
objective assessment of other techniques for assessing 
depth of anaesthesia such as the ESG or frontalis muscle 
activity.
The aim of the work presented in this thesis was to:
1 Develop a computer driven control system to maintain 
a patient's SAP at a predetermined target value by 
altering the inspired concentration of volatile
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anaesthetic.
2 To determine if we achieved (1 ) would we produce a 
state recognisable as general anaesthesia.
The relevant aspects of control theory and the 
equipement used in this study are discussed in the 
following two chapters.
CHAPTER
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ASPECTS OF CONTROL THEORY.
IN T R O D U C T IO N .
Control systems are designed to make the measured 
o u t p u t  from the controlled process follow a reference (or 
target) input (figure 30). There are two basic types of 
control system: open-loop control systems (OLCS) and
closed-loop control syste»( c l c s ). The terminology used in 
this thesis is based on that suggested by Doeblin (194).
In an OLCS the strategy is to provide a dosage 
regimen based on previously computed data and no provision 
is made to link the controlled variable to the manipulated 
variable (figure 31). A washing machine is an OLCS. The 
user selects the appropriate program depending on the type 
of washing (cotton, linen, coloured etc.); the control 
director (the program) then instructs the control effector 
(the washing machine) to carry out the necessary steps 
(wash, spin etc.). No provision is made to sample the 
controlled variable (i.e. the cleanliness of the wash) and 
to alter the program if the wash is not proceeding 
satisfactorily.
A CLCS incorporates a feedback path and is designed 
to m a i n t a i n  the c o n t r o l l e d  v a r i a b l e  c l o s e  to a 
predetermined target value in spite of variations in the 
disturbance input. The temperature control system of a 
domestic oven forms a simple CLCS (figure 32). In this 
system the heating element, oven space and its contents 
are the controlled process; the oven temperature is the 
controlled variable; the oven thermometer is the feedback 
transducer; the setting of the temperature dial is the 
target value; the thermostat is the control director; and
Target Vamf
j
Controller ;
Disturbance
Controlled
Process Outpu
Feeaoack Ratf)
Figure 30 The configuration of a basic control system.
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Figure 31 An open loop control system
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Figure 32 A closed loop control system
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the energy supply is the manipulated variable. Possible 
disturbance inputs in this system would be opening the 
oven door, a change in ambient temperature etc. In a well 
designed system the controller will quickly re-establish 
the dial setting following a disturbance input. A change 
in dial setting is a change in the target value and not a 
change in the process.
Most therapeutic situations in medicine use feedback 
information to optimise drug dosage (e.g. a patients 
response to surgery is used to assess his anaesthetic 
requirement). This type of system will be considered 
further.
THE COMPONENTS OF A BIOLOGICAL CONTROL SYSTEM.
Five "components" may be identified in a biological 
feedback system (figure 33, ref. 195)
1. The process:
The patient, as the central part of the control 
system, is the process and may be described by a 
model which represents the relationship between drug 
dose and response. Such a model is complex as it will 
represent the pharmacodynamic and pharmacokinetic 
pathways and effects within the individual.
2. The input to the controlled process:
The dosage is the manipulated input to the process 
and is delivered continuously or intermittently.
3. The process response:
The response of the process to the manipulated and 
disturbance inputs comprises the controlled and 
indirectly controlled variables. The controlled
Disturbance
Input
Controlled
Venable
Manipulated
variableControl ProcessEtfector
Predicted 
Peepone#
Model
update
Model
Control
AdaplorDirector
Indirectly
Controlled
variables
Figure 33 The components of a control system.
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variable represents that part of the process response 
on which therapeutic decisions are made. Ideally the 
controlled variable should be the "true" therapeutic 
variable (e.g. depth of anaesthesia) but this is 
rarely possible and "intermediate" variables (e.g. 
blood pressure and heart rate) are often substituted. 
To be useful, an intermediate variable should have a 
high predictive value for the true variable, be 
accessible for repeated measurement and allow the 
investigation and assessment of the relationship 
between dose and response. For efficient control the 
time for equilibrium between dose and response should 
be short.
4. The adaptor:
Some systems incorporate a formal mathematical model 
which is presumed to represent the true process 
model. An adaptive algorithm updates the parameters 
which describe this model according to the recent 
behaviour of the system. Not all CLCS have an 
adaptive element.
5. The controller:
The controller comprises of 3 parts; a transducer, 
the control director and the control effector. The 
control director calculates the required dose by 
comparing data received from the transducer to the 
target value (reference input) and carries out any 
change through the control effector.
If the system is adaptive the controller also 
carries out the necessary steps to update the model's 
parameters•
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A CLASSIFICATION OF CLOSED LOOP CONTROL SYSTEMS.
CLCS can be further classified into tight-loop 
systems which exclude the physician's interaction from the 
feedback loop and loose loop systems which advise the 
physician who makes the final decision about the dose 
requirement (195). These can be sub-divided into adaptive 
and non-adaptive types.
In non-adaptive control systems the assumption is 
made that the process has constant parameters which can be 
determined from test runs using empirical rules e.g. 
Zeigler-Nicholas rules (196). Efficient tuning of these 
systems requires knowledge of the relationship between the 
controlled variable and the manipulated variable so that 
the "average" features of the dynamic process can be 
determined and an appropriate controller designed.
For a control system to work well the sampling 
frequency must be correct, the appropriate control 
strategy applied and the characteristics of an individual 
patient not deviate significantly from those individuals 
from which the strategy was devised.
Adaptive control methods recognise that some features 
of the process can change and allowances are made for 
these. These features relate to inter-individual variation 
in drug response and intra-individual variation in drug 
requirement. This type of system often incorporates a 
formal model of the process and although it should 
theoretically cope more efficiently with these problems 
they rely on an accurate description of the process model 
and are therefore difficult to design. An adaptive system 
designed around a PID controller (vide infra) might update
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the gain values during a control run.
A non-adaptive system was used in this study and these 
will be considered further.
the principles of n o n -a d a p t i v e s y s t e m s .
The strategy in a non-adaptive CLCS is to minimise 
the difference between the target value and the measured 
output (the error signal), ideally keeping it at zero. 
Because the feedback signal is subtracted from the target 
value this type of system is often called a negative 
feedback system.
The response to an error signal is dependent on the
control algorithm and the gain of each component in the
algorithm. Gain is the m a g n i t u d e  of response of the
controller to the error signal.
TECHNIQUES OF CONTROL AND TYPES OF ALGORITHM.
"BANG-BANG" SYSTEMS.
An on-off (bang-bang) system is the simplest type of 
control system. In this system the input to the process is 
either on or off e.g. the thermostat in the oven. Although 
these systems are crude and oscillation is inevitable they 
are simple to design, rugged and may provide adequate 
control in some circumstances.
P-I-D CONTROL SYSTEMS.
The most commonly used control systems incorporate 
one (or more) of three principle control effects (197). 
These are generally described as:
1 . Proportional Control
2. Integral Effect
3. Derivative Effect
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PROPORTIONAL CONTROL.
In this type of system the output of the controller 
varies linearly with the error. The response of a 
proportional system to a change in the error signal is 
dependent on its gain. If the gain is high then any 
tendency for the error signal to become significant will 
result in a rapid response and the error is reduced. With 
a high gain any offset will be small (the offset is the 
difference between the value of the controlled variable 
and the target value in the steady state). However, if the 
gain is too high the system will tend to overcorrect any 
error r e s u l t i n g  in a w o r s e  e r r o r  in the o p p o s i t e  
direction, further over correction and so on i.e. the 
system will oscillate. Although oscillation is less likely 
if the gain is low the off-set tends to increase and the 
response to a disturbance may become inadequate.
The c o r r e c t  g a i n  for a s y s t e m  is t h e r e f o r e  a 
compromise between rapid response, off-set and the risk of 
oscillation.
If unac ce pt ab l e o s ci l l a to r y behaviour is to be 
avoided, the off-set reduced and an adequate response 
attained a simple proportional system is often found to be 
inadequate.
INTEGRAL EFFECT.
The integral effect is achieved by summing all the 
errors and applying a suitable gain. It tends to reduce 
the off-set towards zero and improve the steady-state 
accuracy of a p r o p o r t i o n a l  s y s t e m  but can c a u s e 
oscillation. This detrimental effect increases as the gain
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is itself increased.
DERIVATIVE FUNCTION.
This function allows the controller to respond to the 
rate of change in the error signal. Use of a derivative 
tends to stabilise a potentially unstable system and
decrease the response time.
COMBINATIONS OF EFFECT.
The output from a combined P-I-D system can be 
calculated from a simple equation:
Dose = (K * e) + ( *^ e )  + [ * (e - e')]
where Kp, Kj_ and are the gains for the proportional,
integral and derivative components; and e, J.e, and e - e' 
represent the error, the sum of the errors and the current 
error minus the previous error.
?, PI, ?D and PID control systems are described
(197). Figure 34 is a block diagram of the control system 
used in this study and it is discussed in detail later.
Disturbance
Vaporizer Drive Uni; 
(Control EJtectO")
\A**tu« Anee-nneHc natient 
(Process)
Heart Rote 
{sweet irtc etc.
SAP
interlace Unit
Computer 
(Control Drector)
Target Systolic Arterial 
Pressure
Figure 34 A block diagram of the control system, used 
in this study.
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EQUIPMENT USED IN THE STUDY.
1. DINAMAP BLOOD PRESSURE MONITOR, MODEL 1346 (CRITIKON
INC., TAMAPA, FLORIDA).
The Dinamap range of blood pressure monitors was 
introduced in the mid-1970s and is an acronym for "Device 
for Indirect Non-invasive Mean Arterial Pressure". The 
model used in this study (figure 35) automatically and 
non-invasively measures systolic arterial pressure (SAP), 
diastolic arterial pressure (DAP), mean arterial pressure 
(MAP) and pulse rate (PR).
GENERAL DESCRIPTION.
The machine may operate in one of three modes; manual 
mode (i.e. the operator initiates a single determination 
by pressing the start button), auto mode (i.e. the user 
determines a cycle time of 1-90 minutes following which 
the m a c h i n e  w i l l  a u t o m a t i c a l l y  p e r f o r m  f u r t h e r  
measurements) and stat mode (i.e. the machine will do 
sequential determinations for a 5 minute period).
FUNCTIONAL DESCRIPTION
The o p e r a t i n g  c y c l e  c o n s i s t s  of 4 p a rt s ,  the 
inflation time, the deflation time, the evaluation time 
and the w a i t  t i m e  ( f i g u r e  36). At the s t a r t  of a 
determination sequence the cuff is inflated to a pressure 
30 mmHg above the previous systolic reading or, if no 
previous systolic pressure is stored, to a pressure of 
178 mmHg. If this pressure is lower than the patient's 
systolic pressure the Dinamap automatically re-inflates 
the cuff to a higher value, to a maximum of 250mmHg.
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Inflation is followed by a stepped deflation sequence, 
with each step occurring when 2 pulsations of relatively 
equal amplitude are encountered. This process rejects 
artefact due to patient movement and greatly enhances the 
accuracy of the machine.
A microprocessor, linked to a sensitive pressure 
transducer, calculates SAP, MAP, DAP and PR during the 
deflation sequence. Following determination the cuff is 
deflated to zero pressure. A residual pressure of greater 
than 20mmHg during the wait period causes the machine to 
alarm. The performance specifications of this machine are 
listed in table 7 and figure 37 illustrates the 
determination sequence.
In some circumstances e.g. shock the systolic and 
diastolic pressures may not be accurately determined and 
in these cases only the MAP is displayed.
THE HOST-SERIAL COMMUNICATIONS PORT.
This is an RS-232 compatible serial interface and is 
set up to tr a n s m i t  and receive ASCII characters 
asynchronously in an 8 bit format at a fixed baud rate of 
600. This facility allows the Dinamap's memory to be 
polled. The serial output to the host is shared with 
serial output to the printer and a delay (usually 0.5 - 1 
sec.) occurs before transmission following a request. The 
Dinamap automatically goes into the receive mode when 
switched on and will not transmit until a valid request is 
received from the host. A valid request for transmission 
is a 4 character string of the format "3BA-carriage 
return." The response is a 30 character string. The port 
connections and content of the 30 character string are
Table 7. The performance specifications of the
Dinamap (model 1846).
Specification 
Cuff pressure range 
Initial cuff inflation 
SAP determination 
MAP determination 
DAP determination 
Pulse Rate 
Determination time
* the determination t 
rate of the patient (adapte
Compliance
0 - 2 50 mmHg
178 +/- 15 mmHg
30 - 2 45 mmHg
20 - 22 5 mmHg
10 - 210 mmHg
40 - 200 bpm (+/- 3.5%)
20 - 45 sec., max 120sec.'
rne is dependent on the pulse
. from ref. 198).
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detailed in Appendix I.
ACCURACY OF THE THE DINAMAP.
With any device utilising a blood pressure cuff it is 
important to use the correct size of cuff (relative to the 
limb circumference) and to apply the cuff correctly. We 
used a "normal" size cuff and all patients with an arm 
circumference greater than that for which it is designed 
(43 cm) were excluded from the study.
In a study (199) comparing the 845 model to intra- 
arterial pressure the Dinamap was shown to produce 
reliable trend information during anaesthesia. These 
workers calculated a correlation coefficient of 0.96% and 
95% confidence limits of +/- 16.4 mmHg for SAP. The 
authors suggest that, as the confidence limits for the 
mean lie closer to the regression line precipitous action 
should not be taken on unexpected individual readings 
unless it is supported by other clinical observations. The 
machine failed to follow large, rapid changes in blood 
pressure due to the determination time of 20 - 45 sec. and 
tended to under-read at high pressures and over-read at 
low pressures. The Dinamap may not function on patients 
with dysrhythmia.
S i n c e  t h i s  s t u d y  b o t h  t h e  p n e u m a t i c  a n d  
m i c ro pr oc es so r components of the Dinamap have been 
improved. A study by Critikon (200), comparing direct 
c e n t r a l  a o r t i c  p r e s s u r e  m e a s u r e d  d u r i n g  c a r d i a c  
catheterization to that measured by the Dinamap described 
a mean difference (from 473 recordings) of 2.80 mmHg and a 
standard deviation of 5.22 mmHg for SAP. The results from
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this study are listed in table 8.
SAFETY.
There is a risk of ulnar palsy when the cuff is 
incorrectly positioned (201) and frequent readings over 
prolonged periods may increase this. Both an electronic 
malfunction and contamination of the air release valve 
have been associated with factitiously low blood pressures
(202). In each case the heart rate, as recorded by the 
Dinamap was significantly lower than that derived from the 
ECG.
We followed the manufacturers directions and took 
added precautions in light of the above.
2. THE RML COMPUTER.
The RML 380Z-D computer (figure 35) used in this 
study is a robust, stand-alone, 32k, 3 bit machine which 
uses the CP/M operating system. All programs used in this 
study were written in BASIC (RML version 5.0G). The input- 
output (I/O) ports used in the control system and the 
software are described in Appendix I. The integration of 
the various components in the control system is discussed 
below.
3. THE VAPORIZER CONTROLLER AND VAPORIZER DRIVER
UNITS.
The vaporizer controller was developed and built at 
the Department of Clinical Physics and Bio-Engineering in 
Glasgow. It comprises a drive unit and an interface unit
(203) .
THE DRIVE UNIT.
The drive unit (figures 35 and 38) incorporates a
Table S. The accuracy of the Dinamap 1 846 compared
central aortic pressure.
SAP DAP MAP HR
Mean difference 2.80 2.91 2.13 -1.17
SD. 5.22 4.79 5.15 2.68
No. of records 473 473 461 486
These data were obtained from adult male patients 
undergoing cardiac catheterization (from ref. 200).
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stepping motor, gear box, toothed belt transmission, upper 
and lower limit switches, and a "position" checking 
potentiometer. The gear box provides a 50 : 1 reduction 
and gives increased resolution for each step of the motor. 
Approximately 3200 pulses drive the vaporizer from the 
'OFF1 position to the 5% setting. Limit switches at these 
settings allow initialisation and prevent damage to the 
drive unit. Initialisation involves driving the unit until 
the lower limit switch is activated i.e. the vaporizer is 
driven to a known setting, the 'OFF1 position. The number 
of pulses required to drive the vaporizer to any marked 
setting from the 'OFF1 position is determined in the 
laboratory and the current 'position' of the vaporizer 
(relative to the 'OFF' position) is then determined by 
keeping a count of the number of pulses used, and the 
direction of travel taken each time the vaporizer is 
driven to a new setting. A small backlash of approximately 
50 pulses occurs with each change of direction and this is 
allowed for in the computer program.
The output voltage of a potentiometer coupled to the 
rotatory drive of the vaporizer is used to check the 
vaporizer setting via the analogue to digital converter in 
the computer. The output voltage changes by some 3 volts 
over the full vaporizer range and the output at each 
marked vaporizer setting is determined in the laboratory.
THE INTERFACE UNIT.
Figure 3S is a block diagram of this unit (see also 
figure 35). The unit, under instruction from the computer 
drives the vaporizer via the drive unit to the correct
Figure 39.
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A block diagram of the interface unit for the 
vaporizer controller (from ref. 203).
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setting. Activation of a limit switch disables the 
stepping motor, permitting movement only in the opposite 
direction. When this occurs a signal is sent to the 
computer indicating that the state of the switch has 
changed. The interface unit can also be instructed to 
switch off the motor to prevent power dissipation.
SAFETY FEATURES.
The position of the vaporizer is determined by 
keeping account of the number and direction of driving 
pulses from the 'OFF' position (vide supra). Each new 
v a p o r i z e r  s e t t i n g  is c o m p a r e d  to the e x p e c t e d  
potentiometric output voltage at that setting and any 
significant discrepancy from the expected value results in 
a warning being given to the operator by the computer. The 
program then re-initialises the vaporizer unit and drives 
the vaporizer back to the desired setting. The original
dial of the vaporizer is visible and can be used as a
further check.
The watch-dog is a retriggerable moncstable in the 
interface and is connected to a visual alarm and an 
audible warning. If a signal is not received from the 
computer by the monostable in any 9 second period an alarm
is sounded. The audible warning may be disabled.
The vaporizer and drive unit fit on a standard Ohmeda 
Selectatec back bar and can be quickly removed and 
replaced with a standard vaporizer if necessary.
Electrically the controller and drive unit meet all 
the requirements of class I type B equipment. The unit is 
not designed for use with inflammable agents.
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PERFORMANCE.
An attached vaporizer can be driven from the 0 to 5% 
positions in 15 sec., when driven by a 3ASIC program.
As the v a p o r i z e r  s c ale is n o n - l i n e a r  and the 
resolution of the system is one step of the stepping motor 
the accuracy of the unit is dependent on the setting. At 
0% one step corresponds to 0.0006% and at 5% to 0. 003%. 
When the backlasn is considered the accuracy in terms of 
concentration is better than +/-0.01% at 0% and +/-0.05% 
at 5%.
Prolonged testing before its use in theatre and 
during the study have demonstrated no shift in the 
settings.
CHANGING THE VAPORIZER.
Although the unit is designed to drive any Cyprane 
Tec III vaporizer, the attachment to the drive unit is not 
straight-forward and was done by the Engineering 
Department. Following this, the unit was recalibrated for 
the new vaporizer i.e. the number of steps to and 
potentiometric output at each marked setting, as well as 
the backlash correction factor, determined. These changes 
were incorporated in the control program and the system 
tested prior to its use in theatre. The whole procedure 
takes 2 - 3  days.
4. PUPILLOMETSR.
A purpose built pupillometer (84) was used to measure 
pupil diameter. This device (figure 40) consists of a 
welder's goggle through which passes a fixed length focal 
microscope. A graticule scale, graduated to 0.1 mm, comes
Rock
Upper co I lor
Poir of 
0  riivjs
Lower collar
Bulb
igure AO.
A drawing of the pupillcmeter (from ref. 84)
A drawing of the pupillcmeter showing its construction. 
The pinion engaging the rack sllows controlled verticle 
movement of the microscope. The 0 rings permit lateral 
movement. The spring loaded ball bearings keep the rack 
and pinion engaged. The welder's goggle fits closely 
the patient's eye and the pupil is illiminted from the 
side by laryngoscope bulbs (only one shown).
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into focus when the pupil itself is in focus (figure 41). 
The aluminium block which supports the microscope allows 
both lateral and vertical movement of the microscope. 
Vertical travel is limited by a stop to prevent damage to 
the cornea.
Oblique lighting is supplied by 2 laryngoscope bulbs 
connected to a constant voltage battery box. A third bulb 
can be flashed directly at the pupil to assess the light 
response.
A correlation coefficient of 0.985 has been described 
for sequential measurements made by two observers (84). 
The device is therefore both a safe and reliable method of 
assessing pupillary changes during anaesthesia.
5. THE NEUROTRAC ELECTROENCEPHALOGRAPHIC ANALYSER 
(INTERSPEC, CONSHOHOCKEN, USA.).
During the latter part of the study this monitor 
became available on loan and was used on a small number of 
cases.
GENERAL DESCRIPTION.
The Neurotrac is a two channel EEG monitor designed 
to collect analyse and display the EEG signal (figure 42). 
A facility for measuring evoked potentials is also 
available. The system consists of a main unit which 
comprises a control panel and display unit, and an 
optional printer unit. An RS232 interface is available to 
transfer either the raw EEG or spectral data to an 
external computer. Unfortunately we did not have the 
facilities to utilise this option.
A view of the pupil seen when making a measurement with 
the pupilaneter (from ref. 84).
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OPERATIONAL CHARACTERISTICS.
The operational cycle has 3 stages:
a) Signal collection, amplification and conversion.
b) Data analysis
c) Formatting and Display
A) SIGNAL COLLECTION, AMPLIFICATION AND CONVERSION.
i) The Electrodes.
Paediatric ECG electrodes are suitable; the positive 
electrodes are attached close to the hair-line on each 
side of the forehead, the negative electrodes behind the 
ear on the mastoid process and the reference electrode to 
the middle of the forehead.
Electrode impedance is checked during the "start-up" 
procedure and if the impedance of any active lead is over 
10 Kohms use of the channel involved is prohibited. During 
operation the impedance is checked every 2 minutes, if an 
impedance test failure occurs the monitor "beeps" and the 
letter "I" is printed on the screen.
ii) Amplification.
The gain of the internal amplifiers is automatically 
set during the start-up. During operation the gain can be 
reset if required. The amplified signal is filtered with a 
pass band of 4 - 30Hz. The signals from the two channels 
are multiplexed, passed to an analogue to digital 
converter and sampled at 128 Hz per channel.
iii) Artefact Detection.
A 3 part algorithm is used to detect artefact. If the 
incoming signal to the ADC, the power contribution of the
30.5 - 63.5 Hz band (muscle activity) or the 49.5 -50.5 Hz
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band (mains activity) exceed their pre-set limits then an 
artefact is noted on the screen. The raw EEG signal can be 
displayed on the monitor and visually checked.
B) DATA ANALYSIS.
A Fast Fourier Transformation algorithm is used to 
calculate the spectral values of each 2 second EEG epoch 
(256 data points) for each channel. Power bands are 
calculated for each 0.5 frequency bin over the range 0 -
63.5 Hz. Only the lower half of these values (0 - 30 Hz) 
is subsequently displayed. The power in each band is 
derived mathematically from the peak voltage in the raw 
EEG signal at that frequency.
C) DATA FORMATTING AND DISPLAY.
One of four formats may be used; the raw EEG, the 
compressed spectral array (CSA), the spectral histogram 
and the power band display.
1 The raw EEG is displayed in two second strips on the 
screen. A hard copy may be made of any strip.
2 A general description of the CSA has already been 
given (figure 17). The Neurotrac allows the use of 
two scales (1 to 15 and 1 to 30 Hz). The spectral 
edge frequency may be superimposed and a density 
modulated display is available.
3 The Spectral Histogram displays each 0.5 Hz power 
value over the range 1 - 30 Hz, a new histogram is 
placed on the screen at the selected up-date 
interval.
4 The Power Band Display displays four user defined 
power bands as a bar graph, again these are replaceG
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on screen at the selected up-date time. The default
settings select the classical alpha, beta, delta and
theta bands.
The update time may be set from 2 seconds to 4 
minutes. Exponential weighting is used to calculate the 
values fro up-date rates of more than 2 seconds.
6) OTHER EQUIPMENT.
A) VENTILATOR AND ACCESSORIES.
All the patients studied were ventilated with a Bain 
circuit, driven by an OAV ventilator.
With this system, providing the minute volume of 
ventilation is greater than the fresh gas flow (FGF), the 
patients arterial PaC02 will depend on the FGF and is 
"highly predictable" (204). Henville and Adams, using a 
FGF of 100 mls/kg, a respiratory rate of 12 breaths per 
minute and a tidal volume of 10 mls/kg, describe a mean 
PaC02 of 34.3 mmHg and standard deviation of 4.5 mmHg
(204).
B) OTHER EQUIPMENT.
All patients were attached to an ECG monitor 
(Datascope 2000) during surgery and a Normac, anaesthetic 
agent monitor (Datex Instrumentarium Corporation, 
Helsinki) was used to check the function of the vaporizer. 
A capnograph was not available.
THE SOFTWARE.
The software (computer program) is central to any
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computer driven control system. The program used was 
designed to interpret the input from the Dinamap, 
determine the required output following each valid input 
and make any necessary change through the vaporizer 
control unit. The program relies on the Dinamap to cycle 
automatically at 1 minute intervals. A hard copy of 
cardiovascular and other data is made and stored to disk 
at the end of the control run. A full description of the 
program is given in Appendix I. Figure 34 is a flow 
diagram showing how the various components of the control 
system are integrated. Figure 43 shows the equipement in 
use in theatre.
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DEVELOPMENT OF THE CONTROL SYSTEM.
GENERAL REMARKS.
A standard anaesthetic technique was used:
1 All the patients studied were ASA grade I - II and 
any patient with a disease state or on medication 
known to effect the cardiovascular or central nervous 
system was excluded. The only exception was patients 
prescribed "sleeping" tablets.
2 Anaesthesia was induced in the anaesthetic room and 
the controller not activated until the patient had 
been transferred to theatre.
3 All patients were paralysed and received a 'basal' 
anaesthetic of nitrous oxide (70%) in oxygen. 
Supplementary enflurane requirement was determined, 
and automatically delivered, by the controller.
4 All patient's received 0 . 5 - 1  litre of crystalloid 
per hour to cover insensible fluid losses. Blood loss 
was replaced as clinically indicated.
No attempt was made to standardise other aspects of 
the anaesthetic (induction agent, premedicant etc.), 
except that opiates were not given until the controller 
was discontinued.
DETERMINING THE TSAP.
Defining a patients 'normal' blood pressure is 
difficult. However, if arterial pressure is to be used as 
the controlled variable an individually valid target 
value must be available.
Using age-sex related SAP data in the Geigy tables
(205) regression lines of SAP against age were calculated
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for both sexes and used to predicted SAP for individual 
patients. The relationship is described by the equations:
Pred = 108 + (0.75 * age) for males and
Pred = 58.5 + (0.5 * age) for females.
Where Pred is the predicted systolic arterial 
pressure in mmHg and age is in years.
Using this as a baseline the TSAP was defined as 90% 
of the predicted value during the development of the 
system and in main study. To 'check' this value three 
patients were studied with a TSAP representing 85% of PRED 
after the algorithm used in the main study had been 
determined (vide infra). Achieving and maintaining the 
TSAP in these cases required a high inspired concentration 
of enflurane and an unacceptably long recovery time 
ensued, suggesting that these patients were "over­
anaesthetised" .
DETERMINING THE CONTROL ALGORITHM.
Step-tests (i.e. measuring the response of the 
controlled process to changes in input) are often used by 
engineers to to determine the gain settings when a control 
system is being developed. In this situation the effects 
of surgical stimulation are continually changing the 
process and it is not possible to use this method. Instead 
knowledge of dose - response - disturbance relationships, 
gained through clinical experience, was used to design the 
i n i t i a l  c o n t r o l  a l g o r i t h m  w h i c h  was r e f i n e d  
experimentally.
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A PROPORTIONAL CONTROL SYSTEM.
Initially a proportional control system with a gain 
of 0.1 was set up i.e. 0.1% enflurane was delivered by the 
controller for every rnmKg the SAP was above the TSAP. This 
system was studied in 4 patients and a mean off-set from 
the TSAP of 13.7 mmHg occurred (range 13.1 - 20.4). The
stability of control about this mean off-set value was 
good and is reflected by a mean standard deviation of 
5.7mmHg. Figure 44 shows a typical example with this 
control system.
A PROPORTIONAL - INTEGRAL CONTROL SYSTEM.
To reduce this off-set an integral component was 
added to the algorithm. The gain for this component was 
initially set at 0.05, the gain of the proportional 
component being left at 0.1. Although this corrected the 
off-set the rapid cumulation in integral value following 
SAP increases led to the patient receiving excess 
enflurane when the TSAP was again reached. In the case 
illustrated (figure 45) the integral value increases by a 
further 37% following the initial peak in SAP and before 
the TSAP is acheived. This results in the patient 
receiving 5% enflurane at the TSAP. The integral was 
therefore reduced to 0.01.
In a small series of runs with the P - I gains set at 
0.1 and 0.01 control of SAP during surgery was generally 
good (figures 46 and 47). However, some problems had now 
become apparent:
1 As discussed above the Dinamap may only register the
mean pressure in some situations, returning "0"
readings for SAP and DAP. The original program
Proportional Control
SAP(mmHg), HR(bpm), Enfluran©(%).
200 p
150
TSAP
100 h
t
0 . »
5% 50 h
3010 20 40 50
Time (min.)
* HR — SAP ~ I n s p i r e d  [enflurane]
Figure 44. An example of proportional control.
Note the offset from the target value and that no enflurane 
was delivered for the first 6 minutes. The latter effect 
results in an SAP "peak" following the start of surgery (at 
seven minutes in the figure).
P - I Control
SAP(mmHg), HR(bpm), Enf.(%), lnt(%)
200 r
150 |-
TSAP
100 f-
5% 50 r
0 20 30 40
Time (min.)
HR —  SAP Inspired Enflurane * Integral
Figure 45.
An example of P - I control with the gains set at 0.1 
and 0.05.
In this figure, and all subsequent figures in which the 
integral is plotted; the integral is expressed as the 
dose of enflurane (0-5%) which would result from the 
integral term alone i.e. if the proportional component 
was ignored.
Note that the rapid cumulation of the integral results 
in this patient receiving an excessive dose (5%) when TSAP 
is acheived following a peak in SAP at 10 minutes.
P - I Control
SAP(mmHg), HR(bpm), Enf.(fc), lnt(%)
200
150 h
0% 0
6040
Time (min.)
* HR ~ — SAP “ A - Enflurane * Integral
Figure 46.
An example of P-I control with the gains set at 0.1 and
0.01.
This patient was hypertensive relative to the TSAP following 
transfer to theatre. Control of SAP in this case is good.
The arrow indicates a M0M SAP measurement (not marked) which 
the controller treated as a valid input, reducing the 
integral by 127 (the value of the TSAP). In this case 
control was probably improved as an overshoot, which can be 
anticipated, does not occur.
P - I Control
3AP(mmHg), HR(bpm), Enflurane(%).
200 r
150
TSAP
5% 50 (-
10
0% 0
0 20 30 40
Time (min.)
Heart Rate SAP Inspired [enflurane]
Figure 47.
An example of P-I control with the gains set at 0.1 and 
0.01.
The arrows indicate ”0" SAP measurements (not plotted) which 
the controller is instructed to ignore and to leave the 
inspired enflurane concentration unchanged.
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treated a zero systolic pressure as a valid input and 
acted accordingly i.e. the vaporizer was driven to 
the "0" position and the integral was reduced by the 
value of the TSAP (figure 46). As this occurrence 
represents an error signal the program was altered so 
that zero readings were ignored and the vaporiser 
setting was left unchanged until the next valid SAP 
input (figure 47).
2 As the integral value is accumulated gradually, SAP 
readings of less than the target value at the start 
of the control period may result in the patient 
receiving no or minimal concentrations of volatile 
anaesthetic when surgery commences, with the risk of 
the patient being "inadequately" anaesthetised at 
this point. Further, those patients who received 
limited amounts of volatile initially appeared to 
have a larger pressor response to surgical 
stimulation (compare figures 44 and 45 to figures 
46 and 47). This can be expected to increase the 
time taken to achieve adequate control of SAP. In 
general, the longer the period between induction and 
incision the more likely a patient is to be 
hypotensive relative to their TSAP at the start of 
surgery. As this delay is unpredictable it was 
decided that a minimum dose of 0.6% enflurane should 
be delivered for the first 10 minutes in an attempt 
to limit the effect of this occurrence (figure 48).
3 On the other hand some patients were relatively 
hypertensive on arrival in theatre (figure 46). A 
ore-loaded integral was incorporated to decrease the
Rule 1 - Minimum Concentration
SAP(mmHg), HR(bpm), Enflurane {%).
200 p
150 K
TSAP
100
Min. Cone.5% 50 I-
•oooo#
0 20 40 60
Time (min.)
Heart Rate SAP Enflurane
Figure 48. The first additional rule.
Although the patient is hypotensive relative to the TSAP, 
the controller delivers a minimum concentration of 0.6% for 
the first 10 SAP measurements . There is a limited pressor 
response to the initial surgical stimulus (at seven min).
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time the system took to gain control of these cases. 
Tnis value was based on age and determined as:
INL = 20 + (100 - Age)
Where INL is the pre-load for the integral and age is 
in years. The value was chose to both improve the 
response in those hypertensive (with respect to the 
TSAP) but to have little effect in patients who were 
relatively hypotensive.
THE PILOT STUDY.
The system was now felt to be ready for formal 
testing. A small pilot was carried out to determine:
1 Any additional features for the protocol to be used 
in the main study.
2 The adequacy of the control system with regard to:
a) The initial response to surgery (i.e. to assess 
the effects of the modifications).
b) The degree of control exerted on the SAP.
3 If the anaesthetic state produced by the system was 
clinically acceptable.
The protocol used in the pilot study was similar to
that used in the main study and is detailed in the
following chapter. No patient in the pilot study received 
an opiate prior to induction and the TSAP was defined as 
90% of that predicted by age and sex (vide supra).
Seven patients aged 28 - 61 (mean 41 .9) years,
scheduled for abdominal hysterectomy, were studied and 
results are listed in table 9.
The results from the first four cases, in terms of 
control, were encouraging. In all cases the mean off-set
Table 9. Results of the pilot study.
Case TSAP ATPR SAP TSAP- RliSD HR VAP
No.
1 1 1 9 8 120.2
SAP 
1 .2 6.06 87.2 1 .9
2 1 08 23 111.9 3.9 6.02 92.3 3.4
3 1 09 22 112.6 3.6 7.24 86.4 3.3
4 120 4 119.8 -0.2 6.24 70.1 0.8
5 1 21 4 119.9 -1 .1 9.91 67.1 1 .3
6 131 9 139.9 8.9 17.15 71 .2 1 .9
7 1 1 4 1 4 118.6 4.6 7.16 85.6 2.0
TSAP = target systolic arterial pressure (mmlig)
ATPR = anaesthetic termination patient response time (min) 
SAP = systolic arterial pressure (mmHg)
TSAP-SAP = the difference between the TSAP and the SAP.
RMSD = root mean square deviation
VAP = the inspired enflurane requirement
HR = heart rate.
note: the RMSD is the root mean square deviation and is
analagous to the standard deviation but uses the TSAP in 
place of the mean SAP. This term reflects the goodness of 
control about the TSAP.
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was less than 4 mmHg and the RMSD values (table S) ranged 
from 6.02 to 7.24 i.e. SAP was successfully controlled 
with respect to the TSAP. However the second and third 
cases took an excessively long time to recover, as 
determined by the time taken to respond to command.
These cases had developed integral values of over 350 
by the time the controller was discontinued i.e. an 
enflurane concentration of over 3.5% was required to 
maintain the SAP at the target level and the patients were 
excessively anaesthetised (figure 49).
In an attempt to improve the recovery time without 
changing the target value the following modification was 
made to the controller:
If the inspired enflurane concentration exceeded 15% 
over 5 consecutive vaporizer settings and each 
individual setting exceeded 2.5% then the controller 
instructed the operator to give a bolus of morphine 
(0.05mg/kg) and to reset the integral to its pre-load 
value. This was done by pressing a key on the 
keyboard. This rule could only be executed once in 
any 15 minute period. In practice the loop remained 
" t i g h t "  i.e. all d e c i s i o n s  w e r e  m a d e  by the 
controller, the operator having a passive role.
This new rule was tested in 3 cases (cases 5 to 7), 
and was used twice (cases 6 & 7). The rule appeared to 
have the desired effect of limiting the integral value 
which appeared to stabilise at a lower level following the 
morphine bolus (figure 50). The recovery time in both 
these cases was acceptable (i.e. less than 15 minutes).
Relative Over-dose
SAP(mmHg), HR(bpm), Enflurane (%).
200
150
TSAP
100 -
5% 50
100 20 30 40 50
Time(min.)
Heart Rate ~ S A P  inspired entlurane
Figure 49. An example of a case who received a relative 
overdose of anaesthetic.
Although control of SAP is good, this patient took an 
excessive time to recover.
Rule 2 - Additional Morphine
SAP(mmHg), HR(bpm), Enf.(%). Int(%
200
150
TSAP
100 -
Int.Reset.
5% 50 h!0
0% 0
0 20 40 60
Time (min.)
HR SAP $ Inspired enflurane * Integral
Figure 50. The second additional rule.
As this patient was receiving an excessive dose of enflurane 
the computer instructed the anaesthetist to give a bolus of 
morphine and to reset the integral (arrow in the diagram). 
This results in a lower enflurane requirement. Resetting the 
integral prevents further overdose. Note the rising integral 
value prior to the bolus, and that the integral stabalises 
after this event.
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In the initial part of the control period only one 
patient had a pressure response to surgical stimulation of 
more than 25mmHg (with respect to the TSAP). Supplying a 
minimum dose of 0.6% enflurane over the first ten minutes 
appeared to have had the desired effect. The rule was used 
in five of the seven cases.
As the P - I system with the additional rules produced 
an acceptable anaesthetic state and adequate control in 
the majority of patients studied it was decided to proceed 
with the main study.
CHAPTER
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THE MAIN STUDY.
Local Hospital Ethical Committee approval was 
obtained and all participating patients gave informed, 
v/ritten consent to the study.
DETAILS OF THE CONTROL SYSTEM.
The P-I control system gains were set at 0.1 and
0.01 . A pre-loaded integral and two additional rules we re 
incorporated (vide supra):
1 All patients received a minimum inspired volatile 
concentration of 0.6%
2 If the inspired concentration exceed a pre-set limit 
then the controller instructed the operator to give a 
bolus of morphine (0.05mg/kg) and to reset the 
integral to the pre-loaded value.
PATIENTS AND METHODS.
INCLUSION CRITERIA.
1 Age 1 7 - 7 0  years of age.
2 Health status - ASA Grade I or II
3 Any patient who satisfied the above criteria in whom 
the anaesthetic technique (see below) was deemed 
appropriate, with the following exclusions:
a) History of caraio-vascular disease. Specifically 
those patients suffering from or treated for 
hypertension, arrythmias or cardiac failure.
b) Patients with psychiatric or other CMS disease.
c) Patients on CNS "active" drugs except sleeping 
tablets.
d) Patients in whom the anaesthetic technique was 
felt inappropriate e.g. epileptics.
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e) Patients with an arm circumference of more than 
43 cm.
As a simple "change" of vaporizer is not possible 
(vide supra) patients could not be randomly allocated to 
receive enflurane or isoflurane. Therefore the first group 
of patients studied received enflurane (n = 22) and the 
second group isoflurane (n = 35).
Only those changes necessary to adjust the controller 
to the isoflurane vaporizer were made following the 
enflurane study. The PI gains, initial minimum inspired 
co n c e ntration and dose limit that determined the 
requirement of additional morphine were left unchanged.
PRE-OPERATIVE VISIT.
All patients were visited pre-operatively and the 
nature and relevant details of the study explained. 
Written consent was obtained and all patients weighed.
PRE-MEDICATION.
1 R a n i tidine (150mg) at 06.00 on the day of the 
operation.
2 Temazepam (10-20 mg) 1-2 hours pre-operatively.
INDUCTION SEQUENCE IN THE ANAESTHETIC ROOM.
1 Measurement of SAP (Dinamap 845)
2 Placement of intra-venous cannula (14 or 16 gauge) 
under local anaesthetic in the left arm or hand.
3 Induction, morphine 0.1mg/kg followed by thiopentone 
(2.5 m g /k g ) and, if the eyelid reflex was still 
present after 30 seconds, an additional 1mg/kg of 
thiopentone was given. The second part of this
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sequence was repeated as necessary.
4 Following loss of the eyelid reflex Vecuronium (0.1 
mg/kg) followed by:
5 Manual ventilation with a facemask (and airway if 
required) for 90 seconds with a mixture of nitrous 
oxide (70%) in oxygen supplemented with 1% enflurane 
(or 1% isoflurane).
6 Intubation and following fixation of the endotracheal 
tube transfer to theatre.
MAINTENANCE OF ANAESTHESIA.
1 Ventilation on a Bain circuit supplied with a fresh
gas flow of 1OOmls/kg (nitrous oxide 70% in oxygen) 
and driven by an OAV ventilator at a rate of 12 
breaths per minute and a tidal volume of 10 mls/kg.
2 Enflurane (or isoflurane) was delivered by the 
controller and additional morphine on instruction 
from the controller.
3 Relaxation was maintained with timed boluses of 
vecuronium (30% of induction dose) given every 25 
minutes.
4 All patients received 10 - 15 mls/kg Ringer Lactate 
over the first hour and 5 - 1 0  mls/kg over subsequent 
hours to cover basal fluid requirements. Blood loss 
was replaced with crystalloid, colloid or blood 
products as clinically indicated.
5 Minor interventions e.g. alteration of the table
slope, passing of a naso-gastric tube, re-siting of 
p e r i p h e r a l  c a n n u l a e  etc. were noted. M a j o r  
interventions in particular the administration of
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o t h e r  d r u g s  (unl e s s  on i n s t r u c t i o n  from the 
controller) constituted a breach of protocol and 
depending on the situation the use of the control 
system might be abandoned. These cases are not 
included in the analysis.
MONITORING.
1 All patients had their ECG (lead II) continually 
monitored.
2 Blood pressure was recorded every minute by the 
Dinamap (model 1845) interfaced to the controller. 
The integral alarms in the controller and Dinamap 
were used.
3 If the Norrnac analyser was available then end-tidal 
enflurane (or isoflurane) concentration was measured 
and recorded graphically.
4 Tidal volume, respiratory rate and peak airway 
pressure v/ere monitored and appropriate alarm values 
selected.
5 If a neuromuscular function monitor was available 
then the train of four was maintained at 2 or less.
6 A clinical assessment of anaesthetic adequacy was 
made every 5 minutes. This consisted of:
a ) PRST score (91 )
b) Capillary Refill
c ) Venous Tone
b) Pupil diameter and light reflex using the
pupillometer.
END OF SURGERY.
Five minutes from the end of surgery as judged by the
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anaesthetist the controller was discontinued i.e. the 
volatile agent was switched off. Following the last skin 
suture or staple the nitrous oxide was discontinued and 
the patient ventilated with 5% carbon dioxide in oxygen. 
The r e l a x a n t  was a n t a g o n i s e d  at this point w i t h  
neostigmine (2.5mg) and glycopyrollate (0.6mg).
Following the return of spontaneous ventilation 
(defined as a tidal volume of over 5 mls/kg) all patients 
who did not receive an additional bolus of narcotic were 
given morphine (0.05mg/kg).
The patients were then extubated.
RECOVERY.
Recovery was deemed complete (for the purposes of the 
study) following purposeful response to command i.e. 
sticking out the tongue or opening their eyes when 
requested.
POST-OPERATIVE DETAILS AMD VISITS.
The patients were kept in theatre until they became 
responsive. Following this they were transferred to a 
recovery area where they stayed for 4 - 8  hours. Routine 
post-operative care was undertaken i.e. oxygen 35% was 
given by facemask, intravenous fluids continued as 
necessary and analgesia given on demand. Combinations of 
papaveretum and prochlorperazine or morphine and cyclizine 
were used but no attempt was made to standardise these.
All patients were visited in recovery and the 
following day. At the second interview they were asked:
1 Last event recalled prior to induction
2 First event recalled after the termination of
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anaesthesia.
3 If they recalled any event between these i.e. 
suffered from awareness.
DATA AND STATISTICAL METHODS.
1 . PATIENT GROUPS.
Two groups of patients were studied, an enflurane 
g r o u p  and an i s o f l u r a n e  group. These g r o u p s  w e r e  
in effect subdivided by the controller into those who 
required extra morphine during the procedure and those who 
did not.
In the initial part of the isoflurane study three 
patients suffered a severe bradycardia (heart rate less 
than 20). These were effectively treated by stopping 
surgery and giving atropine (0.6 mg). In view of this all 
subsequent patients with heart rates of less than 50 bpm 
were given glycopyrollate, 0.2 mg every 2 minutes, until
the rate was greater than 55 bpm. The observer determined 
this requirement from the ECG rate. As no patient in this 
group required an additional bolus of morphine five 
patients groups resulted:
1 Group E; ethrane, morphine bolus at induction, no
additional morphine.
2 Group EM; ethrane, morphine bolus at induction and
a d d i t i o n a l  b o l u s ( e s )  of m o r p h i n e  d u r i n g  the
control run.
3 Group I; isoflurane, morphine bolus at induction, no
additional morphine.
4 Group IM; isoflurane, morphine bolus at induction and 
an additional bolus of morphine during the control 
run.
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5 Group IA; isoflurane, morphine bolus at induction and 
an anticholinergic agent during the control run.
The groups are therefore identified by one or two 
letters. The first letter (E or I) identifies the volatile 
anaesthetic agent the patients received; the second 
letter, if present, identifies those patients who required 
additional morphine (M), or an anticholinergic agent (A), 
during the proceedure.
Group M is used to describe all the patients who 
received additional morphine, irrespective of the volatile 
agent used, and Group NO all the patients who did not 
require additional morphine. The latter group includes 
those patients who received an anticholinergic drug.
2. TIMES.
Time was measured from induction and the following 
determined:
1 Total Anaesthetic Time (TAT), time from induction to 
t e r m i n a t i o n  of the a n a e s t h e t i c  (i.e. the  
discontinuation of the nitrous oxide).
2 Total System Time (T S T ), time from starting the 
controller to its discontinuation.
3 System Termination Patient Response Time (STPR), the 
time taken to respond to command after the controller
was switched off.
4 Anaesthetic Termination Patient Response Time (ATPR), 
the time to response to command from the termination 
of the anaesthetic (i.e. the discontinuation of the
nitrous oxide).
5 The period over which the cardiovascular, SAP control
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and inspired volatile requirements were calculated is 
designated the control period (CP). The CP includes 
all valid records from the 11th. to the end of the 
control period. The first 10 records are excluded to 
allow the c o n t r o l l e r  to achieve a degree of 
stabilisation. A recording was considered invalid if 
the SAP measured was "0" mmHg and all data determined 
at that record was discarded. All cases with a CP of 
less than 15 minutes were excluded from the study.
2. CARDIOVASCULAR DATA AND VOLATILE REQUIREMENTS.
The HR, SAP, MAP, DAP were measured by the Dinamap 
e a c h  m i n u t e  and the RPP and r e q u i r e d  v o l a t i l e  
concentration determined by the computer. This data was 
stored to disc at the end of a control run.
A program was written to read the data from disc and 
calculate the criteria used to assess the adequacy of 
control (vide infra). A utility program was used to 
convert the data to the format used by Statmode 1 (SM1), a
well known commercial statistical package. The mean and 
standard deviations for the cardiovascular and inspired 
volatile data were calculated for each patient with this 
program.
3. PRST SCORES.
The mean PRST score was calculated for each group by 
summing all P, R, S, and T values and dividing the total 
by the number of PRST records. The percentage contribution 
of each component to the total group score was also 
calculated.
Page No. 141
4. PUPILLARY DIAMETER (PD).
PD measurements were made at the start of a Dinamap 
inflation sequence. The correlation between SAP and PD was 
claculated using Statmode 2 (SM2).
5. ASSESSMENT OF SAP CONTROL.
The control of SAP is assessed by three criteria (see 
Appendix II for details):
1 The root mean square deviation (RMSD). The RMSD is 
analogous to the standard deviation but uses the TSAP 
value in place of the mean in its calculation. This 
parameter gives an idea of the spread of SAP about 
the target value.
2 The point ratio (PR). The PR is the ratio of the 
percentage of SAP points falling above the TSAP to 
the percentage of points falling below the TSAP.
3 The mean deviation from the TSAP (MDnPAT5). This
1 O  Jr
reflects the difference between the mean measured SAP 
and the TSAP.
These three indices should be considered together, 
control of SAP is considered "good" if:
1 The RMSD is less than lOmmHg.
2 The PR lies between 0.4 and 2.3
3 The MDTSAp is less than 5 mmKg.
6. THE ANAESTHETIC STATE PRODUCED.
The anaesthetic state was considered acceptable if:
1. Physiological variables were maintained within 
acceptable limits:
a. The SAP control v/as adequate (vide supra).
b. The mean HR ranged from 50 to 100 beats per minute.
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c. The mean RPP was less than 12000.
d. The PRST scores were less than 4.
Other physiological variables e.g. ventilation and 
neuromuscular blockade are assumed to be within normal 
limits.
2. Recovery was achieved within 15 minutes of the 
discontinuation of the nitrous oxide. However, a 
difference of more than 5 minutes between the STPR 
and ATPR indicates that the controller was switched 
off too s o o n  a n d  t h a t  the A T P R  m a y  be 
misrepresentative of the recovery period. To allow 
for this a corrected ATPR (cATPR) was calculated:
cATPR = ATPR + (STPR - ATPR) - 5 min.
For each minute the difference between the STPR and 
ATPR exceeds 5 minutes one minute is added to the 
cATPR. The cATPR is therefore a better reflection of 
recovery if the controller was switched off "early".
3. If direct questioning established no recall of 
events between induction and extubation.
STATISTICAL METHODS.
The calculation of mean and standard deviation values 
for the cardiovascular and related data has been explained 
(vide supra).
A two-tailed Mann-Whitney U test was used for all 
inter-group comparisons. Probability values were 
calculated with SM2. A probability value of 0.05 or less 
is considered significant.
The values calculated by SM1 and SM2 were checked
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manually for three patients selected at random.
SPECTRAL EDGE FREQUENCY.
The neurotrac was used to record the SEF in 8 
patients in the isoflurane group during surgery. As we did 
not have the facilities to record the EEG data on disc the 
neurotrac printer was set to record the CSA with the SEF 
superimposed. The control program was modified to allow 
the operator to "mark" the data print-out by pressing "E" 
on the keyboard. As the neurotrac incorporates an event 
marker the operator can then "mark" both print-outs 
simultaneously so that the two records can be related 
later.
To determine if a relationship between SEF and SAP 
exists two "numbers" are required, a single SEF frequency 
and the corresponding SAP measurement. The SEF frequency 
was determined by measuring the distance from the 0 Hz 
baseline to the start of the SEF "box" and applying the 
appropriate correction factor (figure 51).
Although a series of SAP measurements and SEF 
frequencies are available and these series can be related 
in time, it is not possible to relate any single Dinamap 
reading to a specific SEF because the Dinamap takes a 
variable, unknown time to check any single reading and the 
neurotrac always gives a time weighted average.
When these are considered it is apparent that 
statistical analysis would be of limited value. We decided 
to take a period during each run over which the SAP was 
relatively stable and to plot SAP, SEF and HR against time 
to determine if any visual relationship was apparent. It
Figure 51 Measuring the SEF.
The distance from this baseline is measured in rim.
(d in the example). This distance is then converted to 
Hertz, ie.
frequency (Hz) = c * (42/30)
Note the tracing from the left hemisphere is ignored.
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must be accepted that the SEF and SAP may be out of phase 
by up to one minute.
CHAPTER
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RESULTS
GROUPS.
Fifty seven patients consented to the study, 22 
received enflurane and 35 isoflurane. Adequate control of 
SAP was not acheived in two patients and they received an 
excessive dose despite additional morphine. These cases 
were abandoned. A breach of protocol occured in three of 
the isoflurane cases:
1 One patient was not given a bolus of morpine at the 
correct time.
2 One patient suffered a blood-loss of 3.5 liters and
was hypotensive with respect to the TSAP for some 50
minutes.
3 One patient gave a history of her heart "slowing down
and stopping" during a previous laparoscopy. This
patient was admitted to the study but received 
glycopyrollate at induction.
The latter 2 cases are considered seperatly.
Fifty two patients are therefore included in the 
inter-group comparisons. The generation of the five groups 
has been discussed and is summarised in table 10.
The details of the patients and their operations are 
listed in tables 11 and 12. There was no statistical 
diference between the groups with respect to age, weight, 
pre-operative and pre-induction blood pressures, total 
anaesthetic time or total system running time.
CONTROL OF SAP.
Figures 52 to 56 are examples of the control of SAP 
acheived during individual runs. These examples are
Table 10. The five patient groups.
GROUP CHARACTERISTICS
E Received morphine at induction and were
controlled with enflurane alone.
EM Received morphine at induction and
enflurane for maintenance but required 
additional morphine during the proceedure. 
This requirement was determined by the 
controller.
I Pveceived morphine at induction and were
controlled with isoflurane alone.
IM Received morphine at induction and
isoflurane for maintenace but required 
additional morphine during the proceedure. 
This requirement was determined by the 
controller.
IA Received morphine at induction and were
controlled with isoflurane alone. These 
patients were given an anticholinergic 
agent because of a bradycardia.
Note, all patients were ventilated and received 66% 
nitrous oxide in oxygen.
Table 11. Group details (1), the surgery performed.
Group
Operation E EM _I IA
Hysterectomy (+/- 3S0) 9 7 13 8
Ovarian Cystectomy 1 2 1
Uterine Myomectomy 1 - - -
Vaginal Hysterectomy 2 - 1 1
and P.F.R.
Reversal of 1
Sterilisation
BSO
BSO = Bilateral Salpingo-oopherectomy 
P.F.R = Pelvic Floor Repair
Table 12 - Group details (2), general information.
Age Weight
Group Mean SD Range Mean SD Range
E 41 .8 9.87 24 - 57 60.8 1 1 .97 45 - 33
EM 37.6 10.47 25 - 54 60.7 11 .88 45 - 30
1 43.1 9.07 32 - 65 60.1 8.97 43 - 82
IA 42.2 7.27 33 - 62 64.3 10.13 53 - 82
IM 37.6 7.27 26 - 73 64.6 16.56 45 - 91
Pre- induction BP Total Anaest hetic Time
Group Mean SD Range Mean SD Range
E 129.2 1 0.52 118 - 151 67.2 23.14 47 - 135
EM 123.9 8.21 120 - 140 74.9 17.27 45 - 100
I 128.6 1 3.99 110 - 151 65.0 20.05 34 - 106
IA 123.9 10.21 109 - 142 52.3 22.32 58 - 96
LM 129.8 4.99 123 - 135 69.8 1 3.24 58 - 92
Total System Time 
Mean SD Range
55.3 23.42 35.9 - 123.7
62.7 16.37 35.3 - 36.6
54.3 18.31 29.0 - 85.2
51 .0 20. 99 24 . 1 - 35.2
56.5 14.76 43.8 - 81.7
Group
T71
EM
I
IA
IM
Example from Group E.
SAP(mmHg), HR(bpm),Enf.(%),lnt(%)
200 r
150
TSAP
100
5% 50
0% 0
6040200
Time (min.)
HR ~~~ SAP Inspired enflurane Integral
Figure 52. An example from group E.
The RMSD in this case was 6.6.
Example from Group EM.
SAP(mmHg), HR(bpm), Enf.(%), lnt(%)
200 r
150
TSAP
100 -
I •• ♦1 • « ■*
V
5% 50
0% 0
600 20 40
Time (min.)
HR SAP Inspired enflurane “ Integral
Figure 53. An example from group EM.
The RMSD in this case was 11.47. This patient 
required two boluses of morphine (arrowed). 
Following the second bolus the inegral 
stabilised.
Example from Group I
SAP(mmHg)IHR(bpm),lso.(%)llnt(%)
200
150
TSAP
100
5% 50
0% 0
0 20 40 60
i ime (min.)
HR SAP Inspired isoflurane * Integral
Figure 54. An example from group I.
The RMSD in this case was 6.64.
Example from Group IA
SAP(mmHg), HR(bpm), lso.(%),lnt(%)
200
150
TSAP100
5% 50 -
0% 0
0 20 40 60
Time (min.)
HR — SAP Inspired isoflurane * Integral
Figure 55. An example from group IA.
The RMSD in this case was 6.03. This patient 
received atropine 0.3mg for a bradycardia of 
30 bpm (arrowed). This event was not recorded 
by the Dinamap.
Example from Group IM
SAP(mmHg),HR(bpm),l80.(fc),lnt(fc)
200
150
TSAP
100
6% 50
40 50
0% 0
0 3010 20
Time (min.)
SAP Inspired Isoflurane Integral ~ H R
Figure 56. An example from group IM.
The RMSD in this case was 7.46. This patient 
received a single additional bolus of morphine 
(arrowed).
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selected to be representative of the group from which the 
patients were chosen, the RMSD values in each case being 
close to the mean value for the group.
The mean and standard deviations for TSAP, measured 
SAP, r'IDTSAP' and PR for each of the five groups are
listed in table 13. There was no diference between the 
groups with respect to the TSAP or mean SAP values.
Control of SAP, as reflected by the RMSD was poorer 
in group EM when compared to the other groups (table 14). 
However, when the PR and MDrpg^p are also considered 
control was significantly better in the groups which did 
not require additional morphine.
Overall, control of SAP was "inadequate" (vide supra) 
in 19 patients i.e. 36.5% of the total (see Appendix III 
for details). Of these, 10 patients were in the two groups 
who required additional morphine i.e. all the criteria 
were not fulfilled in 83.3% of these patients, compared to 
22.5% of patients in the other groups. Two or more of the 
three control criteria were acheived in 37 of the 40 
p a t i e n t s  in the thr e e  g r o u p s  of p a t i e n t s  in w h o m  
additional morphine was not required i.e. 92.5%.
The overall control of SAP is illustrated graphically 
in figure 57. This figure illustrates the main diference 
between the patients who required additional morphine and 
those who did not i.e. those patients who did require 
additional morphine appear to be controlled about a higher 
TSAP.
THE ADEQUACY OF THE ANAESTHETIC STATE.
A. PRST SCORES.
At no time did any of the anaesthetists involved,
Table 13. Group details (3), SAP control data.
TSAP
Group' Mean SD Ranqe
E 117.4 6.85 105-128
EM 114.4 7.25 106-126
I 118.0 5.38 110-133
IA 117.3 5.29 111-131
IM 114.4 5.13 106-118
MDTASP
Group Mean SD Ranqe
s -•0.52 1 .35 -3.03- 2.16
EM 6.33 3.11 3.38-13.00
I 0.38 3.09 -7.40- 7.74
IA 0.28 1 . 77 -4.48- 1.6
IM 4.65 1 .55 3.20- 6.4
SAP
Mean SD Ranqe
116.9 6.27 105.7-126.3
120.8 8.60 111 .2-132.8
118.4 7.53 109.1-133.5
117.6 5.62 111 .7-132.5
119.0 6.15 109.6-124.3
RMSD
Mean SD Ranqe
7.27 2.34 4.81-13.37
10.60 3.45 6.73-17.60
7.00 2.17 4.20-11.70
7.66 1 .66 5.77-10.60
8.48 2.49 4.31-10.82
(continued)
Table 13. Group details (3), SAP control data (continued).
Group Point Ratio % SAP at TSAP.
E 1.25 {+/- 1.69) 8.0
EM 3.41 (+/- 2.28) 6.2
I 2.64 (+/- 5.98)* 5.6
IA 1 .08 (+/- 0 . 34 ) 5.1
IM 3.24 (+/- 1.14) 5.7
* A ratio of 24.81 in one patient in this group greatly 
effects this value. If the patient is excluded a mean of 
1.16 (+/- 0.93) results.
Table 14. Inter-group comparisons (1), control of SAP
E-EM E-1
Group.
E-IA E- IM EM-I
M^tsap
RMSD
PR
0 . 0 0 0 1  
0.007 
0.0008
ns
ns
ns
ns
ns
ns
0 . 0 0 1
ns
0.003
0.0002
0.008
0.004
EM-1A
Group. 
EM-IM I-IA I - IM I A - IM
MDr 'SAP
RMSD
PR
0 . 0 0 0 1
0.03
0.0002
ns
ns
ns
ns
ns
ns
0.0007
ns
0.009
0.002
ns
0.0007
ns = not significant (P > 0.05)
SPREAD OF SAP.
%  deviation from the TSAP.
40
30
20 -
30200 10-10-20
Percentage of SAP measurements.
~ I s o . ( - )  “ Q“  lso.(+) Enf.(+) Enf.(-)
Figure 57 A diagram to show the spread of SAP about the 
TSAP.
A utility program was used to calculate the 
number of records in each control run falling 
in 5% brackets about the TSAP, ie. -27.5% 
to + 27.5%. Points + or - 30% were considered to 
fall at 30%. The number of measurements in 
each bracket are plotted as the percentage of 
the total number of records in each group.
The minus and plus signs designate those 
patients who received additional morphine ( + ), 
and those who did not (-). Enf. and Iso. refer 
to the volatile anaesthetic agent the patients 
received, enflurane or isoflurane.
Note that there is a greater percentage of 
measurements in all brackets over +12.5% in 
the enflurane ( + ) group when compared to the 
isoflurane (+) group.
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including independant anaesthetists, feel that a patient 
was too "lightly" anaesthetised. The mean PRST scores were 
all less than 2 and was lowest in Group E (table 15). The 
higher values in the other groups reflect the higher heart 
rates in these patients.
B. PHYSIOLOGICAL STATE.
The control of SAP has been considered in detail. The 
HR, RPP and inspired volatile requirement in each group is 
listed in table 16 and the inter-group comparisons in 
table 17. In two patients in group EM and one in group IM 
the RPP exceeded 1 2000. The mean heart rate was greater 
than 100 in only one case (group EM). The physiological 
state, with respect to HR and RPP was therefore acceptable 
in all but 3 patients. All of these cases were in the two 
groups which required additional morphine. The heart rate 
was generally lower in those cases who did not require 
additional morphine or an anticholinergic agent.
The inspired volatile requirements were significantly 
lower in groups NO when compared to groups M. There was no 
statistical diference between the inspired isoflurane and 
inspired enflurane requirements in otherwise comparable 
groups. Specifically, the inspired volatile requirement in 
group IA was similiar to that in groups I and E, the other 
two groups who did not require additional morphine.
As the end-tidal concentrations during the control 
period were not stable long enough for equilibration 
between the alveolar and brain concentrations to take 
place analysis of this data was not undertaken.
Table 15. Group details (4), mean PRST scores.
Group Observ- Total Variable Score Mean PRST
ations P R S T
E 145 3 10 4 50 0.46
(4.5) (14.9) (6.0) (74.6)*
EM 80 13 45 1 7 0.82
(19.7) (63.2) (1.5) (10.6)
I 137 13 81 11 48 0.82
(8.5) (52.9) (7.2) (31.4)
IA 82 4 55 0 19 0.95
(5.1) (70.5) (0.0) (24.4)
IM 46 8 49 5 14 1.10
(10.5) (64.5) (6.6) (18.4)
The observations are the number of PRST measurements made 
in each group and the total variable score the summed 
total ?, R , S and T values for all the observations in 
that group. The figures in brackets are the percentage 
contribution of the individual components to the total 
score.
Table 16. Group details (5), cardiovascular and vaporizer 
data.
Heart Rate. Vaporizer Output.
Group Mean SD Ranqe Mean SD Ranqe
E 66 . 9 8.15 55.6- 83.5 1 .0 0.66 0.11 - 1.80
EM 83.1 16.66 61.7-109.6 2.2 0.45 1 .83 - 3.13
I 73.6 8.06 62.7- 87.3 1 .0 0.54 0.25 - 2.00
IA 80.3 10.28 63.5- 99.1 0.8 0.46 0.12 - 1.68
IM 89.4 9.78 77.0- 99.4 2.1 0.36 1.76 - 2.52
Rate Pressure Product.
Group Mean SD Ranqe
E 7821 .9 1059.9 6518.7 - 10606.8
EM 10105.4 2384.0 8225.4 - 14214.8
T 8677.4 1144.5 7191.6 - 11100.6
IA 9462.6 1230.3 4788.7 - 11452.1
IM 10634.0 1030.4 9603.6 - 12248.7
Table 17. Intergroup comparisons (2), cardiovascular and 
inspired volatile requirements.
Group
E-EM E-I E-IA E- IM EM-I
HR 0.02 ns 0.004 0.0007 ns
VAP 0.0001 ns ns 0.002 0.0001
RPP 0.02 0.04 0.002 0.001 ns
Group
EM- IA EM-IM I-IA I-IM IA-IM
HR ns ns ns 0.009 ns
VAP 0.0001 ns ns 0.002 0.0007
RPP ns ns ns 0.009 ns
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C. RECOVERY TIMES.
A relative anaesthetic overdose, defined as an ATPR 
time of more than 15, minutes occured in 6 isoflurane 
cases and half of these occured in group IM. The ATPR 
times were acceptable in all the ethrane patients. As the 
ATPR may be misrepresentative (vide supra) a cATPR was 
calculated for each patient (table 18). The recovery 
assessed by the cATPR is excellent in groups E and I, in 
more than 70% of cases in groups EM and IA but poor in 
group IM. The differences between the groups are listed in 
table 19.
D. OVERALL INTER-GROUP COMPARISONS.
The criteria defining adequate control and an 
adequate anaesthetic state were acheived in the majority 
(70%) of patients in groups NO. These were acheived in 
only 1 patient in groups M (table 20). Seven point five 
percent of patients in groups NO failed two or more of the 
criteria compared to 83.3% of patients who required 
additional morphine.
"INTERESTING CASES" AND THOSE EXCLUDED FROM THE STUDY.
1. EXCLUSIONS.
In these two cases the TSAP was reset to higher value 
during the proceedure because the patients were receiving 
an excessive doseage of volatile despite additional 
morphine (vide supra). In both cases the pre-operative 
blood pressure, as recorded by the nursing staff, was 
160/90 mmHg and these patients were not considered as 
"hypertensive". In the patient who received enflurane 
further questioning post-operativly revealed a history of
Table 18. Group details (6), recovery times.
ATPR Time
No. of Cases with a
Mean SD Ranqe cATPR > 15 minutes.
E 4.9 1 .93 2 - 9 0 (0%)
EM 10.0 3.74 5 - 15 2 (28.6%)
I 7.1 5.31 1 - 21 1 (6.3%)
IA 8.5 6.62 2 - 22 2 (20%)
IM 20.4 9.34 1 3 - 36 3 (60%)
The cATPR is the corrected ATPR and is calculated:
cATPR = ATPR + (STPR - ATPR) - 5.
Any significant (more than 5 minute) prolongation of t!
STPR - ATPR time is reflected by an increase in th
value •
STPR t i m :E STPR - ATPR m  T  M T p1 hiHj
Group Mean SD Range Mean SD Range
TP
l_j 9.6 3.55 5 - 1 7 4.7 2.75 1 - 10
EM 17.3 5.67 8 - 2 6 7.3 5.83 3 - 2 0
I 11.9 5.84 2 - 2 5 4.8 2.32 1 - 1 0
IA 12.7 8.82 3 - 2 9 4.2 2.90 0 - 7
IM 24.8 6.53 17 - 40 4.4 1.67 2 - 6
Table 19. Intergroup comparisons (3), recovery times.
E- EM E-1 E-IA E-IM EM-1
ATPR 0 . 004 ns ns 0.0002 ns
STPR 0 . 004 ns ns 0.0003 0.05
EM -IA EM-IM I-IA I-IM IA- IM
ATPR ns 0.02 ns 0.0007 0.03
STPR ns 0.0003 ns 0.002 ns
Table 20. Group details (7), the patients in whom 
the control of SAP or the anaesthetic state 
produced was inadequate.
The number of patients in each group in whom the criteria 
for adequate control or an acceptable anaesthetic state 
were not acheived. See text for the definition of these 
criteria and Appendix III for details of the inadequacies.
Group
No. of Criteria E EM I_ IA IM
not acheived.
1 2 1 4  4 -
2 1 5  1 0  2
3^ or more . 0 1 1 0  2
Total: 3 7 6 4 4
%_ of_ group: 21 .4 1 00 37. 5 40 .0 30 .0
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"previous" hypertension despite a denial of problems with 
a "raised blood pressure" pre-operativly. In both cases 
the preinduction blood pressure was within acceptable 
limits.
Like the patients in group M, control of SAP was not 
acheived with clinically acceptable volatile doseage and 
the controller instructed the operator to give additional 
morphine. However, the effect of the morphine boluses in 
these cases was minimal and the integral continued to rise 
(compared figure 58 to figures 50, 53 and 56). The
controller did not acheive control of SAP in these cases, 
despite high doses of volatile anaesthetic, and the TSAP 
was reset to prevent over-dose.
2. THE EFFECT OF HAEMORRHAGE.
In one patient the surgeon had to go "through" the 
uterus to gain access to the uterine vessels. This 
resulted in a large blood loss (over 3.5 liters), a SAP 
below the TSAP and the patient receiving no isoflurane for 
approximatly 20 minutes. At no point during this period 
did either of the two anaesthetists invlolved feel that 
anaesthesia was inadequate or that the action taken by the 
controller was inappropriate. Following restoration of the 
blood volume the SAP gradually rose towards the TSAP and 
the integral was reset to the pre-loaded value by the 
operator. Control of SAP frcm this time (see figure 59) 
was good.
3. THE EFFECT OF GLYCOPYROLLATE AT INDUCTION.
One patient received glycopyrollate at induction 
(0.6mg). The control of SAP and anaesthetic state acheived
Inadequate Control
SAP(mmHg), HR(bpm), Enf.(%), lnt(%
200
TSAP Changed
150
TSAP
100
Morphine Bolus I  Integral Reset
5% 50
0% 0
0 20 40 60
Time (min.)
HR ——  SAP Inspired enflurane — Integral
Figure 58 An example of inadequate control.
This patient received a relative overdose of 
enflurane despite two additional boluses of 
morphine (lower arrows) and the TSAP was 
changed (upper arrow). The integral did not 
stabilise after either bolus of morphine but 
continued to accumulate.
Effect of Haemorrhage
SAP(mmHg), HR(bpm), Isoflurane { % )
200
150
TSAP
100
5% 50
0% 0
10 20 30 40 50 60 70
Time (min.)
HR SAP Inspired isoflurane
Figure 59. The effect of haemorrhage.
This patient lost over 3.5 litres of blood 
during the procedure and was hypotensive, 
relative to the TSAP, for most of the control 
run. When the TSAP was achieved the integral 
was reset (arrow) and from this point control 
of SAP was acceptable.
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in this patient were acceptable in all respects (table 
21 ) .
4. THE PATIENT WHO RECEIVED ENFLURANE AND ISOFLURANE.
A 26 year old patient, admitted for abdominal 
hysterectomy for severe dysfunctional bleeding, was 
admitted to the latter part of the enflurane study. This 
patient required two additional boluses of morphine during 
the proceedure at which an "abnormal" right ovary was 
biopsied. Histological examination later confirmed an 
abnormality which was suggestive of carcinoma in-situ and 
the patient was re-admitted for a b* lateral oopherectorny. 
By this time we were studying isoflurane and the patient 
consented to the use of the controller for her second 
operation. At this operation the patient required a single 
additional bolus of morphine. The data from the two 
operations is listed in table 22.
Apart from a higher heart rate during the second 
proceedure the results appear comparable although control 
was marginally better during the second proceedure. 
Statistical comparison of two data sets would be of 
limited use and was not undertaken.
PUPIL DIAMETER.
Pupil diameter was measured in 34 patients. A 
significant correlation was found in 5 cases. The 
correlation coefficients and P values for these cases are 
listed in table 23. These patients are derived from 4 of 
the 5 groups and, when considered as a group in their own 
right, there is no single outstanding feature which 
suggests that the anaesthetic state in these cases difered
Table 21 . Data from the patient who received 
glycopyrollate at induction.
TSAP = 116 mmHg HR = 96 . 7 bpm
SAP = 118.6 mmHg RPP = 11470.4
m d tsap = 2.6 mmHg ATPR = 11 min.
RMSD = 8.5 mmHg cATPR = 12 min.
PR 1 .5
Table 22. Data from the patient who received enflurane 
and isoflurane.
Enflurane Isoflurane
TSAP 1 06 1 06
SAP 111.2 109.6
m d tsap 5.2 3.6
RMSD 9.24 8.62
PR 2.9 2.7
HR 78.0 99.4
RPP 8725.7 10891.0
VAP 2.21 1 .76
cATPR 1 7 23
Table 23. Correlation between pupil diameter and SAP.
Group No. of Records Correlation P Value
EM 14 0.62 0.02
I 7 0.83 0.05
I 9 0.69 0.05
IA 1 6 0.63 0.02
IM 1 4 0.62 0.02
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significantly in any other way from the rest of patients 
studied (table 24).
SPECTRAL EDGE FREQUENCY.
The Neurotrac was used to measure the SEF in 8 
patients who received isoflurane. Of these, 4 came from 
group IA, 3 from group I and one from group IM. Figures 60 
and 61 show the relationship between SEF and SAP for the 
patients in groups I and IA. In four of these cases there 
appears to be a relationship between the SAP and SEF, 
which is most apparent in diagrams (a) and (b) in figure
60. In three cases no relationship was apparent (figure 
61 ) .
If these 7 cases are divided into two groups; Group A 
(n = 4), those who appear to display a relationship 
between SEF and SAP, and Group B (n = 3), those who do 
not; these groups are found to be comparable (table 25).
Insufficient markers where put on the trace from the 
patient who required morphine to allow the relationship 
between SEF and SAP to be determined. The trace recorded 
from this patient is itself interesting (figure 62). At 
the time the controller instructed the operator to give a 
bolus of morphine burst suppresion was apparent and the 
CSA became isoelectric shortly after this. This continued 
for some 8 minutes before burst suppresion occured and 
continual activity resumed. The control of SAP in this 
case is displayed in figure 56.
Table 24 - Data from the 5 patients with a significant 
correlation between PD and SAP.
Variable Mean SD Ranqe
ATPR 9 7.52 4 - 22
TSAP 117.2 6.72 106 - 124
SAP 120.3 8.14 109.6 - 131.7
— TSAP 3.1 3.82 -1.4- 7.74
RMSD 8.7 1 .32 6.7 - 10.0
HR 80.4 15.21 63.5 - 99.3
VAP 1 .5 0.65 0.7 - 2.0
25. A comparison of the 4 cases who (
visual relationship between SAP and SEF and 
the three patients who do not.
Visual Relationship No Visual Relationship
Variable Mean S.D. Mean S.D
ATPR 12.3 8.3 6.3 3.1
TSAP 117.8 1 .7 110.7 0.6
SAP 118.2 1 .2 113.8 2.8
M2tsap 0.4 1 .5 1 .4 1 .0
RMSD 3.7 1 .7 6.4 3.3
HR 77.5 12.1 75.8 5.6
VAP 0.9 0.1 1 .0 0.1
SAP vs SEF
SAPtmmHo) a 8EF(H2«K»
260
200
160
100
60
0 20 40 60
Tims (SEF records).
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SAP vs SEF
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200
160
140
120
XX)
8020 40 600 10
Time (SEF records). 
—  sap —  SEF
Figure 60. The 4 cases in whom a visual relationship 
between SAP and SEF was apparent.
(continued)
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Figure 60 (continued).
The 4 cases in whom a visual relationship between 
SAP and SEF was apparent.
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Figure 61. The 3 cases in whom a visual relationship 
between SAP and SEF was not apparent.
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Figure 62 The single case 
in group IM in when the SEF 
was monitored.
4 £. i i S
-fi
............... At time the ccrputer
instructed the operator to 
give an additional bolus of 
morphine burst suppresion was 
apparent on the CSA trace (a). 
The trace became isoelectric 
shortly after this (b).
5 - Dfc
An EEG trace was taken to conf irm this (c).
c,
v  "  K  K  i  L
: i : i
*  I c r r
d; £
w  — 'y
The only visible activity on 
this trace is EGG contamination 
After 8 minutes EEG activity 
returned (d) and became 
continuous after 30 seconds (e)
The figures show the activity 
in the right hemisphere, the 
left trace was identical.
The missing segment is 
isoelectric.
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DISCUSSION
A RESUME:- DIFFICULTIES IN ASSESSING TECHNIQUES PROPOSED 
AS MONITORS OF THE ANAESTHETIC STATE.
If it is accepted that the anaesthetic state results 
from the balance between the effects of anaesthetic dose 
and the effects of surgical stimulation on the CMS, then 
it is reasonable to assume that any variable which 
reflects changes in these determinants may "measure" this 
state. However, the validity of such variables, as 
measures of the true anaesthetic state, is unknown. This 
is because:
1 Surgical stimulation cannot be quantified. And, 
although it may be described qualitatively as a 
graded sequence of responses, the validity of these 
responses as a measure of the true anaesthetic state 
is unknown.
2 The wide variation in anaesthetic requirement means 
that anaesthetic dose per se cannot be used as a 
measure of the anaesthetic state. The limitations of 
indices, such as MAC, have been discussed (chapter 
2 ) .
Therefore, if the various techniques proposed as 
monitors of the anaesthetic state (see chapter 3) are to 
be fully assessed, an individually valid anaesthetic state 
must be available for reference.
THE USE OF CLINICAL SIGNS AS A STANDARD OF ANAESTHETIC 
ADEQUACY.
Clinical signs are currently the only practical,
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universally accepted method of assessing anaesthetic 
adequacy and are used to guide the administration of 
thousands of successful anaesthetics each day. Individual 
anaesthetists must therefore be able to identify the zone 
of surgical anaesthesia, for individual patients, with the 
techniques he uses (see introduction). However the exact 
location and best definitions for the boundaries of this 
zone are unknown. The current defi n i t i o n  of what 
constitutes an adequate clinical anaesthetic state is 
therefore, both subjective and variable.
If a computer control system, operating from rules 
based on clinical signs, produces an individually tailored 
anaesthetic state that achieves the goals of anaesthesia, 
a clinically standardised anaesthetic state would be 
available. The use of a computer control system would 
ensure that the description of the state is objective and 
not subjective, eliminating the individual variation 
caused by the different ways anaesthetists work.
There are obvious limitations to the use of clinical 
signs i.e. they cannot be expected to give reliable 
information during some types of surgery (e.g. cardio­
pulmonary bypass surgery) and, in some situations, the 
validity of individual signs may be reduced e.g. heart 
rate changes will have less importance following atropine. 
However, within these limitations, the controller could be 
used to evaluate other techniques in circumstances where 
the validity of these signs is clinically established and 
complicating factors e.g. atropine and beta blockers are 
excluded.
Such a control system would therefore allow the
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various techniques proposed as monitors of anaesthetic 
adequacy to be more fully assessed. Further, the degree of 
effect variables, which are known to detract from the 
usefulness of clinical signs, have on the validity of 
these signs as an index of anaesthetic adequacy, could be 
more fully assessed.
It should be noted that although clinical signs may 
not contain sufficient information to determine whether a 
patient is "aware", there is currently no proven method of 
assessing "awareness" intraoperativly. The absence of 
intraoperative recall must therefore be determined 
postoperativly. The difference between amnesic wakefulness 
and awareness has been discussed.
SAP AS AN INDICATOR OF THE ANAESTHETIC STATE.
The use of SAP as the sole variable to control the
delivery of anaesthetic agents can be criticised on
several grounds. Anaesthetists use combinations of 
clinical signs to determine the anaesthetic state and SAP 
alone cannot be expected to give reliable information in
all cases, hypovolaemic and hypertensive patients being
obvious examples. In this study we have attempted to limit 
the effects of these factors by careful patient selection.
However, SAP is one of the few quantifiable clinical 
indices of anaesthetic adequacy and the author's consider 
that a SAP within the range expected for normal sleep is 
one of the many clinical r e q u i r e m e n t s  of a good 
anaesthetic and, in routine anaesthetic practice, 
increases in SAP are often treated with anaesthetic drugs.
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CONTROLLING SAP.
Systems, designed to control arterial pressure, have 
been described (206,207,208).
Suppan (206) described a system in which the operator 
selected SAP limits, determined after a clinically 
satisfactory anaesthetic state was achieved. The 
controller maintained SAP within these limits by 
d e l i v e r i n g  one of three, p r e s e l e c t e d ,  h a l o t h a n e  
concentrations. This system is crude and requires careful 
supervision by the anaesthetist.
A s e l f - t u n i n g  c o n t r o l  s y s t e m  has be e n  u s e d  
to control MAP during hypotensive anaesthesia with both 
isoflurane and nitroprusside (207,209). And a "discrete 
digital control system" , which uses a combination of MAP 
and recent drug requirement to determine the dose 
requirement, has been used to control MAP with both 
halothane (208) and nitroprusside (210). This system has 
only been used in laboratory animals. A PID controller has 
been used to control SAP following cardiac surgery (211).
In our study SAP was controlled with doses of 
a n a e s t h e t i c  used in r o u t i n e  p r a c t i c e  and SAP was 
controlled at normal, not hypotensive, levels. We chose to 
select the simplest system which would achieve control of 
SAP because the pharmacological situation is complex and 
simple systems gives the best understanding of the process 
with the maximum safety. Control of SAP with such a system 
has many limitations e.g. it cannot anticipate drug demand 
and cannot be expected to produce optimal control in all 
patients. Improvement may be difficult as more complex 
systems e.g. self tuning systems which might have the
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flexibility to cope with the inevitable non-linearities 
which exist, v/hen one is trying to suppress the SAP 
response to surgery, might require more data than SAP 
sampled once a minute.
Most workers e.g. Woodcock and his co-workers (207 ) 
have assessed control by the time taken to achieve the 
target and the goodness of control about the target once 
it is reached. We chose to assess SAP control over most of 
the control run, excluding only the initial ten records, 
so that the overall quality of the anaesthetic (in terms 
of SAP) and the controller could both be assessed. A 
direct comparison of our results to those of other workers 
is therefore not appropriate.
THE TARGET SAP.
Choice of a TSAP corresponding to a reasonable 
anaesthetic state is difficult. Spot measurements in the 
w a r d  or in the a n a e s t h e t i c  room are l i k e l y  to be 
unrepresentative due to anxiety or sedation. For this 
reason we used age and sex related values from tables. A 
TSAP of 90% of this value was chosen after initial trials 
suggested that a TSAP of 85% of this value overdosed the 
patients.
This method of selecting the TSAP is crude. The 
standard deviations of the mean SAP in females, quoted in 
the tables we used (205) range from 11.8mmHg, in the 20-24 
year age group; to 29.0mmHg, in the 65-69 year age group. 
It is possible that those patients who required additional 
morphine reflect those in whom the TSAP is too low.
Berger monitored arterial pressure directly in 3 4 
female patients for a 36 hour period over the p e r i ­
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operative period (212). These workers determined a 
preoperative baseline (POB), the average value recorded in 
the second hour of monitoring; and a preanaesthetic 
standard (PAS), the average value of 15 consecutive 
m e a s u r e m e n t s  made at 1 m i n u t e  i n t e r v a l s  p r i o r  to 
induction. The mean POB was 130.8mmHg and the standard 
deviation 26mmHg. The PAS (in the 26 patients receiving 
general anaesthesia) was 150.1mmHg. These workers 
concluded that "... continuous or at least repeated 
measurements of blood pressure and heart rate obtained 
while the patient is not under the influence of drugs 
should be the most appropriate baseline". The direct 
measurement of blood pressure preoperatively is not 
appropriate in general anaesthetic practice. Repeated 
preoperative measurements in a "relaxed" setting, with a 
Dinamap or similar machine to prevent observer bias and 
"white coat" hypertension (213), may give a more valid 
reference value.
THE ADDITIONAL RULES.
out
In the p r e l i m i n a r y  work, c a r r i e d ^ b e f o r e  the 
additional rules were introduced, some limitations of the 
control system became apparent. The additional rules were 
introduced in light of these findings.
A major limitation of the control system is that it 
cannot anticipate "predictable" changes in the level of 
surgical stimulation and therefore anaesthetic requirement 
e.g. following skin incision. In anaesthetic practice, 
some stimuli can be anticipated and the anaesthetic 
dose increased. We attempted to imitate this
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practice by delivering a minimum concentration for the 
first 10 minutes to "cover" the effects of skin incision.
A second problem is that the system delivered a 
relative overdose of anaesthetic to some patients. In 
anaesthetic practice it is common to give a bolus of 
narcotic to limit the requirement of volatile anaesthetic. 
The second rule, which required additional morphine if the 
dose of volatile agent became excessive, was an attempt to 
imitate this practice. The resetting of the integral 
prevented overdose in these patients. This rule was based 
on anaesthetic requirement i.e. over-dose was defined in 
terms of anaesthetic dose. This is not ideal.
The dose limit i.e. a total inspired concentration of 
15% over 5 consecutive vaporizer settings with each 
individual setting exceeding 2.5%, was left the same 
following the change to isoflurane. If the 5 groups are 
ranked by the percentage of patients in each group, in 
whom the criteria defining an adequate anaesthetic state 
were achieved (see table 20 for details), it is found 
that:
E > I > IA > > > EM > IN
(the groups are ranked from left to right)
That an acceptable anaesthetic state was achieved in 
a slightly higher percentage of patients in group I when 
compared to group IA suggests that small doses of 
anticholinergic agents detract from the usefulness of SAP 
as an indicator of anaesthetic adequacy (vide infra). The 
differences between otherwise comparable isoflurane and 
enflurane groups (i.e. groups I and E; and groups III and
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EM) may reflect the limitation of the second rule.
In terms of MAC, isoflurane is more potent than 
enflurane. If this relationship is true, with respect to 
the SAP response to surgical stimulation then, on a 
population basis, the "split" between those patients who 
required additional morphine and those who did not will 
have occurred at a "lighter" level of anaesthesia in the 
enflurane group. There is some evidence to suggest this is 
true:
1. Only 16% of the isoflurane patients required 
additional morphine compared to 33% of the enflurane 
patients.
2. No p a t i e n t  in g r o u p  IM r e q u i r e d  mo r e  than 1 
additional bolus of morphine while 3 of the 7 
enflurane patients in group EM required 2 boluses and 
one patient required 3.
3. Although there is no statistical difference in 
recovery times between comparable groups the 
percentage of cases in whom the cATPR was over 15 
minutes rises from 0% in group E to 60% in group I 
(table 18).
If t h i s  e x p l a n a t i o n  is c o r r e c t  a n d  a m o r e  
representative TSAP cannot be defined (vide supra), then 
an individually valid method of determining when 
anaesthesia is excessive is required
In the single isoflurane patient who had SEF measured 
and required additional morphine, the requirement of 
morphine might have been determined by EEG changes i.e. 
burst suppression. The processed EEG might therefore be 
used, with isoflurane, to determine the requirement of
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morphine. However, the automated recognition of this EEG 
pattern is not easy (150) and burst suppression does not 
always indicate that the clinical state is adequate, far 
less excessive (117,119,120).
A bang-bang control system using two feedback 
variables, MAP and SEF, has been developed (214). The 
on/off MAP and EEG systems were tested separately in 4 
experiments and the combined system in one dog. Although 
the results suggest the system may be useful in the 
future, the animal was not undergoing surgery and several 
step tests were required to determine the MAP and SEF 
thresholds before the loop could be closed.
DOES THE CONTROLLER ACHIEVE THE GOALS OF ANAESTHESIA.
Mo patient showed clinical signs that suggested 
anaesthesia was inadequate and no patient complained of 
awareness post-operativly.
Although clinical scoring systems have severe 
limitations, the PRST score is a simple method of 
summating the significance of clinical signs and was used 
in this study as a general measure of anaesthetic 
adequacy. The highest score recorded was 4 and the mean 
values suggest that anaesthesia was adequate. However, the 
lowest mean value occurred in Group E which, in terms of 
recovery, was the most lightly anaesthetised group and the 
highest score in group IM which, by the same criteria, was 
the most deeply anaesthetised group.
In group E only 14.9% of the total PRST score is 
attributable to heart rate but in the other groups the 
heart rate contribution exceeds 50% of the total score.
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The higher heart rates in these groups is probably drug 
related and not attributable to increased autonomic 
activity.
The PRST score cannot therefore differentiate between 
adequate and excessive anaesthesia as low scores occurred 
in all groups. However, as the clinical assessment of the 
anaesthetic state is largely successful, it is likely that 
clinical signs are a sensitive measure of insufficient 
anaesthesia. The PRST score will reflect this occurrence.
THE EFFECT OF ANTICHOLINERGIC AGENTS.
There are no statistically significant differences 
b e t w e e n  g r o u p s  I and IA. H o w e v e r ,  an a c c e p t a b l e  
anaesthetic state was achieved in only 40% of patients in 
group IA compared to 31.2% in group I. Small doses of 
anticholinergic agents may therefore detract from the use 
of SAP as an indicator of anaesthetic adequacy. This 
effect appears to be limited as the goals of anaesthesia 
were achieved by the controller in the patient who 
received a bolus of glycopyrollate at induction.
THE R E L A T I O N S H I P  B E T W E E N  P U P I L  D I A M E T E R  AND THE 
ANAESTHETIC STATE.
We believe that eye signs have limited value during 
anaesthesia and surgery and were surprised to find a 
correlation between PD and SAP in several cases. However, 
there appears to be no relationship between the clinical 
anaesthetic state (as defined by SAP) and pupil diameter.
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THE RELATIONSHIP BETWEEN SEF AND SAP.
The visual relationship between SAP and SEF is 
apparent during relatively small fluctuations in SAP 
(approximately 10 to 20mmKg). If fluctuations in SAP of 
this size reflect changes in the true anaesthetic state, 
then SAP may be a more sensitive indicator of the 
anaesthetic state than previously accepted e.g. one of the 
criteria Thornton and his co-workers used to define a 
"marked" autonomic response was an increase in SAP of 
20mmEg or more (174).
However, our method of determining a relationship 
between SEF and SAP is crude; we only compared SEF and SAP 
during a short period in a small number of patients; we 
did not find a relationship in all cases; and it is not 
known if SEF is related to the true anaesthetic state. 
Further, we did not demonstrate any significant difference 
between those patients in whom a relationship was apparent 
and those in whom it was not. Therefore, it cannot 
currently be proven that SAP is a sensitive measure of the 
anaesthetic state.
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CONCLUSIONS.
In conclusion, the controller achieved the immediate 
aim of controlling SAP and also produced a pattern of 
clinical signs recognisable as general anaesthesia, 
thereby approaching a standardised anaesthetic state. 
Although further work is required to determine a more 
valid TSAP and a method of determining a relative 
anaesthetic overdose, this technique could ultimately be 
used in developing new anaesthesia monitoring methods.
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APPENDIX I.
THE SOFTWARE
GENERAL REMARKS.
The control program is written in BASIC and designed
to:
1 Read HR, SAP, MAP and DAP from the Dinamap's memory.
2 Determine the required dose from the control 
algorithm and the additional rules after each SAP 
determination.
3 Drive the vaporizer to the required setting. 
Additional facilities allow a hardcopy of the control
data to be printed, and stored to floppy disk; and SAP and
the inspired volatile concentrations to be plotted on the 
screen.
In the following discussion the numbers in square 
brackets ("[ ]" ) refer to lines in the program. The
description of the program assumes the reader has a 
working knowledge of BASIC and has read the sections on 
"Equipment" and "Development of the Control System".
Before discussing the program the output from the 
Dinamap; the input output (I/O) chip and the analogue 
board in the computer; and the commands used to control 
the printer and Dinamap are considered.
THE DINAMAP'S RESPONSE TO THE STATUS REQUEST "BBA <cr>".
Host Dinamap Response
Signal
BBA < cr > BBAhhmmssMDhhmmssSAPBPMSAPDAP < cr >
(Character No. 1--------------------------------30)
The transmitted string of 30 characters can be separated 
into the following components:
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Section of Meaning
String
1-3 Message type, echo of host request
4-9 Current 1 346 time of clay (hours-min-sec)
10 Operational status:- "0" if manual mode
"1" if auto mode
"2" if stat mode
11 Functional status:- "0" if active
"1" if idle
12-17 Time of determination (hours-min-sec)
13-20 MAP in mml-Ig
21-23 Pulse rate in bpm
24-26 SAP in mmHg
27-29 DAP in mmHg
30 Terminating carriage return (Hex CD)
Notes.
As the host communication port is multiplexed with 
the printer output a delay of around 1 sec occurs prior to 
the transmission of the string following a request. At the 
set baud rate of 600, 0.5 sec is required to transmit the 
full string. NULs and control characters (except the 
carriage return) are ignored. Some alarms are 'fatal' and 
preclude any response to a host request e.g. the over­
pressure alarm. Other valid request strings initiate 
di f f e r e n t  responses which may be active (e.g. an 
instruction to make a determination).
THE I/O CONNECTIONS USED.
The input - output (1/0) ports interface the computer 
to peripheral equipment. In the control system the 
computer is interface to the following :
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1. Dinamap
2. Controller a)via the A-D converter
b)via the PIO chip
3. Printer 
THE PIO CHIP.
This chip is specifically designed to connect 
directly to the Z80 processor and provides the user with 
two 8 bit p a r a l l e l  ports (Ports A and 3). The 16 
peripheral data lines from this chip are designated PAO - 
PA7 and P30 - P37, for ports A and 3. In addition to these 
lines each port has a pair of h a n d s h a k i n g  lines. 
Handshaking is a technique used to control the rate and 
timing of data flow between two devices and need not be 
considered further. The PIO ports are used to drive the 
vaporizer (via the controller) to the desired setting. 
They are also used to send the watch-dog signal to the 
controller. In BASIC the commands "OUT" and "IN?", in 
association with the correct address are used to send 
information to and receive information from the PIO chip 
(and analogue board).
THE ANALOGUE BOARD.
This board provides 2 digital to analogue converters
(DAC) and one analogue to digital converter (ADC), each
with a 10-bit resolution. The ADC has a 16 channel input 
multiplexer so any of 16 input signals can be selected and 
converted. This board is used to check the position of the 
vaporizer via its integral potentiometer.
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THE DINAMAP AND PRINTER: CONNECTIONS AND COMMANDS.
The printer is connected to the parallel user port 
and the Dinamap to the serial port. In BASIC the command 
"PRINTER A,B" is used to address these. The first argument 
"A" is used to select the printer type, 3 selects the 
parallel port and 4 the serial port. The second argument 
"BM is used to set the baud rate and is necessary for
serial devices. The code "2" selects a baud rate of 600
which is compatible with the Dinamap.
A DESCRIPTION OF "LETHE."
Figure 63 is a flow diagram of "Lethe". The program 
comprises:
INITIALISATION (10-1740).
The main variables are listed and set, the controller 
initialised (vide infra) and data requested from the 
operator. Some of this information is used to construct 
the filename. The filename (F$ at line 1 230 ) is an 8 
character string and is constructed from the patients 
initials, age and sex; a series number and a software code 
[200]. Other data; date, type of operation and whether a 
narcotic was given at induction is used as part of the 
hardcopy heading [1410-1510] but not stored to disc.
The predicted arterial pressure is calculated from 
the age and sex data [1 230]. Both this value, and 90% of
this value [1290] are printed on the screen. The operator
is instructed to input the desired target systolic 
arterial pressure (90 - 150 mmHg, at lines 1330-1340). The 
pre-loaded value for the integral component of the P - I 
control algorithm is determined at line 1350.
INITIALISATION
PROC DR
PROC GRAF
=o SCREEN MESSAGE
GET LOOP
POLL DINAMAP
CHECK RESPONSE
I
PROC VLUE___________
PROC SP---------------------
I
PROC AD MORPHINE R
INTERPRET RESPONSE
 CALCULATE NEW SETTING
EQUIREMENT RESET
Figure 63.
A flow diagram of the control program 'TETHE".
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Array D [1640], dimension (6, size) is used to store 
the cardio-vascular and inspired volatile data. "Size" is 
the variable which defines the number of records which can 
be stored and is set at 240 [210]. Each record comprises
the time (from starting the controller), HR, SAP, MAP, 
DAP, RPP, and inspired concentration. "C" is the counter 
for the Dinamap cycle [ 220 ]. "TS" is the first time read 
from the Dinamap's memory [230 & 2230]; T" is the current 
time in the Dinamap1s memory [240, 2 50]; "T1" is the
elapsed time i.e. T1 = T - TS [ 2230-2240 ]; and "BD" is 
the previous value of "T" [250 & 2190]. Three arrays
designated PU, CO and VO are created and filled [530-770]. 
These arrays hold data which relates the marked vaporizer 
settings (array CO, in which 'OFF1 is designated -0.2); to 
the number of pulses required to drive the vaporizer to 
that setting from the 'OFF' position (array PU) and the 
read-out voltage from the potentiometer at that setting 
(array VO). The data for the arrays PU and VO were 
determined in the laboratory as was the back-lash 
correction factor (NB, line 460) which is required when 
the vaporizer is driven in the opposite direction to the 
previous motion. The peripheral input output ports, 
analogue to digital converter ports and multiplexer 
channel are also selected and addressed [790-930],
PROC DR [3750-4 050] is used to initialise the 
vapoiuzer and is called at line 930. This procedure drives 
the vaporizer to the 'OFF' setting, which corresponds to 
-C.2 in array CO. The motor in the drive unit is switched 
on, the vaporizer driven 3500 pulses in an anti-clockwise 
direction and the motor then switched off. During the
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driving sequence a signal is sent to the watchdog. With 
this number of pulses the vaporizer will be "over-driven" 
to the 'OFF' position from any previous setting and the 
lower limit switch activated. The status of the limit 
switches [3920] is checked; if correct i.e. lower-limit 
switch active and upper-limit switch inactive the program 
proceeds, if incorrect a warning is displayed and the 
program halts [3930-4030]. 3efore returning to the main 
program PROC AD is called [4230-4310]. This procedure 
determines the potentiometer voltage. If the measured 
voltage is outwith 0.02 volts of the expected voltage (in 
array VO) then a warning is printed and the program halts.
After the vaporizer has been initialised and the 
requested data received the operator is instructed to set 
the Dinamap to cycle at one minute intervals and then 
press "R". PROC GRAF [ 4360-4620 ] is called to set up the 
screen graphics, a signal sent to the watchdog [1680-1690] 
and the operator instructed to press "R" to close the 
control loop [1730-1740].
THE MAIN PART OF THE PROGRAM.
The main section of the program comprises a loop (see 
figure 63 ) . A print out of the program is included at the 
end of this appendix.
1. SCREEN MESSAGE [1840-1860]: The current SAP, 
vaporizer setting and time followed by the 5 options 
available to the operator (see GET loop) are printed 
on the screen.
2. GET LOOP (1870-1920): This loop is a timed, single 
character input routine which gives the operator 5
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options:
a. ,fE" to end the control run (2590-281 0): "End of 
Run" is printed on the hardcopy, the vaporizer driven 
to "OFF" [with PROC DR], the data stored to disc 
[2640-2700] and the option of a screen dump given 
[ 2720-2790 ] .
b. "0" to open the control loop: the vaporizer is 
driven to off but the computer continues to collect 
data.
c. "C" to close the loop if opened. These two inputs 
("0" and "C") have their effect at lines 2440 and 
2450 .
d. "N" initiates a subroutine at 4810. This 
subroutine resets the integral and the bolus counter 
(vide infra); and prints this event.
e. "S" to reset the TSAP. The TSAP may be reset to 
any value between 90 and 150mmKg (1930-2000). The 
graphic display is updated.
If no input is made the program continues.
3. POLL DINAMAP [2040-2130]; the Dinamap is polled
[2050-2080] and "T" determined [2160].
4. CHECK RESPONSE (2160-2190): If "T" does not equal
"3D" then a further d e t e r m i n a t i o n  of SAP has 
occurred; "3D" is updated [2190] and the program 
proceeds. If not, the program loops back to "SCREEN 
MESSAGE".
5. INTERPRET RESPONSE [2210-2320]: The rest of the
D i n a m a p  s t r i n g  is i n t e r p r e t e d  and a r r a y  D 
incremented.
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6. CALCULATE NEW SETTING: a subroutine [2860-3030] is
called at line 2360. The error signal [2900] is 
determined, the integral calculated [2930-2940] and 
the required dose ("SP") determined [2960]. If the 
required setting is less than 0.6% (the value of "MC" 
set at line 470) and less than 10 SAP readings have 
been made then 0.6% is delivered [2970-2980]. These
steps constitute the first additional rule (see 
"Development of the Control System"). Lines 2990 and 
3000 prevent the computer attempting to drive the 
vaporizer to less than 0% or more than 5%. The data 
in array D corresponding to the current Dinamap input 
is printed [3020 ] .
7. SCREEN UPDATE: PROC VLUE [4650-4780] is called
[2400]. This procedure updates the screen graphics.
8. DRIVING THE VAPORISER to the required setting; PROC
VAP [3080-3700], is called at line 2400. The number 
of pulses (N1 ), required to drive the vaporizer from 
its current position to the new position equals the 
difference between the number of pulses required to
drive the vaporizer to its new position from "OFF"
(PI ) and the number of pulses required to drive the 
vaporizer to its current position (P0) i.e.
N1 = P1 - P0 [3270]
The value P1 is determined by linear interpolation
between the elements in array PU which bracket the 
required concentration. P0 is updated to P1 after the 
vaporizer has been driven to its new position. P0 is 
initially set at "0" [4040]. If the vaporizer is to 
be driven in the opposite direction from its previous
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motion then an allowance must be made for the 
backlash. The direction of travel (relative to the 
previous direction) is determined by multiplying the 
number of pulses used previously (MO, which includes 
sign) by N1 [ 3300]. If the product is less than zero 
then a change of direction is involved and backlash 
correction is necessary [3310]. After the vaporizer 
has been driven to the new setting NO is updated 
[i.e. N0=N1, at line 3500], The actual number of 
pulse used (N2) is the absolute value of N1 (+ an 
allowance for backlash if necessary, lines 3290 and 
3310) .
After N 2 and the direction of travel have been 
determined the motor is switched on, the direction 
set [3430], a signal sent to the watchdog [3 4 4 0— 
3450], the vaporizer driven the necessary number of 
steps [ 3460-3490 ], NO and P0 updated and the motor 
switched off [3520].
6 CHECKING THE POTENTIOMETER VOLTAGE: PROC AD is called 
[3580] to determine the potentiometer voltage (vide 
supra). The concentration corresponding to the 
m e a s u r e d  v o l t a g e  is d e t e r m i n e d  by l i n e a r  
interpolation between the elements of CO that bracket 
the voltage. If the measured voltage is within 0.02 
volts of the expected voltage [3590-3604] then the 
program continues [3640]. If the voltage is outwith 
these limits a warning is given and the vaporizer re­
initialised .
9. MORPHINE REQUIREMENT: If the time since the last
bolus of morphine or start of the control run is less
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than 15 minutes [2460] the computer determines the 
total dose over the previous 5 settings [2470-2480] 
and, if m o r e  than 15% [2510], i n i t i a t e s  the
subroutine at 4730. This subroutine plots a on
the screen and prints "Bolus of Morphine Required". 
The operator then gives the morphine and presses "N" 
to record the event, reset the integral and reset the 
timer.
10. The program then loops back to "Screen Messages".
LETHE
10 REM PROGRAM LETH.BAS [WG : 29-JUN-87; LAST UPDATE :
06-AUG-87]
20 REM UPDATE BY KMR 11-NOV-87 
30 '
40 ' PROGRAM TO CONTROL FORTEC 
50 '
60 CLEAR 150 ' CLEAR SOME SPACE FOR STRINGS 
70 '
80 ' INITIALISATION & DESCRIPTION OF VARIA3LES 
90 '
100 PB=0 1 BASE ADDRESS FOR PIO PORTS 
110 A3=&20 1 BASE ADDRESS FOR A/D PORTS
120 DA$ = " " 1 DATS. NOT STORED ON FILE BUT PRINTED OUT 
130 NA$=""'NARCOTIC GIVEN, NOT STORED ON FILE BUT PRINTED 
OUT
140 OP$ = " "'OPERATION. NOT STORED ON FILE BUT PRINTED 
OUT
150 N$=""'PATIENTS INITIALS 
160 A$=""'PATIENTS AGE 
170 S$=""'SEX OF PATIENT
180 SE$ = ""1 THE SERIAL NUMBER WHEN THERE ARE >1 RUNS ON ONE 
PATIENT
190 F$ =""'THE FULLY ASSEMBLED FILENAME OF THE PATIENT DATA 
FILE
200 V$="I" ' IDENTIFIER FOR SOFTWARE VERSION 
210 SIZE=240'THE NUMBER OF SEQUENTIAL RECORDS 
220 C=0'THE COUNTER OF THE DINAMAP CYCLES 
230 TS=0' THE STARTING VALUE TIME SO THAT T-TS=ELAPSED 
TIME
240 T=0' TIMER FOR CHECKING FOR A NEW RESPONSE WITH 3D 
250 3D=0'PREVIOUS TIMING FROM DINAMAP TO IDENTIFY A NEW 
READING 
260 H=0'THE NUMBER OF HOURS
2 70 M=0'THE NUMBER OF MINUTES
280 S=0'THE NUMBER OF SECONDS
290 MAP=0' MEAN ARTERIAL PRESSURE
300 SAP=0' SYSTOLIC ARTERIAL PRESSURE 
310 DAP=01 DIASTOLIC ARTERIAL PRESSURE
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320 DSAP = 1201 DESIRED SYSTOLIC PRESSURE IN mm Hg 
330 ESAP=0'THE SAP ERROR
340 RP=10 '% REDUCTION OF PREDICTED PRESSURE 
350 'CP= CALCULATED DSAP
360 G=0.1 ' THE GAIN OF THE PROPORTIONAL COMPONENT
370 LOOP$="CLOSED"'FLAG FOR THE LOOP CONDITION 
380 LOOP=ASC("C")'FLAG TO CONTROL LOOP ie OPEN CLOSED OR 
END
390 WMEAN=0'EXPONENTIALLY SMOOTHED MEAN
400 V7T =1.0' THE WEIGHTING FACTOR FOR THE CURRENT VALUE IN 
WMEAN
410 PRED=120' THE BP PREDICTED FROM AGE AND SEX 
420 INL=0'THE RUNNING INTEGRAL
430 IG=0.01 'THE GAIN OF THE INTEGRAL COMPONENT 
440 SP=0 ' CALCULATED SETTING FOR VAPORIZER 
450 SP$="OFF" 'STRING FOR VAPORIZER SETTING ("OFF" WHEN 
LOOP OPEN)
460 NB=50 'NO. OF PULSES FOR BACKLASH CORRECTION
470 MC=0.6 'SETS MINIMUM CONCENTRATION GIVEN FOR PERIOD IP
480 IP = 10 ' PERIOD MEASURED IN "COUNTS"
430 REM ZZ$ = INPUT FOR DUMP 
500 TD=0 'TD = TOTAL DOSE
510 IB=0 'IB IS INTRA BOLUS PERIOD MARKER
520 'A$=AG$=AGE AG$ USED TO RESET INL IF NARCOTIC GIVEN
530 '
540 CALL "RESOLUTION",0,2 ' CLEAR THE SCREEN OF GRAPHICS 
550 '
560 PUT 31,21 ’ CLEAR SCREEN & SET CURSOR TO TOP LEFT; SET
UP FLASHING CURSOR 
570 '
580 ' INITIALISATION OF VAPORIZER CONTROLLER 
590 '
600 ' SET UP ARRAYS 
610 '
620 ' PU( ), CO( ) & VO( ) HOLD CORRESPONDING VALUES OF NO 
OF PULSES,
630 ' CONCENTRATION & POSITION READOUT VOLTAGE
RESPECTIVELY.
640 '
650 DIM PU(11), CO(11), VO(11)
660 DATA 0,615,1040,1435,1775,2075,2255,2485,2650,2845, 
3040,3230
670 DATA -0.2,0.0,0.5,1.0,1.5,2.0,2.5,3.0,3.5,4.0,4.5,5.0 
680 DATA 0.430,1.036,1.447,1.885,2.146,2.436,2.608,2.834, 
2.993,3.183,3.372,3.543 
690 FOR 1=0 TO 11 
700 READ PULSE(I)
710 NEXT I
720 FOR 1=0 TO 11
7 30 READ CO(I)
7 40 NEXT I
750 FOR 1=0 TO 11
760 READ VO(I)
770 NEXT I
780 ’
790 ' SET UP ADDRESSES FOR A/D PORTS 
800 '
810 A1 = AB + 1 1 ADDRESS FOR PORT 1 OF A/D CONVERTER
820 A2 = AB + 2 ' ADDRESS FOR PORT 2 OF A/D CONVERTER
830 A3 = AB + 3 ' ADDRESS FOR PORT 3 OF A/D CONVERTER
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840 '
850 ' SET UP PIO PORTS 
860 '
870 OUT PB+2,127 'SET PI07A TO INPUT 
880 OUT PB+3,15 ' SET PI07B TO OUTPUT
8S0 PA=PB+1 ' PORT ADDRESS FOR OUTPUT DATA WORD TO PI07B
900 '
910 ' SELECT MULTIPLEXER CHANNEL 1 FOR A/D CONVERTER 
920 '
930 OUT AB,1 
940 '
950 '
960 ' DRIVE VAPORIZER TO "OFF"
970 '
980 PROC DR 
990 '
1 0 0 0  '
1010 'DEFINE THE FUNCTION TO TRIM OFF EXCESS DECIMAL 
PLACES"
1 020  '
10 30 DEF FNTR(X )=(INT(X*100))/100 
1 040 '
1 050 '
1060 INPUT "DATE ";DA$
1070 INPUT "OPERATION ";OP$
1030 INPUT "HAS A NARCOTIC BEEN GIVEN";NA$
1090 REM TAKE IN BASIC IDENTIFICATION DATA FOR FILENAME 
CONSTRUCTION
1100 INPUT "TYPE IN THE PATIENTS THREE INITIALS"; N$
1110 IF LEN(N$)> 3 OR LEN(N$)=0 THEN PRINT "INCORRECT 
INITIALS - RETYPE" :GOTO 1100 
1120 PUT 31
1130 INPUT "TYPE IN THE PATIENTS AGE IN WHOLE YEARS ";A$ 
1140 IF LEN(A$) > 2 THEN PRINT"AGE RANGE BETWEEN 10 AND 
99 ONLY PLEASE":GOTO 1130 
1150 AG$=A$
1160 PUT 31
1170 INPUT "TYPE IN THE PATIENTS SEX M OR F "; S$
1180 IF LEFT$(S$,1)="M" OR LEFT$(S$,1)="F" THEN GOTO 1190 
ELSE PRINT"ONLY M OR F ALLOWED": GOTO 1170 
1190 PUT 31
1200 INPUT"TYPE IN THE SERIES NO FOR THAT PATIENT 0 - 9  
ONLY"; SE$
1210 IF LEN(SE$)>1 THEN PRINT " ONE DIGIT ONLY 0 - 9  
PLEASE ": GOTO 1200 
1220 PUT 31
1230 F$="B:"+N$+A$+S$+SE$+V$+".DAT"
1 240 IF LOOKUP(F$)< >0 THEN PUT 31: PRINT"YOUR FILENAME
ALREADY EXISTS - CHANGE THE SERIES NO" : DIR"B:*.*": 
GOTO
1 1 00 
1 250 '
1260 'THE FILE WILL NOW BE OK TO GO ON THE DISC 
1270 PUT 31
1280 IF S$="M" THEN PRED = 108+0.5*VAL(A$) ELSE PRSD=
98.6+0.7 6*VAL(A$)
12 90 CP = PRED-(PRED*RP/1 00)
1300 PRINT"SAP PREDICTED FROM AGE AND SEX IN A FIT PERSON 
= ";PRED
1310 PRINT;RP;"% REDUCTION OF PREDICTED PRESSURE="CP
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1320 WMEAN=PRED
1330 INPUT"TYPE IN THE DESIRED SYSTOLIC PRESSURE IN mm 
Hg"; DSAP
1340 IF DSAP <90 OR DSAP>150 THEN PRINT " OUT OF RANGE !
90-150 PLEASE GOTO 1330 
1350 INL=20+(100-VAL(A$)) 1 PRELOADED VALUE FOR INTEGRAL
1360 PUT 31 
13 70 PRINTER 3
1380 LPRINT CHR$(27);"C";CHR$( 70) ; ' SET PAPER LENGTH TO
70 LINES
13 90 LPRINT CHR$(27);"N";CHR$(4); 1 SET PRINTER TO SKIP 4
LINES AT FOOT OF PAGE 
1400 LPRINT CHR$(18) ' CANCEL CONDENSED PRINTING MODE
1410 LPRINT CHR$(14);"FEEDBACK CONTROL OF SAP ": LPRINT
1420 LPRINT "DISC FILENAME = ";F$: LPRINT
1430 LPRINT "DATE = ";DA$:LPRINT
1440 LPRINT "OPERATION = ";OP$:LPRINT
1450 LPRINT "NARCOTIC GIVEN = ";NA$:LPRINT 
1460 LPRINT"PREDICTED SAP = "; PRED;" mm Hg","DESIRED SAP 
= ";DSAP;" mm Hg"
1470 LPRINT: LPRINT"PROPORTIONAL GAIN = ";G ,"INTEGRAL
GAIN = ";IG
1 480 LPRINT: LPRINT "EXPONENTIAL WEIGHTING FACTOR = ";WT 
1490 LPRINT: LPRINT "INITIAL INTEGRAL TERM = ";INL:LPRINT 
1500 LPRINT "MINIMUM CONCENTRATION OF ";MC;" GIVEN FOR 
";IP;"COUNTS":LPRINT 
1510 LPRINT CHR$(15);"TIME"," HEART RATE"," SAP"," MAP"," 
DAP"," RRP", "LOOP STATE"," OUTPUT"," WMEAN", "INT": 
LPRINT
1520 PRINT "FILENAME ALLOCATED TO THIS RUN IS ";F$
1530 PRINT:PRINT"ENSURE THAT THE DINAMAP IS CONNECTED AND 
THAT IT IS SET TO 
1540 PRINT"CYCLE AT ONE MINUTE INTERVALS IN AUTO MODE - 
NOT STAT MODE"
1 5 50 PRIMT"DINAMAP MUST HAVE TAKEN ONE CYCLE BEFORE THE 
COMPUTER IS STARTED 
1560 PRINT: PRINT "PRESS <R> TO START THE COMPUTER SYSTEM" 
1 570 IF GET(0)< >82 THEN GOTO 1570 
1 580 '
1590 'SET UP THE GRAPHICS DISPLAY 
1600 PROC GRAF (DSAP)
1610 '
1 620 '
16 30 'SET UP DATA ARRAY D 
1640 DIM D (6,SIZE)
1 650 '
1 660 '
1670 ' SWITCH ON WATCHDOG
1680 OUT PA,4 ' WATCHDOG PULSE ON
16 90 OUT PA,0 ' WATCHDOG PULSE OFF
1 700 '
1710 '
1720 PUT 31: PRINT "SWITCH ON 'AUDI3LE WARNING' ALARM ON 
CONTROLLER"
1730 PRINT "PRESS <R> WHEN READY"
1 7 40 IF GET(0)< > 82 THEM 17 40
17 50 OUT PA,4 ' WATCHDOG PULSE ON
1760 OUT PA,0 ' WATCHDOG PULSE OFF
1 770 '
1 780 '
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1790 ' DINAMAP POLLING ROUTINE 
1 800 '
1810 '
1820 PRINTER 4,2 'SELECT DINAMAP SERIAL INTERFACE AS 
'PRINTER'
1830 PUT 31
1840 PRINT "SYSTOLIC PRESSURE = ";SAP;" MM HG; VAPORIZER 
SETTING = ";SP$;"; TIME = ";TI 
1850 PRINT "TO TERMINATE THE PROGRAM AND STORE THE DATA 
PRESS < E >"
1860 PRINT "TO CLOSE/OPEN/RESET FEEDBACK LOOP OR REGISTRER 
NARCOTIC PRESS (C)/(0)/(S)/(N)"
1870 LOOP=GET (300)
1880 IF LOOP=ASC("E") THEN GOTO 2590
1890 IF LOOP=ASC("O") THEM LOOP$="OPEN":PROC VAP(-0.2)
1900 IF LOOP=ASC("C") THEN LOOP$="CLOSED": PROC VAP(SP)
1910 IF LOOP=ASC("N") THEN GOSUB 4810
1920 IF LOOP <>ASC("S") THEN 2020 
1930 CALL "PLOT",C*2+40,DSAP,0
19 40 CALL "LINE",310,DSAP,0
1950 INPUT "NEW TARGET SAP IS";DSAP
1960 IF DSAP <90 OR DSAP >150 THEM PRINT "OUT OF RANGE !
90-1 50 PLEASE" .-GOTO 1950 
1 970 CALL "PLOT",C*2 + 40,DSAP, 1 
1980 CALL "LINE",310,DSAP,2 
1990 PRINTER 3
2000 LPRINT:LPRINT "THE NEW DESIRED SAP IS";DSAP:LPRINT 
2010 PRINTER 4,2 
2020 PUT 31
2030 PRINT "SYSTOLIC PRESSURE = ";SAP;" MM HG; VAPORIZER 
SETTING = ";SP$;"; TIME = ";TI
20 40 PRINT:PRINT"POLLING DINAMAP "
2050 LPRINT "BBA"
2060 OPEN #10,"RDR:"
2070 INPUT #10,A$
2080 CLOSE #10 
2090 '
21 00 '
2110 H = VAL(MID$(A$,12,2))
2120 M = VAL(MID$(A$,14,2))
2130 S = VAL(MID$(A$,16,2))
21 40 '
2150 ' CHECK FOR NEW DINAMAP RESULT - RECYCLE TILL FOUND
2160 T=(((H*60)+M)*S0+S)
2170 OUT PA,4 ' WATCHDOG PULSE ON 
2180 OUT PA,0 ' WATCHDOG PULSE OFF 
2190 IF BD=T THEN GOTO 1840 ELSE BD=T 
2200 '
2210 ' INTERPRET REST OF DINAMAP RESPONSE AND INCREMENT
COUNTER TO FILL D 
2220 D (3,C ) = VAL(MID $(A $, 1 8,3))
2230 IF C=0 THEM D(0,0)=0 :TS=T ELSE D (O ,C )=(T-TS)/60 
2240 TI=D(0,C)
2250 D (1 ,C ) = VAL(MID$(A$,21 ,3))
2260 D (2,C ) = VAL(MID$(A$,24,3))
2270 D (4,C ) = VAL(MID$(A$,27,3))
2280 D (5,C )= D (1,C)*D(2,C)
2290 SAP=D(2,C )
2300 '
2310 PRINTER 3
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2320 IF C=SIZE THEN 2590 
2330 '
23 40 ' CALCULATE NEV7 VAPORIZER SETTING 
2350 '
2360 GOSUB 2860 
2370 '
2380 ' PLOT SAP & VAPORIZER SETTING ON SCREEN 
2390 '
2400 PROC VLUE (C, D(2,C), SP)
2410 '
2420 SP$=STR$(SP)+"%"
2430 C=C+1
2440 IF LOOP$="CLOSED" THEN PROC VAP(SP)
2450 IF LOOPS = "OPEN" THEN PROC VAP(-0.2):GOTO 1820 
2460 IF C < IB+15 THEN GOTO 1820 
2470 FOR J=(C-5) TO (C-1)
2480 TD=D(6 , J )+TD
2490 IF D ( 6 , J ) < 2.5 THEN 1820
2500 NEXT J
2510 IF TD > 15 THEN GOSUB 4730 
2520 TD=0 
2530 GOTO 1820 
2540 '
25 50 PRINTER 3
2560 CALL "PRINTER", 1 'DEFINES PRINTER TYPE 
2570 CALL "DUMP",0,0,31 9,1 91 ,1 
2580 ' STORE RESULTS
2590 PRINTER 3:LPRINT:LPRINT CHR$(14);"END OF 
RUM";CHR$(12);CKR$(15)
2600 PUT 31
2610 PRINT "SWITCH 'AUDIBLE ALARM' OFF"
2620 PROC DR ' DRIVE VAPORIZER TO 'OFF'
26 30 PUT 31
2640 PRINT "DATA BEING WRITTEN TO DISC"
2650 CREATE#10,F$
26 60 QUOTE #10,34 
2670 FOR J=0 TO C-1
2680 PRINT#10, D (0,J ),D (1,J ),D (2,J ),D (3,J ),D (4,J ),D (5,J ), 
D ( 6 , J )
26 90 NEXT J 
2700 CLOSE #10 
2710 PUT 31
2720 INPUT "DO YOU WANT A SCREEN DUMP";ZZ$
2730 IF LEFTS(ZZ$,1)="Y" OR LEFTS(ZZ$,1)="N" GOTO 2740 
ELSE 2720 
2740 IF LEFTS(ZZ$,1)="N" GOTO 2790 
2 7 50 LPRINT:LPRINT "DISK FILENAME = ";F$:LPRINT 
2760 CALL "PRINTER",1,1 'DEFINE PRINTER TYPE AND SET DUAL 
DENSITY
2770 CALL "DUMP",0,0,319,241 ,1 
2780 LPRINT CHRS(12)
27 90 CALL "CLEAR" .‘TEXT 
2800 PUT 31
2810 END 
2320 '
2330 '
2840 'SUBROUTINE TO CALCULATE THE OUTPUT 
2850 'EXP SMOOTHED MEAN
2860 IF D(2,C)=0 THEN D(6,C)=SP : GOTO 3020 ' IF SAP 
READING = 0, KEEP VAPORIZER SETTING AS BEFORE
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2870 IF C=0 THEN WMEAN=D(2,0) ELSE 
WMEAM=D(2,C)*WT+WMEAN*(1.0-WT)
2880 '
2890 'SAP ERROR IS :
2900 ESAP=WMEAN-DSAP 
291 0 '
2920 'ACCUMULATE THE INTEGRAL OF ERROR IN INL
2930 INL=INL+ESAP
2940 IF INL< 0 THEN INL=0
2950 '
296 0 SP=G*2SAP +IG*INL
2970 IF C>IP GOTO 2990 'ALLOWS MINIMUM CONC FOR INITIAL 
PERIOD
2980 IF SP<MC THEN SP=MC:GOTO 3000 
2990 IF SP<0 THEN SP=0 
3000 IF SP > 5 THEN SP = 5 
3010 D (6,C )=SP
3020 LPRINT FNTR(D (0,C )),D (1,C ),D (2,C ),D (3,C ),D (4,C ),
D (5,C ),LOOPS,FNTR(D (6,C )),FNTR(WMEAN);TAB(12 4);
FNTR(INL)
3030 RETURN 
3040 '
3050 '
3060 ' PROCEDURE TO DRIVE VAPORIZER TO REQUIRED
CONCENTRATION C & CHECK POSITION READOUT VOLTAGE 
3070 '
3080 DEF PROC VA(C)
3090 '
3100 IF C=-0.2 THEN SP$="OFF" ELSE SP$ = STR$(C )+"% "
3110 PUT 31
3120 PRINT "SYSTOLIC PRESSURE = ";SAP;" MM HG; VAPORIZER 
BEING SET TO ";SP$;"; TIME = ";TI 
3130 ' FIND APPROPRIATE VALUE FOR TOTAL NUMBER OF PULSES 
(P1) BY LINEAR 
3140 ' INTERPOLATION BETWEEN ELEMENTS OF PULSE( ) THAT
BRACKET P1.
31 50 '
3150 FOR 1=1 TO 11
3170 IF CO(I)<C GOTO 3200
3180 P1=PU(I-1) + (PU(I)-PU(I-I ))*(C-CO(I-1 ) )/(CO(I)-CO(I- 
1 ))
3190 GOTO 3270 
3200 NEXT I 
3210 '
3220 ' DRIVE VAPORIZER REQUIRED NO OF PULSES (N2). H1 IS 
NO OF PULSES
3230 ' (INCLUDING SIGN)M FOR PRESENT MOTION. NO IS NO OF 
PULSES (INCLUDING 
3240 ' SIGN) FOR PRECEDING MOTION. IF N0*N1 < 0, CHANGE OF
DIRECTION IS INVOLVED 
3250 ' Sc BACKLASH CORRECTION IS REQUIRED.
3260 '
3270 N1=P1-P0
3230 IF N1=0 THEN PROC RETURN 
3290 N2=ABS(N1)
3300 IF N1*N0 > = 0 GOTO 3320 
3310 N2=N2+NB 'BACKLASH CORRECTION 
3320 IF N1< 0 THEN 3390 
3330 '
33 40 ' ID IS CONTRIBUTION OF DIRECTION BIT (BIT 1) TO DATA
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WORD (0 FOR +VS 
3350 ’ MOTION, 2 FOR -VE MOTION)
3360 '
3370 ID=0 
3380 GOTO 3430 
3390 ID=2 
3400 '
3410 ' SWITCH MOTOR ON & SET DIRECTION 
3420 '
3430 OUT PA,ID
3440 11 = ID+ 5 1 DATA WORD TO TURN STEP & WATCHDOG SIGNALS 
"ON"
3450 I2=ID ' DATA WORD TO TURN STEP & WATCHDOG SIGNALS 
"OFF"
3460 FOR 1=1 TO N2 
3470 OUT PA,11 
3480 OUT PA,12 
3490 NEXT I 
3500 N0=N1 
3510 P0=P1
3520 OUT PA,8 ' MOTOR OFF 
3530 '
35 40 ' CALCULATE VOLTAGE VR CORRESPONDING TO REQUIRED
CONCENTRATION C BY LINEAR INTERPOLATION BETWEEN 
ELEMENTS OF VO( )
3550 ' THAT BRACKET VR. COMPARE VR WITH POSITION READOUT 
VOLTAGE V2. IF DIFFERENCE > 0.02 V, ISSUE WARMING, 
3560 ' RESET VAPORIZER TO OFF & TRY AGAIN.
3570 '
3580 PROC AD
3590 FOR I = 1 TO 11
3600 IF CO(I)<C GOTO 3630
3610 VR = VO(I-1) + (C-CO(I-1))/(CO(I)-CO(I-1))*(VO(I)- 
V O (I -1 ) )
3620 GOTO 3640
36 30 NEXT I
36 40 IF V2>VR-0.02 AND V2<VR + 0.02 THEN PROC RETURN 
3650 PRINT "POSITION READOUT VOLTAGE OUTSIDE ACCEPTABLE 
LIMITS."
366 0 PRINT " VAPORIZER WILL BE DRIVEN TO 'OFF' & RESET"
36 70 LPRINT :LPRINT "POSITION READOUT VOLTAGE
IS";V2;"VOLTS INSTEAD OF";VR;"VOLTS":LPRINT 
3680 PROC DR 
3690 GOTO 3110
37 00 PROC END 
371 0 '
3720 '
3730 ' PROCEDURE TO DRIVE VAPORIZER TO 'OFF' & CHECK 
CONTROLLER FUNCTION 
3740 '
3750 DEF PROC DR 
3760 '
3770 PRINT "VAPORIZER BEING DRIVEN TO 'OFF'"
3780 OUT PA,2 ' SWITCH MOTOR ON AND SET DIRECTION -VE 
(TOWARDS "OFF")
3790 FOR 1=1 TO 3500
3800 OUT PA,7 ' STEP & WATCHDOG "ON"
3810 OUT PA,2 ' STEP & WATCHDOG "OFF"
382 0 NEXT I
38 3 0 OUT PA,8 ' MOTOR OFF
Page No. 205
3840 '
3850 1 CHECK VALUE OF DATA WORD ON PI07A. TOP 6 BITS ARE 
ALWAYS HIGH.
3860 ' FOR VAPORIZER AT 'OFF', BIT 0 SHOULD BE ZERO, 
INDICATING THAT 
3870 ' CLOCKWISE LIMIT SWITCH IS ACTIVATED, & BIT 1 SHOULD 
BE 1 , INDICATING 
3880 ' THAT ANTICLOCKWISE LIMIT SWITCH IS NOT ACTIVATED.
THUS, TI-IE CORRECT 
3890 ' DATA WORD IS 253. THIS VALUE IS NOT OBTAINED UNDER 
ANY COMBINATION 
3900 ' OF FAULT CONDITIONS.
3910 '
3920 IF INP(PB) = 253 THEN 4040
3930 TEXT: PUT 31
3940 PRINT "***WARNING***"
3950 PRINT "WRONG SIGNALS RECEIVED FROM LIMIT SWITCHES 
WHEN PROGRAM"
3960 PRINT "ATTEMPTED TO DRIVE VAPORIZER TO 'OFF'. CHECK 
THE FOLLOWING
3970 PRINT " (1) VAPORIZER CONTROLLER IS SWITCHED ON"
3980 PRINT " (2) CABLE BETWEEN VAPORIZER AND CONTROLLER 
IS SECURE AT EACH END"
3990 PRINT " (3) RIBBON CABLE BETWEEN CONTROLLER AND
COMPUTER IS SECURE"
4000 PRINT
4010 PRINT "IF FAULT FOUND, RECTIFY IT AND RESTART 
PROGRAM"
4020 PRINT "OTHERWISE, DO MOT USE CONTROLLER; REPORT 
PROBLEM TO PHYSICIST"
4030 GOTO 4810
4040 P0 = 0 'P0 IS PULSE NO FOR PRESENT SETTING OF VAPORIZER 
4050 N0 = -1 ' NO IS NO OF PULSES FOR PREVIOUS MOVEMENT.
SIGN IS ALL THAT MATTERS.
4060 '
4070 ' CHECK ANALOG INPUT VOLTAGE 
4080 PROC AD
4090 IF V2 > VO(0)-0.02 AND V2 < V0(0)+0.02 THEN 4180 
4100 PRINT
4110 PRINT "* * * WARNIMG * * *"
4120 PRINT "NO VOLTAGE ON ANALOG INPUT TO COMPUTER"
4130 PRINT "CHECK ANALOG SIGNAL CABLE3ETWEEN CONTROLLER 
AND COMPUTER"
4140 PRINT "IF FAULT FOUND, RECTIFY IT AND RESTART 
PROGRAM"
4150 PRINT "OTHERWISE, DO NOT USE CONTROLLER. REPORT FAULT 
TO PHYSICIST"
4160 GOTO 4450 
41 70 '
4180 PROC END
41 90 '
4200 '
4210 ' PROCEDURE TO PERFORM AND AVERAGE 10 A/D CONVERSIONS 
ON CHANNEL 1 
4220 '
42 30 DEF PROC AD 
4240 V2=0
4250 FOR 1=1 TO 10
4260 OUT A1,1 ' START A/D CONVERSION
4270 WAIT A2,128,0 ' WAIT UNTIL CONVERSION BIT (BIT 7 OF
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4280 
4290 
4300 
431 0 
4320 
4330 
4340 
4350 
4360 
4370 
4380 
4390 
4400 
441 0 
4420 
4430 
4440 
4450 
4460 
4470 
4480
4490 
4500 
451 0 
4520 
4530 
4540
4550 
4560 
4570 
4580 
4590 
4600 
461 0 
4620 
4630 
4640 
4650 
4660 
4670 
4680 
4690 
4700 
471 0 
4720 
4730 
4740 
4750 
4760 
4770 
4780 
4790
480 C
481 0 
482C 
4830
HIGH BYT 
V2 = V2 
NEXT I
V2 = V2/2046 
PROC END
E) = 1 
+ INP(A3) + 2 5 6 *(INP(A2)MOD4)
'SET UP THE GRAPHICS SYSTEM
i
DEF PROC GRAF(DSAP)
GRAPH 1
CALL "RESOLUTION",0,2 
CALL "OFFSET",0,50 
CALL "PLOT",40,70,3 
CALL"LINE",310,70,3 
CALL"LINE",310,241,3 
CALL"LINE",40,241,3 
CALL "LINE",40,70,3
i
'SET VERTICAL SCALE 
CALL "CHARSIZE", 1,1
FOR VERT= 70 TO 170 STEP 20: VERT$=FIX$(STR$(VERT),4) 
+  >■ »»
CALL "STPLOT",0, VERT,VARADR(VERT$),3 
NEXT VERT
i
'SET HORIZONTAL SCALE 
FOR HIZ= 0 TO 240 STEP 30
KIZ$=FIX$(STR3(HIZ/2),4): Q$="A" 'HIZ/2 CHANGES TIME 
BASE TO 0-120
CALL "STPLOT",HIZ+30,55,VARADR(HIZ$),3 
CALL "STPLOT", HIZ+40,63,VARADR(Q$ ),3 
NEXT HIZ
i
' SET THE DESIRED LEVEL FOR THE SAP 
CALL"PLOT", 40, DSAP,1 
CALL "LINE",310,DSAP,2 
PROC END
DEF PROC VLUE (CZ,QSAP,QP)
CALL "PLOT",CZ*2+40,QSAP,3 
CALL "PLOT",CZ*2 + 40 ,1 70 ,2 
CALL "LINE",CZ*2+40,170+20*QP,2 
CALL "PLOT",CZ*2 + 41 ,170,2 
CALL "LINE",CZ*2+41,170+20*QP,2 
PROC END
'SUBROUTINE TO PLOT OVERDOSE 
DP$="*"
CALL "STPLOT",C*2+40,80,VARADR(DP$),3
PRINTER 3
LPRINT:LPRINT "BOLUS OF NARCOTIC REQUIRED AT ";C
PRINTER 4,2
RETURN
I
'SUBROUTINE TO RESET INL AND IB AND LPRINT BOLUS 
PRINTER 3
INL=20+(100-VAL(AG$))
LPRINT : LPRINT "BOLUS OF NARCOTIC GIVEN AT ";C;"AND 
INTEGRAL RESET TO INL:LPRINT
Page No. 211
4840 PRINTER 4,2 
4850 I3=C 
4860 RETURN 
4870 END
APPENDI
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APPENDIX II.
CONTROL EQUATIONS.
The equations used to determine the criteria on which 
the goodness of SAP control was determined.
1. The RMSD is calculated as:
RMSD = /E(SAP-TSAP)2 / (n - 1 )
Where n = the number of SAP measurements.
2. The PR is calculated as:
PR = % of records above TSAP / % of records below TSAP
3. The MDTgAp is calculated as:
MD,j,g^ p = E (SAP - TSAP) / n
Where n = the number of SAP measurements.
APPENDIX
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APPENDIX III.
PATIENTS IN WHOM CONTROL WAS INADEQUATE.
A detailed breakdown of the cases in whom adequate 
control of SAP or of the anaesthetic goals were not 
acheived. See chapter 9 for the criteria defining these 
parameters and for the derivation of the five groups of 
patients. A " - 11 indicates that the variable was within 
acceptable limits.
GROUP RMSD MDtsap PR HR RPP cATPR
E a 13.37 - -
b - 5.35 7
c - 0.34 -
EM a - 5.63 2. 72 -
b 17.60 13.00 8.23 109.6 14214
c 11.47 6.80 -
d - 5.18 2.94 17
e - 5.48 4.21 -
f 10.70 - - - 12127
h - 21
I a 11.70 -7.40 0.21 -
b 1 0 . 1 2  -  -
c - 7.74 24.81 -
d - - 0.37 -
e - 20
(continued)
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GROUP RMSD MDTSAP —  —  RPP
IA a - -
b - -
c 10.22 - -
d 10.60 - -
IM a 10.82 6.27 4.00
b 10.66 6.40 2.67 - 12248
c - 4.83
d - 2.72
CATPR
1 9 
24
1 7
3 5 
23
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Appendix IV.
PUBLISHED ABSTRACTS
1. Robb HM, Asbury AJ, Gray V7M and Linkens DA. Towards 
automatic control of general anaesthesia with 
enflurane. Br J Anaesth 1988; 61: 109P-110P.
C l i n i c a l  s i g n s  a r e  u s e d  as g u i d e l i n e s  f or  t he 
a dm i nistration of anaesthetic drugs. Our ultimate 
objective is to devise a computer control system, 
operating from rules based on clinical signs, to produce 
an individually tailored anaesthetic state. The aim of 
this study was to assess the usefulness of systolic 
arterial pressure (SAP) as an index of anaesthetic depth 
for such a system.
A proportional integral control system was set up with an 
RML 380Z-D computer interfaced to a Dinamap and an 
enflurane vaporizer controller [1]. A program was designed 
to maintain the patient's SAP at 90% of that predicted by 
age and sex. A minimum dose of 0.6% enflurane was given 
for the first 10 min and the user instructed to give 
morphine 0.05mg kg- if the delivered dose of enflurane 
exceeded a preset limit. This rule could only be activated 
once in 15 min.
Following Ethical Committee approval, 21 patients (ASA I 
or II) were studied. After premedication with temazepam 10 
-20mg and ranitidine 150mg, anaesthesia was induced with 
thiopentone 3-5 mg k g - and morphine 0.1 mg k g - . 
Neuromuscular blockade was maintained with vecuronium. The 
patients were ventilated with 66% nitrous oxide in oxygen. 
Enflurane and additional morphine were administered by, on 
or on instruction from, the controller. Nine clinical 
signs were recorded every 5 min as PRST score [2].
No patient complained of awareness. For statistical 
analysis the patients were divided into those who required 
extra morphine (group B) and those who did not (group A). 
There was no intergroup statistical difference in age, 
weight or duration of operation. Results are shown in 
table 1.
Table 1. Results. TSAP = Target SAP; TPR = time to patient 
response; VAP = inspired concentration; RMSD = root mean 
square deviation about TSAP; PRST = PRST score. (Mean 
values +/- SD). * P<0.05 by V,7ilcoxon's sum of ranks test.
Group A (n=14) Group B (n=7)
TSAP (mmHg) 118.8(7.7) 114.4(7.2)
TPR (min) 4.8 (1.9) 10.0 (3.7) *
HR (bpm) 67.3 (7.8) 82.9 (16.6) *
SAP (mmHg) 118.1 (8.1) 119.9(8.4)
VAP (%) 1 .1 ( 0.7) 9.4 (0.5) *
RMSD 7.0 (2.8) 9.4 (2.3) *
PRST 0.46 0.96
In conclusion, it seems that, within the limits of the 
study the rules applied, which technically control SAP, 
produce a pattern of clinical signs recognisable as 
general anaesthesia.
1. Nieman M, Richardson W, Gray WM, Asbury AJ. Journal of 
Medical Engineering Technology 1987; 11: 34-36.
2. Evans JM, Bithell J F , Vlachonikolis IG. British Journal 
of Anaesthesia 1987; 59: 1346-1355.
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2. Robb HM, Asbury AJ, Gray WM, Linkens DA. Towards 
automatic control of general anaesthesia. Accepted 
for publication in the proceedings of the Medical 
Informatics International Conference on Computers in 
Clinical Medicine, to be held on 13-15th September 
1988 at Nottingham University.
INTRODUCTION
Clinical signs of anaesthesia are a result of a balance 
between the effects of surgical stimulation and the
suppression caused by anaesthetic drugs. There are many 
factors which prevent a tight definition of the
intraoperative anaesthetic state, these include: the
immeasurability of surgical stimulation, widely varying
and multiple drug actions, interpatient variation, the
varying strategies used by anaesthetists, and disease
effects themselves.
Without a "gold" standard, many techniques for monitoring 
the anaesthetic state (e.g. the EEG) cannot be fully 
assessed. Clinical signs, despite some obvious 
inadequacies [1,2], are currently the only universally 
accepted indicators of anaesthetic adequacy, and form the 
basis for the administration of thousands of successful 
anaesthetics each day. However, their interpretation is 
subjective and variable.
OBJECTIVES
Our ultimate objective is to develop a computer control 
system, operating from rules based on clinical and other 
indices, to produce an individually tailored anaesthetic 
state. The objective of the current study was investigate 
whether a clinically acceptable anaesthetic state could 
be produced by using a control system to maintain the 
patient's Systolic Arterial Pressure (SAP) at a 
predetermined target value by altering the inspired 
concentration of enflurane. Such a control system, though 
limited in that it uses only one clinical sign, would help 
to standardise management of the anaesthetic state.
METHODS
A proportional integral (PI) control system was set up 
with an RML 380Z-D computer interfaced to a Critikon 
Dinamap 1846 automatic blood pressure monitor and an 
enflurane vaporizer controller [3], A program, written in 
BASIC, was designed to maintain the patient's SAP at 90% 
of that predicted from age and sex standardised tables
[4]. The program took data from the Dinamap's memory at 
one minute intervals, and changed the inspired enflurane 
concentration via the vaporizer controller. The system was 
designed to be supervised by the anaesthetist and allowed 
intervention at any time to open or close the control 
loop. The integral alarms on the Dinamap and vaporizer 
drive unit were used.
The proportional and integral gains for the PI program 
were determined from preliminary trials and set at 0.1 and 
0.01 respectively. The integral term was preloaded with
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the value 20 + (100 - age). Two additional rules were 
used. The first provided a 0.6% enflurane for the first 
ten minutes. The second instructed the operator to give a 
bolus of morphine (0.05mg/kg) and to re-set the integral 
to the preload value if the inspired enflurane 
concentration exceeded a preset limit. This limit was 
defined as a total inspired concentration of more than 15% 
over five consecutive vaporizer settings with each setting 
exceeding 2.5%. This rule could only be activated once 
every fifteen minutes.
The study was carried out in 22 ASA I and II female 
patients, aged 24-57 years, admitted for routine 
gynaecological surgery. Ethical Committee approval was 
obtained and all patients gave written consent to the 
study.
After routine premedication, anaesthesia was induced with 
morphine 0.1 mg/kg and thiopentone 3-5 mg/kg. Relaxation 
was achieved with vecuronium 0.1 mg/kg, which permitted 
endotracheal intubation.
In theatre all patients were artificially ventilated using 
a Bain circuit with a fresh gas flow of 100 ml/kg of 
nitrous oxide (66%) in oxygen. Enflurane and supplementary 
morphine were delivered by or on instruction from the 
controller. Although the operator gave the morphine and 
reset the integral this was on instruction from the 
controller and the loop remained tightly closed. Muscle 
relaxation was maintained by timed boluses of vecuronium 
(one third of the initial dose every 25 minutes). 
Intravenous fluids were provided as clinically indicated. 
Additional clinical signs (sweating and tears) were 
recorded every five minutes and the PRST score calculated
[5] .
The controller was switched off five minutes before the 
end of surgery and the nitrous oxide discontinued 
following the last skin suture or staple. At this point 
the muscle relaxant was antagonised with neostigmine 2.5mg 
and glycopyrrolate 0.6mg.
Recovery was deemed complete (for the purposes of the
study) when the patient made purposeful responses to 
command. All patients were questioned 24 hours 
postoperativly, to discover whether they had been aware 
during anaesthesia.
When analysing the results, we wanted to consider the 
behaviour of the controller after the initial
stabilization period, and so excluded the first ten SAP
recordings in each patient. The Mann-Whitney U test was 
used for all the intergroup comparisons. A two-tailed 
probability less than 0.05 was considered significant.
RESULTS
The results are shown in the table. The controller 
effectively divided the patients into two groups: Group A 
of fourteen patients who only received the initial bolus 
of morphine and Group B of seven patients who required 
additional boluses. The controller was discontinued in one 
patient who received excessive enflurane despite 
additional morphine. This patient had an acceptable 
preoperative blood pressure of 160/90 mmHg but
postoperative questioning revealed a history of "previous"
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hypertension despite a denial of problems with "raised 
blood pressure" preoperatively. This patient is excluded 
from the analysis.
There was no statistical difference between the two groups 
with regard to age, weight, target systolic arterial 
pressure (TSAP), total anaesthetic time (from induction to 
discontinuation of the nitrous oxide) (TAT) or total 
system running time (TST).
In general the system produced a clinically acceptable 
anaesthetic state, and a rapid recovery in all patients. 
This is reflected in the PRST scores, and in the mean SAP, 
HR and rate pressure product. Group B however, took 
significantly longer to recover from anaesthesia than 
group A. Mo patient recalled any event between induction 
and recovery and all patient's said they would accept the 
same anaesthetic again.
The RMSD is the root mean square deviation about the TSAP. 
This term is analogous to the standard deviation but uses 
the TSAP in place of the mean in its calculation, and 
indicates the dispersion of SAP about the target value. In 
both groups the mean SAP is close to the mean TSAP, and 
mean RMSD values of 7.3 and 10.6 confirm that control was 
satisfactory.
Although there was no significant difference between the 
mean SAP and TSAP between the groups, the mean deviation 
from the target value was significantly lower in group A, 
indicating that control was better in this group. Eighty 
seven percent of the SAP records in Group A and 79% of 
those in Group B were within 10% of the TSAP. Only 0.3% of 
the SAP records in Group A and 1.3% of the recorded in 
Group B where outside 30% of the TSAP. The mean heart 
rates, rate pressure products and inspired enflurane 
requirements were lower in Group A when compared to Group 
B.
DISCUSSION X
If a control system produces an individually standardised
anaesthetic state that achieves the goals of general
anaesthesia, adequate general anaesthesia can itself be 
partially defined in terms of the reference values on 
which the system is based.
The use of systolic arterial pressure as a variable to 
control the delivery of anaesthetic agents can be 
criticised on several grounds. Anaesthetists use 
combinations of clinical signs to determine the
anaesthetic state and. SAP alone cannot be expected to give 
reliable information in all cases, hypertensive and 
hypovolaemic patients being obvious examples. However SAP 
is one of the few quantifiable indices and increases in 
SAP are commonly treated with anaesthetic drugs.
We consider that a SAP within the range excepted for
normal sleep is one of the many clinical requirements of a 
good anaesthetic, and in this study factors known to 
detract from the usefulness of this variable were limited 
by careful patient selection and aggressive fluid 
management. Unfortunately SAP cannot be measured more 
frequently than once a minute without resorting to 
invasive monitoring, as the arm becomes swollen.
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The Target SAP
Choice of a target SAP is difficult, as spot measurements 
in the ward or prior to induction are likely to be 
unrepresentative due to anxiety or sedation. For this 
reason we used an age and sex related value from tables. A 
TSAP of 90% of the predicted value was chosen after 
initial trials that suggested that a TSAP of 85% overdosed 
the patients.
Our method of selecting the TSAP, using tables, is crude. 
Group B may reflect those patients in whom the calculated 
TSAP is too low and further work is required to determine 
a better method of assessing this value.
Does the Controller Achieve the "Goals" of Anaesthesia?
No patient showed clinical signs that suggested that 
anaesthesia was inadequate. Although clinical scoring 
systems have severe limitations, the PRST score represents 
a simple method of "summating the significance of these 
widely recognised clinical signs" [5], In this study no 
patient had a score greater than 4, and the mean values 
suggest that anaesthesia was adequate. The recovery times 
suggest that anaesthesia was not excessive. The higher 
PRST score in Group B is mainly attributable to the 
increased heart rate in this group and probably reflects a 
drug effect rather than increased autonomic activity.
The Additional Rules
In the preliminary studies carried out before the 
additional rules were introduced, several patients after 
induction had SAPs below the target value prior to the 
start of surgery. These patients were therefore receiving 
minimal concentrations of enflurane at incision and there 
was a risk that they might be aware at this point. As the 
delay between starting the controller and the start of 
surgery is unpredictable we delivered a minimum dose of
0.6% in the main study to prevent this occurrence.
In the preliminary study the simple PI system gave a 
relative overdose of anaesthetic to some patients. In 
anaesthetic practice it is common to give a bolus of 
narcotic to limit the requirement of volatile agent. We 
attempted to imitate this practice by incorporating the 
second rule, which required additional boluses of morphine 
as the enflurane requirement became excessive. The 
resetting of the integral prevented overdose in these 
patients.
Control
As the pharmacological system is complex we chose a simple 
system to give the best understanding of the process with 
the maximum safety. This system has many limitations but 
improvement may be difficult. More complex systems e.g. 
self-tuning systems might have the flexibility to cope 
with the inevitable non linearities which exist when one 
is trying to suppress the SAP response to surgery, but 
might require more data than SAP sampled once a minute.
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CONCLUSION
The controller achieved the immediate aim of controlling
SAP and also produced a pattern of clinical signs
recognisable as general anaesthesia.
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TABLE
Group A Group 3
Mean SD Mean SD prob.
Age (years) 41 .6 9.5 37.6 10.5 ns
Weight (kg) 60.4 11.7 60.7 11.9 ns
TAT (min) 65.7 22.9 74.9 17.3 ns
TST (min) 54.0 23.4 62.7 16.9 ns
ATPR (min) 5.1 1 .9 10.0 3.7 sig.
STPR (min) 9.6 3.4 17.3 5.7 sig.
TSAP (mmHg) 117.2 6.6 114.4 7.2 ns
SAP (mmHg) 117.1 6.1 1 20.8 8.6 ns
m d t s a p 0.1 2.4 6.4 3.1 sig.
RMSD (mmHg) 7.3 2.2 10.6 3.4 sig.
HR (bpm) 67.5 8.1 83.1 16.7 sig.
Insp. Enf(%) 1 .1 0.7 2.2 0.4 sig.
RPP 7909.8 1070.8 10105.4 2384.0 sig.
PRST 0 .46 0 .82
TAT - Total Anaesthetic Time
TST - Total System Running Time
ATPR - Anaesthetic to Patient Response Time
STPR - System Termination to Patient Response Time
TSAP - Target Systolic Arterial Pressure
SAP - Mean Measured Systolic A.rterial Pressure
MDt s a p = Mean Deviation of SAP from the TSAP
RMSD = Root Mean Square Deviation
HR = Mean Heart Rate
Insp. Enf . = Mean Inspired Enflurane Concentration.
RPP = Rate Pressure Product
PRST = The mean PRST Score
